Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.
Irregular HEART RATE caused by abnormal function of the SINOATRIAL NODE. It is characterized by a greater than 10% change between the maximum and the minimum sinus cycle length or 120 milliseconds.
Striated muscle cells found in the heart. They are derived from cardiac myoblasts (MYOBLASTS, CARDIAC).
Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY.
The hollow, muscular organ that maintains the circulation of the blood.
Unexpected rapid natural death due to cardiovascular collapse within one hour of initial symptoms. It is usually caused by the worsening of existing heart diseases. The sudden onset of symptoms, such as CHEST PAIN and CARDIAC ARRHYTHMIAS, particularly VENTRICULAR TACHYCARDIA, can lead to the loss of consciousness and cardiac arrest followed by biological death. (from Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed., 2005)
The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat).
An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.
Surgery performed on the heart.
Regulation of the rate of contraction of the heart muscles by an artificial pacemaker.
An impulse-conducting system composed of modified cardiac muscle, having the power of spontaneous rhythmicity and conduction more highly developed than the rest of the heart.
The lower right and left chambers of the heart. The right ventricle pumps venous BLOOD into the LUNGS and the left ventricle pumps oxygenated blood into the systemic arterial circulation.
The number of times the HEART VENTRICLES contract per unit of time, usually per minute.
The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow.
A type of cardiac arrhythmia with premature contractions of the HEART VENTRICLES. It is characterized by the premature QRS complex on ECG that is of abnormal shape and great duration (generally >129 msec). It is the most common form of all cardiac arrhythmias. Premature ventricular complexes have no clinical significance except in concurrence with heart diseases.
Method in which prolonged electrocardiographic recordings are made on a portable tape recorder (Holter-type system) or solid-state device ("real-time" system), while the patient undergoes normal daily activities. It is useful in the diagnosis and management of intermittent cardiac arrhythmias and transient myocardial ischemia.
Abnormally rapid heartbeat, usually with a HEART RATE above 100 beats per minute for adults. Tachycardia accompanied by disturbance in the cardiac depolarization (cardiac arrhythmia) is called tachyarrhythmia.
Pathological conditions involving the HEART including its structural and functional abnormalities.
A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.
A group of cardiac arrhythmias in which the cardiac contractions are not initiated at the SINOATRIAL NODE. They include both atrial and ventricular premature beats, and are also known as extra or ectopic heartbeats. Their frequency is increased in heart diseases.
Contractile activity of the MYOCARDIUM.
Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES.
Cessation of heart beat or MYOCARDIAL CONTRACTION. If it is treated within a few minutes, heart arrest can be reversed in most cases to normal cardiac rhythm and effective circulation.
Methods to induce and measure electrical activities at specific sites in the heart to diagnose and treat problems with the heart's electrical system.
Elements of limited time intervals, contributing to particular results or situations.
The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065)
A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
Implantable devices which continuously monitor the electrical activity of the heart and automatically detect and terminate ventricular tachycardia (TACHYCARDIA, VENTRICULAR) and VENTRICULAR FIBRILLATION. They consist of an impulse generator, batteries, and electrodes.
NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).
A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
Procedures in which placement of CARDIAC CATHETERS is performed for therapeutic or diagnostic procedures.
Compression of the heart by accumulated fluid (PERICARDIAL EFFUSION) or blood (HEMOPERICARDIUM) in the PERICARDIUM surrounding the heart. The affected cardiac functions and CARDIAC OUTPUT can range from minimal to total hemodynamic collapse.
The chambers of the heart, to which the BLOOD returns from the circulation.
A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
A generic expression for any tachycardia that originates above the BUNDLE OF HIS.
Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic.
Theoretical representations that simulate the behavior or activity of the cardiovascular system, processes, or phenomena; includes the use of mathematical equations, computers and other electronic equipment.
A condition in which HEART VENTRICLES exhibit impaired function.
Removal of tissue with electrical current delivered via electrodes positioned at the distal end of a catheter. Energy sources are commonly direct current (DC-shock) or alternating current at radiofrequencies (usually 750 kHz). The technique is used most often to ablate the AV junction and/or accessory pathways in order to interrupt AV conduction and produce AV block in the treatment of various tachyarrhythmias.
Rapid, irregular atrial contractions caused by a block of electrical impulse conduction in the right atrium and a reentrant wave front traveling up the inter-atrial septum and down the right atrial free wall or vice versa. Unlike ATRIAL FIBRILLATION which is caused by abnormal impulse generation, typical atrial flutter is caused by abnormal impulse conduction. As in atrial fibrillation, patients with atrial flutter cannot effectively pump blood into the lower chambers of the heart (HEART VENTRICLES).
A voltage-gated sodium channel subtype that mediates the sodium ion PERMEABILITY of CARDIOMYOCYTES. Defects in the SCN5A gene, which codes for the alpha subunit of this sodium channel, are associated with a variety of CARDIAC DISEASES that result from loss of sodium channel function.
Abrupt changes in the membrane potential that sweep along the CELL MEMBRANE of excitable cells in response to excitation stimuli.
The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM.
An electrical current applied to the HEART to terminate a disturbance of its rhythm, ARRHYTHMIAS, CARDIAC. (Stedman, 25th ed)
The study of the electrical activity and characteristics of the HEART; MYOCARDIUM; and CARDIOMYOCYTES.
The hemodynamic and electrophysiological action of the left HEART VENTRICLE. Its measurement is an important aspect of the clinical evaluation of patients with heart disease to determine the effects of the disease on cardiac performance.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
Cardiac arrhythmias that are characterized by excessively slow HEART RATE, usually below 50 beats per minute in human adults. They can be classified broadly into SINOATRIAL NODE dysfunction and ATRIOVENTRICULAR BLOCK.
Visualization of the heart structure and cardiac blood flow for diagnostic evaluation or to guide cardiac procedures via techniques including ENDOSCOPY (cardiac endoscopy, sometimes refered to as cardioscopy), RADIONUCLIDE IMAGING; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY; or ULTRASONOGRAPHY.
A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
Damage to the MYOCARDIUM resulting from MYOCARDIAL REPERFUSION (restoration of blood flow to ischemic areas of the HEART.) Reperfusion takes place when there is spontaneous thrombolysis, THROMBOLYTIC THERAPY, collateral flow from other coronary vascular beds, or reversal of vasospasm.
A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein.
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
Developmental abnormalities involving structures of the heart. These defects are present at birth but may be discovered later in life.
A malignant form of polymorphic ventricular tachycardia that is characterized by HEART RATE between 200 and 250 beats per minute, and QRS complexes with changing amplitude and twisting of the points. The term also describes the syndrome of tachycardia with prolonged ventricular repolarization, long QT intervals exceeding 500 milliseconds or BRADYCARDIA. Torsades de pointes may be self-limited or may progress to VENTRICULAR FIBRILLATION.
An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
Precursor cells destined to differentiate into cardiac myocytes (MYOCYTES, CARDIAC).
PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS.
The amount of BLOOD pumped out of the HEART per beat, not to be confused with cardiac output (volume/time). It is calculated as the difference between the end-diastolic volume and the end-systolic volume.
Cyclopentanophenanthrenes with a 5- or 6-membered lactone ring attached at the 17-position and SUGARS attached at the 3-position. Plants they come from have long been used in congestive heart failure. They increase the force of cardiac contraction without significantly affecting other parameters, but are very toxic at larger doses. Their mechanism of action usually involves inhibition of the NA(+)-K(+)-EXCHANGING ATPASE and they are often used in cell biological studies for that purpose.
A state of subnormal or depressed cardiac output at rest or during stress. It is a characteristic of CARDIOVASCULAR DISEASES, including congenital, valvular, rheumatic, hypertensive, coronary, and cardiomyopathic. The serious form of low cardiac output is characterized by marked reduction in STROKE VOLUME, and systemic vasoconstriction resulting in cold, pale, and sometimes cyanotic extremities.
A conical fibro-serous sac surrounding the HEART and the roots of the great vessels (AORTA; VENAE CAVAE; PULMONARY ARTERY). Pericardium consists of two sacs: the outer fibrous pericardium and the inner serous pericardium. The latter consists of an outer parietal layer facing the fibrous pericardium, and an inner visceral layer (epicardium) resting next to the heart, and a pericardial cavity between these two layers.
The geometric and structural changes that the HEART VENTRICLES undergo, usually following MYOCARDIAL INFARCTION. It comprises expansion of the infarct and dilatation of the healthy ventricle segments. While most prevalent in the left ventricle, it can also occur in the right ventricle.
Impaired conduction of cardiac impulse that can occur anywhere along the conduction pathway, such as between the SINOATRIAL NODE and the right atrium (SA block) or between atria and ventricles (AV block). Heart blocks can be classified by the duration, frequency, or completeness of conduction block. Reversibility depends on the degree of structural or functional defects.
The hemodynamic and electrophysiological action of the HEART VENTRICLES.
Myosin type II isoforms found in cardiac muscle.
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
A device designed to stimulate, by electric impulses, contraction of the heart muscles. It may be temporary (external) or permanent (internal or internal-external).
The abrupt cessation of all vital bodily functions, manifested by the permanent loss of total cerebral, respiratory, and cardiovascular functions.
Glycosides from plants of the genus DIGITALIS. Some of these are useful as cardiotonic and anti-arrhythmia agents. Included also are semi-synthetic derivatives of the naturally occurring glycosides. The term has sometimes been used more broadly to include all CARDIAC GLYCOSIDES, but here is restricted to those related to Digitalis.
Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE).
The transference of a heart from one human or animal to another.
The study of the generation and behavior of electrical charges in living organisms particularly the nervous system and the effects of electricity on living organisms.
A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.
An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.
Occurrence of heart arrest in an individual when there is no immediate access to medical personnel or equipment.
A family of voltage-gated potassium channels that are characterized by long N-terminal and C-terminal intracellular tails. They are named from the Drosophila protein whose mutation causes abnormal leg shaking under ether anesthesia. Their activation kinetics are dependent on extracellular MAGNESIUM and PROTON concentration.
The volume of the HEART, usually relating to the volume of BLOOD contained within it at various periods of the cardiac cycle. The amount of blood ejected from a ventricle at each beat is STROKE VOLUME.
Examinations used to diagnose and treat heart conditions.
Ion channels that specifically allow the passage of SODIUM ions. A variety of specific sodium channel subtypes are involved in serving specialized functions such as neuronal signaling, CARDIAC MUSCLE contraction, and KIDNEY function.
A basic element found in nearly all organized tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes.
Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.
One of the three polypeptide chains that make up the TROPONIN complex. It inhibits F-actin-myosin interactions.
The ENTERIC NERVOUS SYSTEM; PARASYMPATHETIC NERVOUS SYSTEM; and SYMPATHETIC NERVOUS SYSTEM taken together. Generally speaking, the autonomic nervous system regulates the internal environment during both peaceful activity and physical or emotional stress. Autonomic activity is controlled and integrated by the CENTRAL NERVOUS SYSTEM, especially the HYPOTHALAMUS and the SOLITARY NUCLEUS, which receive information relayed from VISCERAL AFFERENTS.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
Recording of regional electrophysiological information by analysis of surface potentials to give a complete picture of the effects of the currents from the heart on the body surface. It has been applied to the diagnosis of old inferior myocardial infarction, localization of the bypass pathway in Wolff-Parkinson-White syndrome, recognition of ventricular hypertrophy, estimation of the size of a myocardial infarct, and the effects of different interventions designed to reduce infarct size. The limiting factor at present is the complexity of the recording and analysis, which requires 100 or more electrodes, sophisticated instrumentation, and dedicated personnel. (Braunwald, Heart Disease, 4th ed)
A transient loss of consciousness and postural tone caused by diminished blood flow to the brain (i.e., BRAIN ISCHEMIA). Presyncope refers to the sensation of lightheadedness and loss of strength that precedes a syncopal event or accompanies an incomplete syncope. (From Adams et al., Principles of Neurology, 6th ed, pp367-9)
Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.
In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.
A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company.
A C19 norditerpenoid alkaloid (DITERPENES) from the root of ACONITUM plants. It activates VOLTAGE-GATED SODIUM CHANNELS. It has been used to induce ARRHYTHMIAS in experimental animals and it has antiinflammatory and antineuralgic properties.
Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.
A 43-kDa peptide which is a member of the connexin family of gap junction proteins. Connexin 43 is a product of a gene in the alpha class of connexin genes (the alpha-1 gene). It was first isolated from mammalian heart, but is widespread in the body including the brain.
Transmission of the readings of instruments to a remote location by means of wires, radio waves, or other means. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
The innermost layer of the heart, comprised of endothelial cells.
Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
Tumors in any part of the heart. They include primary cardiac tumors and metastatic tumors to the heart. Their interference with normal cardiac functions can cause a wide variety of symptoms including HEART FAILURE; CARDIAC ARRHYTHMIAS; or EMBOLISM.
A type of cardiac arrhythmia with premature atrial contractions or beats caused by signals originating from ectopic atrial sites. The ectopic signals may or may not conduct to the HEART VENTRICLES. Atrial premature complexes are characterized by premature P waves on ECG which are different in configuration from the P waves generated by the normal pacemaker complex in the SINOATRIAL NODE.
Optical imaging techniques used for recording patterns of electrical activity in tissues by monitoring transmembrane potentials via FLUORESCENCE imaging with voltage-sensitive fluorescent dyes.
The artificial substitution of heart and lung action as indicated for HEART ARREST resulting from electric shock, DROWNING, respiratory arrest, or other causes. The two major components of cardiopulmonary resuscitation are artificial ventilation (RESPIRATION, ARTIFICIAL) and closed-chest CARDIAC MASSAGE.
An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
The heart of the fetus of any viviparous animal. It refers to the heart in the postembryonic period and is differentiated from the embryonic heart (HEART/embryology) only on the basis of time.
The restoration of the sequential order of contraction and relaxation of the HEART ATRIA and HEART VENTRICLES by atrio-biventricular pacing.
One of the three polypeptide chains that make up the TROPONIN complex. It is a cardiac-specific protein that binds to TROPOMYOSIN. It is released from damaged or injured heart muscle cells (MYOCYTES, CARDIAC). Defects in the gene encoding troponin T result in FAMILIAL HYPERTROPHIC CARDIOMYOPATHY.
A tetrameric calcium release channel in the SARCOPLASMIC RETICULUM membrane of SMOOTH MUSCLE CELLS, acting oppositely to SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES. It is important in skeletal and cardiac excitation-contraction coupling and studied by using RYANODINE. Abnormalities are implicated in CARDIAC ARRHYTHMIAS and MUSCULAR DISEASES.
Modified cardiac muscle fibers composing the terminal portion of the heart conduction system.
One of the ANTI-ARRHYTHMIA AGENTS, it blocks VOLTAGE-GATED SODIUM CHANNELS and slows conduction within the His-Purkinje system and MYOCARDIUM.
A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).
The 10th cranial nerve. The vagus is a mixed nerve which contains somatic afferents (from skin in back of the ear and the external auditory meatus), visceral afferents (from the pharynx, larynx, thorax, and abdomen), parasympathetic efferents (to the thorax and abdomen), and efferents to striated muscle (of the larynx and pharynx).
Potassium channel whose permeability to ions is extremely sensitive to the transmembrane potential difference. The opening of these channels is induced by the membrane depolarization of the ACTION POTENTIAL.
The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988)
A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain.
Institutions specializing in the care of patients with heart disorders.
The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS.
General or unspecified injuries to the heart.
A combination of congenital heart defects consisting of four key features including VENTRICULAR SEPTAL DEFECTS; PULMONARY STENOSIS; RIGHT VENTRICULAR HYPERTROPHY; and a dextro-positioned AORTA. In this condition, blood from both ventricles (oxygen-rich and oxygen-poor) is pumped into the body often causing CYANOSIS.
An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
Impaired impulse conduction from HEART ATRIA to HEART VENTRICLES. AV block can mean delayed or completely blocked impulse conduction.
A voltage-gated potassium channel that is expressed primarily in the HEART.
The veins and arteries of the HEART.
The species Oryctolagus cuniculus, in the family Leporidae, order LAGOMORPHA. Rabbits are born in burrows, furless, and with eyes and ears closed. In contrast with HARES, rabbits have 22 chromosome pairs.
Controlled physical activity which is performed in order to allow assessment of physiological functions, particularly cardiovascular and pulmonary, but also aerobic capacity. Maximal (most intense) exercise is usually required but submaximal exercise is also used.
Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
An optical isomer of quinine, extracted from the bark of the CHINCHONA tree and similar plant species. This alkaloid dampens the excitability of cardiac and skeletal muscles by blocking sodium and potassium currents across cellular membranes. It prolongs cellular ACTION POTENTIALS, and decreases automaticity. Quinidine also blocks muscarinic and alpha-adrenergic neurotransmission.
Cell membrane glycoproteins that are selectively permeable to potassium ions. At least eight major groups of K channels exist and they are made up of dozens of different subunits.
Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.
A small nodular mass of specialized muscle fibers located in the interatrial septum near the opening of the coronary sinus. It gives rise to the atrioventricular bundle of the conduction system of the heart.
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.
A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
The circulation of blood through the CORONARY VESSELS of the HEART.
Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN.
Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.
The protein constituents of muscle, the major ones being ACTINS and MYOSINS. More than a dozen accessory proteins exist including TROPONIN; TROPOMYOSIN; and DYSTROPHIN.
The small mass of modified cardiac muscle fibers located at the junction of the superior vena cava (VENA CAVA, SUPERIOR) and right atrium. Contraction impulses probably start in this node, spread over the atrium (HEART ATRIUM) and are then transmitted by the atrioventricular bundle (BUNDLE OF HIS) to the ventricle (HEART VENTRICLE).
Abnormally rapid heartbeats originating from one or more automatic foci (nonsinus pacemakers) in the HEART ATRIUM but away from the SINOATRIAL NODE. Unlike the reentry mechanism, automatic tachycardia speeds up and slows down gradually. The episode is characterized by a HEART RATE between 135 to less than 200 beats per minute and lasting 30 seconds or longer.
A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs.
A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research.
An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
A congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the RIGHT VENTRICLE wall and loss of myocardial cells. Primary injuries usually are at the free wall of right ventricular and right atria resulting in ventricular and supraventricular arrhythmias.
Signal transduction mechanisms whereby calcium mobilization (from outside the cell or from intracellular storage pools) to the cytoplasm is triggered by external stimuli. Calcium signals are often seen to propagate as waves, oscillations, spikes, sparks, or puffs. The calcium acts as an intracellular messenger by activating calcium-responsive proteins.
Simple rapid heartbeats caused by rapid discharge of impulses from the SINOATRIAL NODE, usually between 100 and 180 beats/min in adults. It is characterized by a gradual onset and termination. Sinus tachycardia is common in infants, young children, and adults during strenuous physical activities.
Computer-assisted processing of electric, ultrasonic, or electronic signals to interpret function and activity.
Treatment process involving the injection of fluid into an organ or tissue.
Long-lasting voltage-gated CALCIUM CHANNELS found in both excitable and nonexcitable tissue. They are responsible for normal myocardial and vascular smooth muscle contractility. Five subunits (alpha-1, alpha-2, beta, gamma, and delta) make up the L-type channel. The alpha-1 subunit is the binding site for calcium-based antagonists. Dihydropyridine-based calcium antagonists are used as markers for these binding sites.
A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
An electrogenic ion exchange protein that maintains a steady level of calcium by removing an amount of calcium equal to that which enters the cells. It is widely distributed in most excitable membranes, including the brain and heart.
The hemodynamic and electrophysiological action of the HEART ATRIA.
A state characterized by loss of feeling or sensation. This depression of nerve function is usually the result of pharmacologic action and is induced to allow performance of surgery or other painful procedures.
Drugs that selectively bind to and activate beta-adrenergic receptors.
The relationship between the dose of an administered drug and the response of the organism to the drug.
Mature contractile cells, commonly known as myocytes, that form one of three kinds of muscle. The three types of muscle cells are skeletal (MUSCLE FIBERS, SKELETAL), cardiac (MYOCYTES, CARDIAC), and smooth (MYOCYTES, SMOOTH MUSCLE). They are derived from embryonic (precursor) muscle cells called MYOBLASTS.
An electrophysiologic technique for studying cells, cell membranes, and occasionally isolated organelles. All patch-clamp methods rely on a very high-resistance seal between a micropipette and a membrane; the seal is usually attained by gentle suction. The four most common variants include on-cell patch, inside-out patch, outside-out patch, and whole-cell clamp. Patch-clamp methods are commonly used to voltage clamp, that is control the voltage across the membrane and measure current flow, but current-clamp methods, in which the current is controlled and the voltage is measured, are also used.
A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
The period of time following the triggering of an ACTION POTENTIAL when the CELL MEMBRANE has changed to an unexcitable state and is gradually restored to the resting (excitable) state. During the absolute refractory period no other stimulus can trigger a response. This is followed by the relative refractory period during which the cell gradually becomes more excitable and the stronger impulse that is required to illicit a response gradually lessens to that required during the resting state.
The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine.
The return of a sign, symptom, or disease after a remission.
Conical muscular projections from the walls of the cardiac ventricles, attached to the cusps of the atrioventricular valves by the chordae tendineae.
Recording the locations and measurements of electrical activity in the EPICARDIUM by placing electrodes on the surface of the heart to analyze the patterns of activation and to locate arrhythmogenic sites.
The pressure within a CARDIAC VENTRICLE. Ventricular pressure waveforms can be measured in the beating heart by catheterization or estimated using imaging techniques (e.g., DOPPLER ECHOCARDIOGRAPHY). The information is useful in evaluating the function of the MYOCARDIUM; CARDIAC VALVES; and PERICARDIUM, particularly with simultaneous measurement of other (e.g., aortic or atrial) pressures.
A form of ventricular pre-excitation characterized by a short PR interval and a long QRS interval with a delta wave. In this syndrome, atrial impulses are abnormally conducted to the HEART VENTRICLES via an ACCESSORY CONDUCTING PATHWAY that is located between the wall of the right or left atria and the ventricles, also known as a BUNDLE OF KENT. The inherited form can be caused by mutation of PRKAG2 gene encoding a gamma-2 regulatory subunit of AMP-activated protein kinase.
The mitochondria of the myocardium.
The excitable plasma membrane of a muscle cell. (Glick, Glossary of Biochemistry and Molecular Biology, 1990)
A type of imaging technique used primarily in the field of cardiology. By coordinating the fast gradient-echo MRI sequence with retrospective ECG-gating, numerous short time frames evenly spaced in the cardiac cycle are produced. These images are laced together in a cinematic display so that wall motion of the ventricles, valve motion, and blood flow patterns in the heart and great vessels can be visualized.
The veins that return the oxygenated blood from the lungs to the left atrium of the heart.
Acidic protein found in SARCOPLASMIC RETICULUM that binds calcium to the extent of 700-900 nmoles/mg. It plays the role of sequestering calcium transported to the interior of the intracellular vesicle.
A paravertebral sympathetic ganglion formed by the fusion of the inferior cervical and first thoracic ganglia.
A form of heart block in which the electrical stimulation of HEART VENTRICLES is interrupted at either one of the branches of BUNDLE OF HIS thus preventing the simultaneous depolarization of the two ventricles.
Calcium-transporting ATPases that catalyze the active transport of CALCIUM into the SARCOPLASMIC RETICULUM vesicles from the CYTOPLASM. They are primarily found in MUSCLE CELLS and play a role in the relaxation of MUSCLES.
A genus of toxic herbaceous Eurasian plants of the Plantaginaceae which yield cardiotonic DIGITALIS GLYCOSIDES. The most useful species are Digitalis lanata and D. purpurea.
The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases, new or old, in the population at a given time.
Surgical therapy of ischemic coronary artery disease achieved by grafting a section of saphenous vein, internal mammary artery, or other substitute between the aorta and the obstructed coronary artery distal to the obstructive lesion.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
Post-systolic relaxation of the HEART, especially the HEART VENTRICLES.
Compounds based on N-phenylacetamide, that are similar in structure to 2-PHENYLACETAMIDES. They are precursors of many other compounds. They were formerly used as ANALGESICS and ANTIPYRETICS, but often caused lethal METHEMOGLOBINEMIA.
An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
The repeating contractile units of the MYOFIBRIL, delimited by Z bands along its length.
Refers to animals in the period of time just after birth.
A benign tumor derived from striated muscle. It is extremely rare, generally occurring in the tongue, neck muscles, larynx, uvula, nasal cavity, axilla, vulva, and heart. These tumors are treated by simple excision. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1354)
Flaps of tissue that prevent regurgitation of BLOOD from the HEART VENTRICLES to the HEART ATRIA or from the PULMONARY ARTERIES or AORTA to the ventricles.
A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins.
Generally, restoration of blood supply to heart tissue which is ischemic due to decrease in normal blood supply. The decrease may result from any source including atherosclerotic obstruction, narrowing of the artery, or surgical clamping. Reperfusion can be induced to treat ischemia. Methods include chemical dissolution of an occluding thrombus, administration of vasodilator drugs, angioplasty, catheterization, and artery bypass graft surgery. However, it is thought that reperfusion can itself further damage the ischemic tissue, causing MYOCARDIAL REPERFUSION INJURY.
A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS.
Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc.
Measurement of intracardiac blood flow using an M-mode and/or two-dimensional (2-D) echocardiogram while simultaneously recording the spectrum of the audible Doppler signal (e.g., velocity, direction, amplitude, intensity, timing) reflected from the moving column of red blood cells.
One of the minor protein components of skeletal muscle. Its function is to serve as the calcium-binding component in the troponin-tropomyosin B-actin-myosin complex by conferring calcium sensitivity to the cross-linked actin and myosin filaments.
Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes.
A general class of ortho-dihydroxyphenylalkylamines derived from tyrosine.
A condition characterized by the thickening of the ventricular ENDOCARDIUM and subendocardium (MYOCARDIUM), seen mostly in children and young adults in the TROPICAL CLIMATE. The fibrous tissue extends from the apex toward and often involves the HEART VALVES causing restrictive blood flow into the respective ventricles (CARDIOMYOPATHY, RESTRICTIVE).
A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable.
The electrical properties, characteristics of living organisms, and the processes of organisms or their parts that are involved in generating and responding to electrical charges.
A process fundamental to muscle physiology whereby an electrical stimulus or action potential triggers a myocyte to depolarize and contract. This mechanical muscle contraction response is regulated by entry of calcium ions into the cell.
Non-human animals, selected because of specific characteristics, for use in experimental research, teaching, or testing.
An antiarrhythmia agent used primarily for ventricular rhythm disturbances.
The voltage differences across a membrane. For cellular membranes they are computed by subtracting the voltage measured outside the membrane from the voltage measured inside the membrane. They result from differences of inside versus outside concentration of potassium, sodium, chloride, and other ions across cells' or ORGANELLES membranes. For excitable cells, the resting membrane potentials range between -30 and -100 millivolts. Physical, chemical, or electrical stimuli can make a membrane potential more negative (hyperpolarization), or less negative (depolarization).
One of two major pharmacologically defined classes of adrenergic receptors. The beta adrenergic receptors play an important role in regulating CARDIAC MUSCLE contraction, SMOOTH MUSCLE relaxation, and GLYCOGENOLYSIS.

Effect of electrotonic potentials on pacemaker activity of canine Purkinje fibers in relation to parasystole. (1/4675)

Isolated false tendons excised form dog hearts were mounted in a three-chamber tissue bath. Isotonic sucrose solution was perfused in the central chamber to provide a region of depressed conductivity between the fiber segments in chambers 1 and 3, which were perfused with Tyrode's solution. The electrotonic influence of spontaneous or driven responses evoked in chamber 3 during the first half of the spontaneous cycle of a chamber 1 peacemaker delayed the next spontaneous discharge. This effect changed to acceleration when the chamber 3 segment fired during the second half of the spontaneous cycle. We found that subthreshold depolarizing current pulses 50-300 msec applied across the sucrose gap caused similar degrees of delay or acceleration. Furthermore, hyperpolarizing currents caused the reverse pattern. The results indicate that the discharge pattern of a parasystolic focus may be altered by the electrotonic influence of activity in the surrounding tissue. The significance of these findings is considered in relation to the mechanism of production of parasystolic rhythms.  (+info)

Evaluation of the force-frequency relationship as a descriptor of the inotropic state of canine left ventricular myocardium. (2/4675)

The short-term force-frequency characteristics of canine left ventricular myocardium were examined in both isolated and intact preparations by briefly pertubing the frequency of contraction with early extrasystoles. The maximum rate of rise of isometric tension (Fmas) of the isolated trabeculae carneae was potentiated by the introduction of extrasystoles. The ratio of Fmas of potentiated to control beats (force-frequency ratio) was not altered significantly by a change in muscle length. However, exposure of the trabeculae to isoproterenol (10(-7)M) significantly changed the force-frequency ratio obtained in response to a constant frequency perturbation. Similar experiments were performed on chronically instrumented conscious dogs. Left ventricular minor axis diameter was measured with implanted pulse-transit ultrasonic dimension transducers, and intracavitary pressure was measured with a high fidelity micromanometer. Atrial pacing was performed so that the end-diastolic diameters of the beats preceding and following the extrasystole could be made identical. Large increases in the maximum rate of rise of pressure (Pmas) were seen in the contraction after the extrasystole. The ratio of Pmax of the potentiated beat to that of the control beat was not changed by a 9% increase in the end-diastolic diameter, produced by saline infusion. Conversely, isoproterenol significantly altered this relationship in the same manner as in the isolated muscle. Thus, either in vitro or in situ, left ventricular myocardium exhibits large functional changes in response to brief perturbations in rate. The isoproterenol and length data indicate that the force-frequency ratio reflects frequency-dependent changes in the inotropic state, independent of changes in length.  (+info)

Arterial blood gas tensions during upper gastrointestinal endoscopy. (3/4675)

Arterial blood gas tensions were measured before and during upper gastrointestinal endoscopy, with (group I) and without (group 2) sedation with intravenous diazepam. There was a highly significant fall in the PaO2, which occurred in both groups and was therefore not attributable to diazepam. Measurement of FEV, and FVC before endoscopy had no predictive value for those patients whose PaO2 fell the most.  (+info)

Bradykinin promotes ischemic norepinephrine release in guinea pig and human hearts. (4/4675)

We previously reported that bradykinin (BK; 1-1000 nM) facilitates norepinephrine (NE) release from cardiac sympathetic nerves. Because BK production increases in myocardial ischemia, endogenous BK could foster NE release and associated arrhythmias. We tested this hypothesis in guinea pig and human myocardial ischemia models. BK administration (100 nM) markedly enhanced exocytotic and carrier-mediated NE overflow from guinea pig hearts subjected to 10- and 20-min ischemia/reperfusion, respectively. Ventricular fibrillation invariably occurred after 20-min global ischemia; BK prolonged its duration 3-fold. The BK B2 receptor antagonist HOE140 (30 nM) blocked the effects of BK, whereas the B1 receptor antagonist des-Arg9-Leu8-BK (1 microM; i.e., 2.5 x pA2) did not. When serine proteinase inhibitors (500 KIU/ml aprotinin and 100 microg/ml soybean trypsin inhibitor) were used to prevent the formation of endogenous BK, NE overflow and reperfusion arrhythmias were diminished. In contrast, when kininase I and II inhibitors (DL-2-mercaptomethyl-3-guanidinoethylthiopropanoic acid and enalaprilat, each 1 microM) were used to prevent the degradation of endogenous BK, NE overflow and reperfusion arrhythmias were enhanced. B2 receptor blockade abolished these effects but was ineffective if kininases were not inhibited. B2 receptor stimulation, by either exogenous or endogenous BK, also markedly enhanced carrier-mediated NE release in the human myocardial ischemia model; conversely, inhibition of BK biosynthesis diminished ischemic NE release. Because atherosclerotic heart disease impairs endothelial BK production, in myocardial ischemia BK could accumulate at sympathetic nerve endings, thus augmenting exocytotic and carrier-mediated NE release and favoring coronary vasoconstriction and arrhythmias.  (+info)

Heart hypertrophy induced by levothyroxine aggravates ischemic lesions and reperfusion arrhythmias in rats. (5/4675)

AIM: To develop a cardiac hypertrophic model in rats. METHODS: Rats were i.p. levothyroxine 0.5 mg.kg-1.d-1 x 10 d. The action potentials of right papillary muscles were recorded by standard glass-microelectrode technique. The left coronary artery was ligated followed by reperfusion and the apparent infarcted zone (AIZ) was determined by tetracycline fluoresence, and the superoxide dismutase (SOD) activity and malondialdehyde (MDA) product in myocardium were also measured. RESULTS: In the rats treated by levothyroxine, the heart was hypertrophic and the action potential duration (APD) and effective refractory period (ERP) were prolonged, the APD20, APD50, APD90, and ERP were prolonged by 80%, 79%, 74%, and 68%, respectively. No changes in resting potential (RP), action potential amplitude (APA), and Vmax were produced. The incidence of heart arrest (8/8) and the risk of death (67 +/- 0) induced by ischemia-reperfusion in rats with hypertrophic heart was higher than those in normal rats (4/10 and 44 +/- 19, respectively). The AIZ was expanded markedly in hypertrophic heart, and attenuated by lidocaine and propranolol. CONCLUSION: Levothyroxine-induced heart hypertrophy is a suitable model for severe ischemia and arrhythmias in rats.  (+info)

Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and revascularization. (6/4675)

AIMS: To assess the anti-ischaemic and anti-arrhythmic effects and overall safety of nicorandil, an ATP sensitive potassium (K+) channel opener, with 'cardioprotective' effects, in patients with unstable angina. METHODS: In a multicentre, randomized, double-blind, parallel-group, placebo-controlled study, oral nicorandil 20 mg twice daily or a matching placebo was administered for a minimum of 48 h to patients admitted with unstable angina. Treatment was standardized to include, where tolerated, oral aspirin, a beta-blocker and diltiazem. Continuous Holter ECG monitoring was performed for 48 h to assess the frequency and duration of transient myocardial ischaemia and any tachyarrhythmia, as the predefined end-points of the study. A pain chart recorded the incidence and severity of chest pain throughout the study period. Patients with myocardial infarction identified retrospectively from troponin-T analysis were excluded. RESULTS: Two hundred and forty-five patients were recruited into the study. Forty-three patients were excluded with an index diagnosis of myocardial infarction, two were not randomized and 12 had unsatisfactory tape data. In the remaining 188 patients, six out of 89 patients (6.7%) on nicorandil experienced an arrhythmia, compared with 17 out of 99 patients (17.2%) on placebo (P=0.04). Three nicorandil patients experienced three runs of non-sustained ventricular tachycardia compared to 31 runs in 10 patients on placebo (P=0.087 patients; P<0.0001 runs). Three nicorandil patients had four runs of supraventricular tachycardia, compared to 15 runs in nine patients on placebo (P=0.14 patients; P=0.017 runs). Eleven (12.4%) patients on nicorandil had 37 episodes of transient myocardial ischaemia (mostly silent) compared with 74 episodes in 21 (21.2%) patients on placebo (P=0.12 patients; P=0.0028 episodes). In the overall safety analysis, which included all patients who received at least one dose of study medication, there were no significant differences in the rates of myocardial infarction or death between the nicorandil or placebo-treated groups. CONCLUSIONS: Nicorandil, added to aggressive anti-anginal treatment for unstable angina, reduces transient myocardial ischaemia, non-sustained ventricular, and supraventricular arrhythmia compared to placebo. The anti-arrhythmic activity with nicorandil is probably a secondary effect resulting from its anti-ischaemic action and we suggest that this may be related to its effect on the ATP sensitive potassium channel causing pharmacological preconditioning.  (+info)

Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group. (7/4675)

OBJECTIVE: To compare the efficacy and safety of a single dose of ibutilide, a new class III antiarrhythmic drug, with that of DL-sotalol in terminating chronic atrial fibrillation or flutter in haemodynamically stable patients. DESIGN: Double blind, randomised study. SETTING: 43 European hospitals. PATIENTS: 308 patients (mean age 60 years, 70% men, 48% with heart disease) with sustained atrial fibrillation (n = 251) or atrial flutter (n = 57) (duration three hours to 45 days) were randomised to three groups to receive a 10 minute infusion of 1 mg ibutilide (n = 99), 2 mg ibutilide (n = 106), or 1.5 mg/kg DL-sotalol (n = 103). Infusion was discontinued at termination of the arrhythmia. MAIN OUTCOME MEASURE: Successful conversion of atrial fibrillation or flutter, defined as termination of arrhythmia within one hour of treatment. RESULTS: Both drugs were more effective against atrial flutter than against atrial fibrillation. Ibutilide was superior to DL-sotalol for treating atrial flutter (70% and 56% v 19%), while the high dose of ibutilide was more effective for treating atrial fibrillation than DL-sotalol (44% v 11%) and the lower dose of ibutilide (44% v 20%, p < 0.01). The mean (SD) time to arrhythmia termination was 13 (7) minutes with 2 mg ibutilide, 19 (15) minutes with 1 mg ibutilide, and 25 (17) minutes with DL-sotalol. In all patients, the duration of arrhythmia before treatment was a predictor of arrhythmia termination, although this was less obvious in the group that received 2 mg ibutilide. This dose converted almost 48% of atrial fibrillation that was present for more than 30 days. Concomitant use of digitalis or nifedipine and prolongation of the QTc interval were not predictive of arrhythmia termination. Bradycardia (6.5%) and hypotension (3.7%) were more common side effects with DL-sotalol. Of 211 patients given ibutilide, two (0.9%) who received the higher dose developed polymorphic ventricular tachycardia, one of whom required direct current cardioversion. CONCLUSION: Ibutilide (given in 1 or 2 mg doses over 10 minutes) is highly effective for rapidly terminating persistent atrial fibrillation or atrial flutter. This new class III drug, under monitored conditions, is a potential alternative to currently available cardioversion options.  (+info)

Overexpression of a human potassium channel suppresses cardiac hyperexcitability in rabbit ventricular myocytes. (8/4675)

The high incidence of sudden death in heart failure may reflect abnormalities of repolarization and heightened susceptibility to arrhythmogenic early afterdepolarizations (EADs). We hypothesized that overexpression of the human K+ channel HERG (human ether-a-go-go-related gene) could enhance repolarization and suppress EADs. Adult rabbit ventricular myocytes were maintained in primary culture, which suffices to prolong action potentials and predisposes to EADs. To achieve efficient gene transfer, we created AdHERG, a recombinant adenovirus containing the HERG gene driven by a Rous sarcoma virus (RSV) promoter. The virally expressed HERG current exhibited pharmacologic and kinetic properties like those of native IKr. Transient outward currents in AdHERG-infected myocytes were similar in magnitude to those in control cells, while stimulated action potentials (0.2 Hz, 37 degrees C) were abbreviated compared with controls. The occurrence of EADs during a train of action potentials was reduced by more than fourfold, and the relative refractory period was increased in AdHERG-infected myocytes compared with control cells. Gene transfer of delayed rectifier potassium channels represents a novel and effective strategy to suppress arrhythmias caused by unstable repolarization.  (+info)

There are many different types of cardiac arrhythmias, including:

1. Tachycardias: These are fast heart rhythms that can be too fast for the body's needs. Examples include atrial fibrillation and ventricular tachycardia.
2. Bradycardias: These are slow heart rhythms that can cause symptoms like fatigue, dizziness, and fainting. Examples include sinus bradycardia and heart block.
3. Premature beats: These are extra beats that occur before the next regular beat should come in. They can be benign but can also indicate an underlying arrhythmia.
4. Supraventricular arrhythmias: These are arrhythmias that originate above the ventricles, such as atrial fibrillation and paroxysmal atrial tachycardia.
5. Ventricular arrhythmias: These are arrhythmias that originate in the ventricles, such as ventricular tachycardia and ventricular fibrillation.

Cardiac arrhythmias can be diagnosed through a variety of tests including electrocardiograms (ECGs), stress tests, and holter monitors. Treatment options for cardiac arrhythmias vary depending on the type and severity of the condition and may include medications, cardioversion, catheter ablation, or implantable devices like pacemakers or defibrillators.

When the sinus node is not functioning properly, it can lead to an arrhythmia, or irregular heartbeat. This can cause a variety of symptoms, including palpitations, shortness of breath, fatigue, and dizziness. In some cases, sinus arrhythmia can be caused by underlying medical conditions such as coronary artery disease, high blood pressure, or cardiomyopathy.

There are several types of sinus arrhythmia, including:

* Sinus tachycardia: a rapid heart rate due to an overactive sinus node. This can be caused by stress, anxiety, or physical exertion.
* Sinus bradycardia: a slow heart rate due to a decreased activity in the sinus node. This can be caused by certain medications, age, or underlying medical conditions.
* Sinus arrest: a complete cessation of sinus node activity, leading to a stop in the heartbeat. This is a rare condition and can be caused by a variety of factors, including electrolyte imbalances or certain medications.

Treatment for sinus arrhythmia depends on the underlying cause and the severity of symptoms. In some cases, no treatment may be necessary, while in other cases, medication or procedures such as cardioversion or catheter ablation may be required. It is important to seek medical attention if symptoms persist or worsen over time, as untreated sinus arrhythmia can lead to more serious complications such as stroke or heart failure.

Some examples of the use of 'Death, Sudden, Cardiac' in medical contexts include:

1. Sudden cardiac death (SCD) is a major public health concern, affecting thousands of people each year in the United States alone. It is often caused by inherited heart conditions, such as hypertrophic cardiomyopathy or long QT syndrome.
2. The risk of sudden cardiac death is higher for individuals with a family history of heart disease or other pre-existing cardiovascular conditions.
3. Sudden cardiac death can be prevented by prompt recognition and treatment of underlying heart conditions, as well as by avoiding certain risk factors such as smoking, physical inactivity, and an unhealthy diet.
4. Cardiopulmonary resuscitation (CPR) and automated external defibrillators (AEDs) can be effective in restoring a normal heart rhythm during sudden cardiac death, especially when used promptly after the onset of symptoms.

Tachycardia, ventricular can be classified into several types based on its duration and the presence of other symptoms. These include:

1. Paroxysmal ventricular tachycardia (PVT): This is a rapid heart rate that occurs in episodes lasting less than 30 seconds and may be accompanied by palpitations, shortness of breath, or dizziness.
2. Sustained ventricular tachycardia: This is a rapid heart rate that persists for more than 30 seconds and may require medical intervention to return the heart to normal rhythm.
3. Ventricular fibrillation (VF): This is a life-threatening condition in which the ventricles are unable to pump blood effectively due to rapid, disorganized electrical activity.

Symptoms of tachycardia, ventricular may include:

* Palpitations or rapid heartbeat
* Shortness of breath
* Dizziness or lightheadedness
* Chest pain or discomfort
* Fatigue or weakness

Diagnosis of tachycardia, ventricular is typically made based on a physical examination, medical history, and results of diagnostic tests such as electrocardiogram (ECG), echocardiogram, or stress test. Treatment options may include medications to regulate heart rhythm, cardioversion to restore normal heart rhythm, and in some cases, implantation of a cardioverter-defibrillator (ICD) to prevent sudden death.

In summary, tachycardia, ventricular is a rapid heart rate that originates in the ventricles and can be caused by a variety of conditions. It is important to seek medical attention if symptoms persist or worsen over time. With proper diagnosis and treatment, it is possible to manage the condition and improve quality of life.

In Vfib, the electrical activity of the heart becomes disorganized, leading to a fibrillatory pattern of contraction. This means that the ventricles are contracting in a rapid, unsynchronized manner, rather than the coordinated, synchronized contractions that occur in normal heart function.

Vfib can be caused by a variety of factors, including coronary artery disease, heart attack, cardiomyopathy, and electrolyte imbalances. It can also be triggered by certain medications, such as digoxin, or by electrical shocks to the heart.

Symptoms of Vfib include palpitations, shortness of breath, chest pain, and loss of consciousness. If not treated promptly, Vfib can lead to cardiac arrest and death.

Treatment of Vfib typically involves electrical cardioversion, which involves delivering an electric shock to the heart to restore a normal heart rhythm. In some cases, medications may also be used to help regulate the heart rhythm. In more severe cases, surgery or other interventions may be necessary to address any underlying causes of Vfib.

Overall, ventricular fibrillation is a serious medical condition that requires prompt treatment to prevent complications and ensure effective cardiac function.

VPCs can cause symptoms such as palpitations, shortness of breath, and dizziness. In some cases, they can lead to more serious arrhythmias and even sudden cardiac death. To diagnose VPCs, a healthcare provider may perform an electrocardiogram (ECG) or other tests to measure the heart's electrical activity. Treatment options for VPCs include medications to regulate the heart rhythm, implantable devices such as pacemakers or defibrillators, and in some cases, surgery to repair or replace a damaged heart valve.

Prevention of VPCs includes maintaining a healthy lifestyle, managing high blood pressure and other risk factors, and avoiding certain medications that can trigger these abnormal heartbeats. Early detection and treatment of underlying heart conditions can also help prevent VPCs from occurring. In summary, Ventricular Premature Complexes are abnormal heartbeats that can disrupt the normal heart rhythm and may be a sign of an underlying heart condition. Diagnosis and treatment options are available to manage this condition and prevent complications.

There are several types of tachycardia, including:

1. Sinus tachycardia: This is the most common type and is caused by an increase in the rate of the normal sinus node. It is often seen in response to physical activity or stress.
2. Atrial fibrillation: This is a type of arrhythmia where the heart's upper chambers (atria) contract irregularly and rapidly, leading to a rapid heart rate.
3. Ventricular tachycardia: This is a type of arrhythmia where the heart's lower chambers (ventricles) contract rapidly, often with a rate above 100 bpm.
4. Premature ventricular contractions (PVCs): These are early or extra beats that originate in the ventricles, causing a rapid heart rate.

Tachycardia can cause a range of symptoms, including palpitations, shortness of breath, chest pain, and dizziness. In severe cases, it can lead to cardiac arrhythmias, heart failure, and even death.

Diagnosis of tachycardia typically involves a physical examination, electrocardiogram (ECG), and other tests such as stress tests or echocardiography. Treatment options vary depending on the underlying cause, but may include medications to regulate the heart rate, cardioversion to restore a normal heart rhythm, or in severe cases, implantation of a pacemaker or defibrillator.

There are many different types of heart diseases, including:

1. Coronary artery disease: The buildup of plaque in the coronary arteries, which supply blood to the heart muscle, leading to chest pain or a heart attack.
2. Heart failure: When the heart is unable to pump enough blood to meet the body's needs, leading to fatigue, shortness of breath, and swelling in the legs.
3. Arrhythmias: Abnormal heart rhythms, such as atrial fibrillation or ventricular tachycardia, which can cause palpitations, dizziness, and shortness of breath.
4. Heart valve disease: Problems with the heart valves, which can lead to blood leaking back into the chambers or not being pumped effectively.
5. Cardiomyopathy: Disease of the heart muscle, which can lead to weakened heart function and heart failure.
6. Heart murmurs: Abnormal sounds heard during a heartbeat, which can be caused by defects in the heart valves or abnormal blood flow.
7. Congenital heart disease: Heart defects present at birth, such as holes in the heart or abnormal blood vessels.
8. Myocardial infarction (heart attack): Damage to the heart muscle due to a lack of oxygen, often caused by a blockage in a coronary artery.
9. Cardiac tamponade: Fluid accumulation around the heart, which can cause compression of the heart and lead to cardiac arrest.
10. Endocarditis: Infection of the inner lining of the heart, which can cause fever, fatigue, and heart valve damage.

Heart diseases can be diagnosed through various tests such as electrocardiogram (ECG), echocardiogram, stress test, and blood tests. Treatment options depend on the specific condition and may include lifestyle changes, medication, surgery, or a combination of these.

The QT interval is a measure of the time it takes for the ventricles to recover from each heartbeat and prepare for the next one. In people with LQTS, this recovery time is prolonged, which can disrupt the normal rhythm of the heart and increase the risk of arrhythmias.

LQTS is caused by mutations in genes that encode proteins involved in the cardiac ion channels, which regulate the flow of ions into and out of the heart muscle cells. These mutations can affect the normal functioning of the ion channels, leading to abnormalities in the electrical activity of the heart.

Symptoms of LQTS can include palpitations, fainting spells, and seizures. In some cases, LQTS can be diagnosed based on a family history of the condition or after a sudden death in an otherwise healthy individual. Other tests, such as an electrocardiogram (ECG), echocardiogram, and stress test, may also be used to confirm the diagnosis.

Treatment for LQTS typically involves medications that regulate the heart's rhythm and reduce the risk of arrhythmias. In some cases, an implantable cardioverter-defibrillator (ICD) may be recommended to monitor the heart's activity and deliver an electric shock if a potentially life-threatening arrhythmia is detected. Lifestyle modifications, such as avoiding stimuli that trigger symptoms and taking precautions during exercise and stress, may also be recommended.

In summary, Long QT syndrome is a rare inherited disorder that affects the electrical activity of the heart, leading to an abnormal prolongation of the QT interval and an increased risk of irregular and potentially life-threatening heart rhythms. It is important for individuals with LQTS to be closely monitored by a healthcare provider and to take precautions to manage their condition and reduce the risk of complications.

There are several types of premature complexes, including:

1. Premature atrial complex (PAC): An extra heartbeat that originates in the atria, usually due to a rapid or irregular heart rate.
2. Premature ventricular complex (PVC): An extra heartbeat that originates in the ventricles, which can be more serious than PACs and may require further evaluation.
3. Premature nodal rhythm: A condition where the AV node (the electrical pathway between the atria and ventricles) fires prematurely, causing a rapid heart rate.

PCCs can be diagnosed using electrocardiography (ECG), which records the electrical activity of the heart. Treatment options for PCCs depend on the underlying cause and may include medications to regulate the heart rhythm, cardioversion (a procedure that restores a normal heart rhythm using electrical shock), or catheter ablation (a minimally invasive procedure that destroys the abnormal electrical pathway).

There are several risk factors for developing AF, including:

1. Age: The risk of developing AF increases with age, with the majority of cases occurring in people over the age of 65.
2. Hypertension (high blood pressure): High blood pressure can damage the heart and increase the risk of developing AF.
3. Heart disease: People with heart disease, such as coronary artery disease or heart failure, are at higher risk of developing AF.
4. Diabetes mellitus: Diabetes can increase the risk of developing AF.
5. Sleep apnea: Sleep apnea can increase the risk of developing AF.
6. Certain medications: Certain medications, such as thyroid medications and asthma medications, can increase the risk of developing AF.
7. Alcohol consumption: Excessive alcohol consumption has been linked to an increased risk of developing AF.
8. Smoking: Smoking is a risk factor for many cardiovascular conditions, including AF.
9. Obesity: Obesity is a risk factor for many cardiovascular conditions, including AF.

Symptoms of AF can include:

1. Palpitations (rapid or irregular heartbeat)
2. Shortness of breath
3. Fatigue
4. Dizziness or lightheadedness
5. Chest pain or discomfort

AF can be diagnosed with the help of several tests, including:

1. Electrocardiogram (ECG): This is a non-invasive test that measures the electrical activity of the heart.
2. Holter monitor: This is a portable device that records the heart's rhythm over a 24-hour period.
3. Event monitor: This is a portable device that records the heart's rhythm over a longer period of time, usually 1-2 weeks.
4. Echocardiogram: This is an imaging test that uses sound waves to create pictures of the heart.
5. Cardiac MRI: This is an imaging test that uses magnetic fields and radio waves to create detailed pictures of the heart.

Treatment for AF depends on the underlying cause and may include medications, such as:

1. Beta blockers: These medications slow the heart rate and reduce the force of the heart's contractions.
2. Antiarrhythmics: These medications help regulate the heart's rhythm.
3. Blood thinners: These medications prevent blood clots from forming and can help reduce the risk of stroke.
4. Calcium channel blockers: These medications slow the entry of calcium into the heart muscle cells, which can help slow the heart rate and reduce the force of the heart's contractions.

In some cases, catheter ablation may be recommended to destroy the abnormal electrical pathway causing AF. This is a minimally invasive procedure that involves inserting a catheter through a vein in the leg and guiding it to the heart using x-ray imaging. Once the catheter is in place, energy is applied to the abnormal electrical pathway to destroy it and restore a normal heart rhythm.

It's important to note that AF can increase the risk of stroke, so anticoagulation therapy may be recommended to reduce this risk. This can include medications such as warfarin or aspirin, or in some cases, implantable devices such as a left atrial appendage closure device.

In conclusion, atrial fibrillation is a common heart rhythm disorder that can increase the risk of stroke and heart failure. Treatment options depend on the underlying cause and may include medications, cardioversion, catheter ablation, or anticoagulation therapy. It's important to work closely with a healthcare provider to determine the best course of treatment for AF.

Medical Term: Cardiomegaly

Definition: An abnormal enlargement of the heart.

Symptoms: Difficulty breathing, shortness of breath, fatigue, swelling of legs and feet, chest pain, and palpitations.

Causes: Hypertension, cardiac valve disease, myocardial infarction (heart attack), congenital heart defects, and other conditions that affect the heart muscle or cardiovascular system.

Diagnosis: Physical examination, electrocardiogram (ECG), chest x-ray, echocardiography, and other diagnostic tests as necessary.

Treatment: Medications such as diuretics, vasodilators, and beta blockers, lifestyle changes such as exercise and diet modifications, surgery or other interventions in severe cases.

Note: Cardiomegaly is a serious medical condition that requires prompt diagnosis and treatment to prevent complications such as heart failure and death. If you suspect you or someone else may have cardiomegaly, seek medical attention immediately.

There are two types of heart arrest:

1. Asystole - This is when the heart stops functioning completely and there is no electrical activity in the heart.
2. Pulseless ventricular tachycardia or fibrillation - This is when the heart is still functioning but there is no pulse and the rhythm is abnormal.

Heart arrest can be diagnosed through various tests such as electrocardiogram (ECG), blood tests, and echocardiography. Treatment options for heart arrest include cardiopulmonary resuscitation (CPR), defibrillation, and medications to restore a normal heart rhythm.

In severe cases of heart arrest, the patient may require advanced life support measures such as mechanical ventilation and cardiac support devices. The prognosis for heart arrest is generally poor, especially if it is not treated promptly and effectively. However, with proper treatment and support, some patients can recover and regain normal heart function.

There are several types of cardiomyopathies, each with distinct characteristics and symptoms. Some of the most common forms of cardiomyopathy include:

1. Hypertrophic cardiomyopathy (HCM): This is the most common form of cardiomyopathy and is characterized by an abnormal thickening of the heart muscle, particularly in the left ventricle. HCM can lead to obstruction of the left ventricular outflow tract and can increase the risk of sudden death.
2. Dilated cardiomyopathy: This type of cardiomyopathy is characterized by a decrease in the heart's ability to pump blood effectively, leading to enlargement of the heart and potentially life-threatening complications such as congestive heart failure.
3. Restrictive cardiomyopathy: This type of cardiomyopathy is characterized by stiffness of the heart muscle, which makes it difficult for the heart to fill with blood. This can lead to shortness of breath and fatigue.
4. Left ventricular non-compaction (LVNC): This is a rare type of cardiomyopathy that occurs when the left ventricle does not properly compact, leading to reduced cardiac function and potentially life-threatening complications.
5. Cardiac amyloidosis: This is a condition in which abnormal proteins accumulate in the heart tissue, leading to stiffness and impaired cardiac function.
6. Right ventricular cardiomyopathy (RVCM): This type of cardiomyopathy is characterized by impaired function of the right ventricle, which can lead to complications such as pulmonary hypertension and heart failure.
7. Endocardial fibroelastoma: This is a rare type of cardiomyopathy that occurs when abnormal tissue grows on the inner lining of the heart, leading to reduced cardiac function and potentially life-threatening complications.
8. Cardiac sarcoidosis: This is a condition in which inflammatory cells accumulate in the heart, leading to impaired cardiac function and potentially life-threatening complications.
9. Hypertrophic cardiomyopathy (HCM): This is a condition in which the heart muscle thickens, leading to reduced cardiac function and potentially life-threatening complications such as arrhythmias and sudden death.
10. Hypokinetic left ventricular cardiomyopathy: This type of cardiomyopathy is characterized by decreased contraction of the left ventricle, leading to reduced cardiac function and potentially life-threatening complications such as heart failure.

It's important to note that some of these types of cardiomyopathy are more common in certain populations, such as hypertrophic cardiomyopathy being more common in young athletes. Additionally, some types of cardiomyopathy may have overlapping symptoms or co-occurring conditions, so it's important to work with a healthcare provider for an accurate diagnosis and appropriate treatment.

There are different types of myocardial infarctions, including:

1. ST-segment elevation myocardial infarction (STEMI): This is the most severe type of heart attack, where a large area of the heart muscle is damaged. It is characterized by a specific pattern on an electrocardiogram (ECG) called the ST segment.
2. Non-ST-segment elevation myocardial infarction (NSTEMI): This type of heart attack is less severe than STEMI, and the damage to the heart muscle may not be as extensive. It is characterized by a smaller area of damage or a different pattern on an ECG.
3. Incomplete myocardial infarction: This type of heart attack is when there is some damage to the heart muscle but not a complete blockage of blood flow.
4. Collateral circulation myocardial infarction: This type of heart attack occurs when there are existing collateral vessels that bypass the blocked coronary artery, which reduces the amount of damage to the heart muscle.

Symptoms of a myocardial infarction can include chest pain or discomfort, shortness of breath, lightheadedness, and fatigue. These symptoms may be accompanied by anxiety, fear, and a sense of impending doom. In some cases, there may be no noticeable symptoms at all.

Diagnosis of myocardial infarction is typically made based on a combination of physical examination findings, medical history, and diagnostic tests such as an electrocardiogram (ECG), cardiac enzyme tests, and imaging studies like echocardiography or cardiac magnetic resonance imaging.

Treatment of myocardial infarction usually involves medications to relieve pain, reduce the amount of work the heart has to do, and prevent further damage to the heart muscle. These may include aspirin, beta blockers, ACE inhibitors or angiotensin receptor blockers, and statins. In some cases, a procedure such as angioplasty or coronary artery bypass surgery may be necessary to restore blood flow to the affected area.

Prevention of myocardial infarction involves managing risk factors such as high blood pressure, high cholesterol, smoking, diabetes, and obesity. This can include lifestyle changes such as a healthy diet, regular exercise, and stress reduction, as well as medications to control these conditions. Early detection and treatment of heart disease can help prevent myocardial infarction from occurring in the first place.

There are two main types of heart failure:

1. Left-sided heart failure: This occurs when the left ventricle, which is the main pumping chamber of the heart, becomes weakened and is unable to pump blood effectively. This can lead to congestion in the lungs and other organs.
2. Right-sided heart failure: This occurs when the right ventricle, which pumps blood to the lungs, becomes weakened and is unable to pump blood effectively. This can lead to congestion in the body's tissues and organs.

Symptoms of heart failure may include:

* Shortness of breath
* Fatigue
* Swelling in the legs, ankles, and feet
* Swelling in the abdomen
* Weight gain
* Coughing up pink, frothy fluid
* Rapid or irregular heartbeat
* Dizziness or lightheadedness

Treatment for heart failure typically involves a combination of medications and lifestyle changes. Medications may include diuretics to remove excess fluid from the body, ACE inhibitors or beta blockers to reduce blood pressure and improve blood flow, and aldosterone antagonists to reduce the amount of fluid in the body. Lifestyle changes may include a healthy diet, regular exercise, and stress reduction techniques. In severe cases, heart failure may require hospitalization or implantation of a device such as an implantable cardioverter-defibrillator (ICD) or a left ventricular assist device (LVAD).

It is important to note that heart failure is a chronic condition, and it requires ongoing management and monitoring to prevent complications and improve quality of life. With proper treatment and lifestyle changes, many people with heart failure are able to manage their symptoms and lead active lives.

There are several possible causes of cardiac tamponade, including:

1. Trauma: Blunt chest trauma, such as a car accident or fall, can cause bleeding within the pericardial sac and lead to cardiac tamponade.
2. Infection: Bacterial, viral, or fungal infections can spread to the pericardial sac and cause inflammation and fluid accumulation.
3. Ischemia: Reduced blood flow to the heart muscle, such as during a heart attack, can lead to inflammation and fluid accumulation within the pericardial sac.
4. Cancer: Cancer that has spread to the pericardial sac can cause fluid accumulation and cardiac tamponade.
5. Hemodynamic instability: Severe hypotension or tachycardia can cause fluid to seep into the pericardial sac, leading to cardiac tamponade.

The symptoms of cardiac tamponade may include:

1. Chest pain: Pain in the chest that worsens with deep breathing or coughing.
2. Shortness of breath: Difficulty breathing due to compression of the heart.
3. Fatigue: Weakness and tiredness due to decreased cardiac output.
4. Palpitations: Abnormal heart rhythms.
5. Low blood pressure: Hypotension.

Cardiac tamponade is a medical emergency that requires prompt treatment to prevent cardiac failure and death. Treatment options may include:

1. Pericardiocentesis: Insertion of a needle into the pericardial sac to drain excess fluid.
2. Surgical drainage: Surgical removal of fluid and any underlying cause of tamponade.
3. Diuretics: Medications to increase urine production and reduce fluid buildup in the body.
4. Inotropes: Medications to increase heart contractility.
5. Mechanical support: Use of a device such as an intra-aortic balloon pump or an implantable cardioverter-defibrillator to support the heart.

In some cases, cardiac tamponade may be a sign of a more serious underlying condition that requires long-term management. It is important to work with a healthcare provider to develop a treatment plan that addresses the underlying cause of the tamponade and helps to prevent recurrences.

Myocardial ischemia can be caused by a variety of factors, including coronary artery disease, high blood pressure, diabetes, and smoking. It can also be triggered by physical exertion or stress.

There are several types of myocardial ischemia, including:

1. Stable angina: This is the most common type of myocardial ischemia, and it is characterized by a predictable pattern of chest pain that occurs during physical activity or emotional stress.
2. Unstable angina: This is a more severe type of myocardial ischemia that can occur without any identifiable trigger, and can be accompanied by other symptoms such as shortness of breath or vomiting.
3. Acute coronary syndrome (ACS): This is a condition that includes both stable angina and unstable angina, and it is characterized by a sudden reduction in blood flow to the heart muscle.
4. Heart attack (myocardial infarction): This is a type of myocardial ischemia that occurs when the blood flow to the heart muscle is completely blocked, resulting in damage or death of the cardiac tissue.

Myocardial ischemia can be diagnosed through a variety of tests, including electrocardiograms (ECGs), stress tests, and imaging studies such as echocardiography or cardiac magnetic resonance imaging (MRI). Treatment options for myocardial ischemia include medications such as nitrates, beta blockers, and calcium channel blockers, as well as lifestyle changes such as quitting smoking, losing weight, and exercising regularly. In severe cases, surgical procedures such as coronary artery bypass grafting or angioplasty may be necessary.

There are several types of SVT, including:

1. Paroxysmal SVT: This type of SVT comes and goes on its own and may be triggered by certain activities or stimuli.
2. Persistent SVT: This type of SVT lasts for more than 24 hours and may require treatment to return the heart to a normal rhythm.
3. Permanent SVT: This type of SVT is ongoing and may require long-term treatment.

Symptoms of SVT may include:

* Rapid or fluttering heartbeat
* Palpitations
* Shortness of breath
* Dizziness or lightheadedness
* Chest pain or discomfort

SVT is caused by a variety of factors, including:

* Abnormal electrical pathways in the heart
* Increased activity of the sympathetic nervous system
* Certain medications
* Caffeine and other stimulants
* Thyroid problems

Treatment for SVT may include:

* Medications to slow the heart rate or regulate the heart rhythm
* Cardioversion, which is a procedure that uses electrical shock to return the heart to a normal rhythm
* Catheter ablation, which is a procedure that destroys the abnormal electrical pathways in the heart
* Implantable devices such as pacemakers or implantable cardioverter-defibrillators (ICDs)

It is important to seek medical attention if you experience any symptoms of SVT, as it can lead to more serious complications such as atrial fibrillation or stroke if left untreated.

There are several types of ventricular dysfunction, including:

1. Left ventricular dysfunction: This occurs when the left ventricle, which is the main pumping chamber of the heart, becomes weakened or impaired. This can lead to reduced cardiac output and can increase the risk of heart failure.
2. Right ventricular dysfunction: This occurs when the right ventricle, which pumps blood into the lungs, becomes weakened or impaired. This can lead to pulmonary hypertension and other complications.
3. Biventricular dysfunction: This occurs when both the left and right ventricles become weakened or impaired. This can lead to severe cardiac impairment and increased risk of heart failure.

Ventricular dysfunction can be diagnosed through a variety of tests, including echocardiography, stress testing, and cardiac magnetic resonance imaging (MRI). Treatment options depend on the underlying cause of the dysfunction and may include medications, lifestyle changes, or surgical interventions. In some cases, implantable devices such as pacemakers or defibrillators may be recommended to help regulate the heart rhythm and improve function.

Symptoms of atrial flutter may include palpitations, shortness of breath, fatigue, and dizziness. In some cases, atrial flutter can lead to more serious complications such as stroke or heart failure if left untreated. Diagnosis is typically made through a combination of physical examination, electrocardiography (ECG), and other tests such as echocardiography or stress testing.

Treatment for atrial flutter depends on the underlying cause and may include medications to control the heart rate or restore a normal heart rhythm, cardioversion (a procedure that uses electrical shock to restore a normal heart rhythm), or in some cases, catheter ablation (a minimally invasive procedure that destroys the abnormal electrical pathway in the heart).

* Heart block: A condition where the electrical signals that control the heart's rhythm are blocked or delayed, leading to a slow heart rate.
* Sinus node dysfunction: A condition where the sinus node, which is responsible for setting the heart's rhythm, is not functioning properly, leading to a slow heart rate.
* Medications: Certain medications, such as beta blockers, can slow down the heart rate.
* Heart failure: In severe cases of heart failure, the heart may become so weak that it cannot pump blood effectively, leading to a slow heart rate.
* Electrolyte imbalance: An imbalance of electrolytes, such as potassium or magnesium, can affect the heart's ability to function properly and cause a slow heart rate.
* Other medical conditions: Certain medical conditions, such as hypothyroidism (an underactive thyroid) or anemia, can cause bradycardia.

Bradycardia can cause symptoms such as:

* Fatigue
* Weakness
* Dizziness or lightheadedness
* Shortness of breath
* Chest pain or discomfort

In some cases, bradycardia may not cause any noticeable symptoms at all.

If you suspect you have bradycardia, it is important to consult with a healthcare professional for proper diagnosis and treatment. They may perform tests such as an electrocardiogram (ECG) or stress test to determine the cause of your slow heart rate and develop an appropriate treatment plan. Treatment options for bradycardia may include:

* Medications: Such as atropine or digoxin, to increase the heart rate.
* Pacemakers: A small device that is implanted in the chest to help regulate the heart's rhythm and increase the heart rate.
* Cardiac resynchronization therapy (CRT): A procedure that involves implanting a device that helps both ventricles of the heart beat together, improving the heart's pumping function.

It is important to note that bradycardia can be a symptom of an underlying condition, so it is important to address the underlying cause in order to effectively treat the bradycardia.

MRI can occur in various cardiovascular conditions, such as myocardial infarction (heart attack), cardiac arrest, and cardiac surgery. The severity of MRI can range from mild to severe, depending on the extent and duration of the ischemic event.

The pathophysiology of MRI involves a complex interplay of various cellular and molecular mechanisms. During ischemia, the heart muscle cells undergo changes in energy metabolism, electrolyte balance, and cell membrane function. When blood flow is restored, these changes can lead to an influx of calcium ions into the cells, activation of enzymes, and production of reactive oxygen species (ROS), which can damage the cells and their membranes.

The clinical presentation of MRI can vary depending on the severity of the injury. Some patients may experience chest pain, shortness of breath, and fatigue. Others may have more severe symptoms, such as cardiogenic shock or ventricular arrhythmias. The diagnosis of MRI is based on a combination of clinical findings, electrocardiography (ECG), echocardiography, and cardiac biomarkers.

The treatment of MRI is focused on addressing the underlying cause of the injury and managing its symptoms. For example, in patients with myocardial infarction, thrombolysis or percutaneous coronary intervention may be used to restore blood flow to the affected area. In patients with cardiac arrest, cardiopulmonary resuscitation (CPR) and other life-saving interventions may be necessary.

Prevention of MRI is crucial in reducing its incidence and severity. This involves aggressive risk factor management, such as controlling hypertension, diabetes, and dyslipidemia, as well as smoking cessation and stress reduction. Additionally, patients with a history of MI should adhere to their medication regimen, which may include beta blockers, ACE inhibitors or ARBs, statins, and aspirin.

In conclusion, myocardial injury with ST-segment elevation (MRI) is a life-threatening condition that requires prompt recognition and treatment. While the clinical presentation can vary depending on the severity of the injury, early diagnosis and management are crucial in reducing morbidity and mortality. Prevention through aggressive risk factor management and adherence to medication regimens is also essential in preventing MRI.

There are several possible causes of dilated cardiomyopathy, including:

1. Coronary artery disease: This is the most common cause of dilated cardiomyopathy, and it occurs when the coronary arteries become narrowed or blocked, leading to a decrease in blood flow to the heart muscle.
2. High blood pressure: Prolonged high blood pressure can cause the heart muscle to become weakened and enlarged.
3. Heart valve disease: Dysfunctional heart valves can lead to an increased workload on the heart, which can cause dilated cardiomyopathy.
4. Congenital heart defects: Some congenital heart defects can lead to an enlarged heart and dilated cardiomyopathy.
5. Alcohol abuse: Chronic alcohol abuse can damage the heart muscle and lead to dilated cardiomyopathy.
6. Viral infections: Some viral infections, such as myocarditis, can cause inflammation of the heart muscle and lead to dilated cardiomyopathy.
7. Genetic disorders: Certain genetic disorders, such as hypertrophic cardiomyopathy, can cause dilated cardiomyopathy.
8. Obesity: Obesity is a risk factor for developing dilated cardiomyopathy, particularly in younger people.
9. Diabetes: Diabetes can increase the risk of developing dilated cardiomyopathy, especially if left untreated or poorly controlled.
10. Age: Dilated cardiomyopathy is more common in older adults, with the majority of cases occurring in people over the age of 65.

It's important to note that many people with these risk factors will not develop dilated cardiomyopathy, and some people without any known risk factors can still develop the condition. If you suspect you or someone you know may have dilated cardiomyopathy, it's important to consult a healthcare professional for proper diagnosis and treatment.

Types of congenital heart defects include:

1. Ventricular septal defect (VSD): A hole in the wall between the two lower chambers of the heart, allowing abnormal blood flow.
2. Atrial septal defect (ASD): A hole in the wall between the two upper chambers of the heart, also allowing abnormal blood flow.
3. Tetralogy of Fallot: A combination of four heart defects, including VSD, pulmonary stenosis (narrowing of the pulmonary valve), and abnormal development of the infundibulum (a part of the heart that connects the ventricles to the pulmonary artery).
4. Transposition of the great vessels: A condition in which the aorta and/or pulmonary artery are placed in the wrong position, disrupting blood flow.
5. Hypoplastic left heart syndrome (HLHS): A severe defect in which the left side of the heart is underdeveloped, resulting in insufficient blood flow to the body.
6. Pulmonary atresia: A condition in which the pulmonary valve does not form properly, blocking blood flow to the lungs.
7. Truncus arteriosus: A rare defect in which a single artery instead of two (aorta and pulmonary artery) arises from the heart.
8. Double-outlet right ventricle: A condition in which both the aorta and the pulmonary artery arise from the right ventricle instead of the left ventricle.

Causes of congenital heart defects are not fully understood, but genetics, environmental factors, and viral infections during pregnancy may play a role. Diagnosis is typically made through fetal echocardiography or cardiac ultrasound during pregnancy or after birth. Treatment depends on the type and severity of the defect and may include medication, surgery, or heart transplantation. With advances in medical technology and treatment, many children with congenital heart disease can lead active, healthy lives into adulthood.


Torsades de pointes is often associated with certain medications, such as antiarrhythmics, beta blockers, and cardiac glycosides, as well as with underlying heart conditions, such as coronary artery disease, hypertension, and heart failure. The condition can cause the heart to beat in an irregular and disorganized manner, which can lead to ineffective pumping of blood and can ultimately result in cardiac arrest and death.

Torsades de pointes is typically diagnosed based on the patient's medical history, physical examination, and results of electrocardiogram (ECG) tests. Treatment for the condition may involve stopping any medications that may be contributing to the arrhythmia, administering anti-arrhythmic drugs, and in some cases, implanting a cardioverter-defibrillator (ICD) to regulate the heart's rhythm.

In summary, torsades de pointes is a serious and potentially life-threatening arrhythmia that can be caused by various medications and underlying heart conditions. It is important for healthcare providers to be aware of this condition and to take appropriate measures to diagnose and treat it promptly in order to prevent complications and improve patient outcomes.

Measurement:

Cardiac output is typically measured using invasive or non-invasive methods. Invasive methods involve inserting a catheter into the heart to directly measure cardiac output. Non-invasive methods include echocardiography, MRI, and CT scans. These tests can provide an estimate of cardiac output based on the volume of blood being pumped out of the heart and the rate at which it is being pumped.

Causes:

There are several factors that can contribute to low cardiac output. These include:

1. Heart failure: This occurs when the heart is unable to pump enough blood to meet the body's needs, leading to fatigue and shortness of breath.
2. Anemia: A low red blood cell count can reduce the amount of oxygen being delivered to the body's tissues, leading to fatigue and weakness.
3. Medication side effects: Certain medications, such as beta blockers, can slow down the heart rate and reduce cardiac output.
4. Sepsis: A severe infection can lead to inflammation throughout the body, which can affect the heart's ability to pump blood effectively.
5. Myocardial infarction (heart attack): This occurs when the heart muscle is damaged due to a lack of oxygen, leading to reduced cardiac output.

Symptoms:

Low cardiac output can cause a range of symptoms, including:

1. Fatigue and weakness
2. Dizziness and lightheadedness
3. Shortness of breath
4. Pale skin
5. Decreased urine output
6. Confusion and disorientation

Treatment:

The treatment of low cardiac output depends on the underlying cause. Treatment may include:

1. Medications to increase heart rate and contractility
2. Diuretics to reduce fluid buildup in the body
3. Oxygen therapy to increase oxygenation of tissues
4. Mechanical support devices, such as intra-aortic balloon pumps or ventricular assist devices
5. Surgery to repair or replace damaged heart tissue
6. Lifestyle changes, such as a healthy diet and regular exercise, to improve cardiovascular health.

Prevention:

Preventing low cardiac output involves managing any underlying medical conditions, taking medications as directed, and making lifestyle changes to improve cardiovascular health. This may include:

1. Monitoring and controlling blood pressure
2. Managing diabetes and other chronic conditions
3. Avoiding substances that can damage the heart, such as tobacco and excessive alcohol
4. Exercising regularly
5. Eating a healthy diet that is low in saturated fats and cholesterol
6. Maintaining a healthy weight.

During ventricular remodeling, the heart muscle becomes thicker and less flexible, leading to a decrease in the heart's ability to fill with blood and pump it out to the body. This can lead to shortness of breath, fatigue, and swelling in the legs and feet.

Ventricular remodeling is a natural response to injury, but it can also be exacerbated by factors such as high blood pressure, diabetes, and obesity. Treatment for ventricular remodeling typically involves medications and lifestyle changes, such as exercise and a healthy diet, to help manage symptoms and slow the progression of the condition. In some cases, surgery or other procedures may be necessary to repair or replace damaged heart tissue.

The process of ventricular remodeling is complex and involves multiple cellular and molecular mechanisms. It is thought to be driven by a variety of factors, including changes in gene expression, inflammation, and the activity of various signaling pathways.

Overall, ventricular remodeling is an important condition that can have significant consequences for patients with heart disease. Understanding its causes and mechanisms is crucial for developing effective treatments and improving outcomes for those affected by this condition.

There are several types of heart block, including:

1. First-degree heart block: This is the mildest form of heart block, where the electrical signals are delayed slightly but still reach the ventricles.
2. Second-degree heart block: In this type, some of the electrical signals may be blocked or delayed, causing the heart to beat irregularly.
3. Third-degree heart block: This is the most severe form of heart block, where all electrical signals are completely blocked, resulting in a complete halt of the heart's normal rhythm.

Heart block can be caused by a variety of factors, including:

1. Coronary artery disease: A buildup of plaque in the coronary arteries can lead to a blockage that affects the electrical signals to the heart.
2. Heart attack: Damage to the heart muscle can cause scarring and disrupt the electrical signals.
3. Cardiomyopathy: Disease of the heart muscle can lead to heart block.
4. Heart valve problems: Dysfunctional heart valves can interfere with the electrical signals to the heart.
5. Electrolyte imbalances: Abnormal levels of potassium, magnesium, or other electrolytes can affect the heart's electrical activity.
6. Medications: Certain drugs, such as beta-blockers and calcium channel blockers, can slow down the heart's electrical signals.
7. Infections: Viral or bacterial infections can damage the heart and disrupt its electrical signals.
8. Genetic conditions: Certain inherited conditions, such as long QT syndrome, can affect the heart's electrical activity.
9. Autoimmune disorders: Conditions such as rheumatoid arthritis or lupus can damage the heart and disrupt its electrical signals.

Symptoms of heart block may include:

1. Slow or irregular heartbeat
2. Palpitations
3. Fatigue
4. Shortness of breath
5. Dizziness or lightheadedness
6. Chest pain or discomfort
7. Pain or discomfort in the arms, back, or jaw

Diagnosis of heart block is typically made with an electrocardiogram (ECG), which measures the electrical activity of the heart. Other tests that may be used to diagnose heart block include:

1. Echocardiography: An ultrasound test that uses sound waves to create images of the heart.
2. Stress test: A test that measures the heart's activity during exercise or other forms of physical stress.
3. Holter monitor: A portable device that records the heart's activity over a 24-hour period.
4. Event monitor: A portable device that records the heart's activity over a longer period of time, typically 1-2 weeks.

Treatment for heart block depends on the severity of the condition and may include:

1. Medications: Drugs such as beta blockers or pacemakers may be used to regulate the heart's rhythm and rate.
2. Pacemaker: A small device that is implanted in the chest to help regulate the heart's rhythm.
3. Cardiac resynchronization therapy (CRT): A procedure that involves implanting a device that helps both ventricles of the heart beat together, improving the heart's pumping function.
4. Implantable cardioverter-defibrillator (ICD): A device that is implanted in the chest to monitor the heart's rhythm and deliver an electric shock if it detects a potentially life-threatening arrhythmia.

In conclusion, heart block is a serious condition that can disrupt the normal functioning of the heart. It is important to be aware of the risk factors and symptoms of heart block, and to seek medical attention immediately if they occur. With proper diagnosis and treatment, it is possible to manage heart block and improve the quality of life for those affected by the condition.

1) They share similarities with humans: Many animal species share similar biological and physiological characteristics with humans, making them useful for studying human diseases. For example, mice and rats are often used to study diseases such as diabetes, heart disease, and cancer because they have similar metabolic and cardiovascular systems to humans.

2) They can be genetically manipulated: Animal disease models can be genetically engineered to develop specific diseases or to model human genetic disorders. This allows researchers to study the progression of the disease and test potential treatments in a controlled environment.

3) They can be used to test drugs and therapies: Before new drugs or therapies are tested in humans, they are often first tested in animal models of disease. This allows researchers to assess the safety and efficacy of the treatment before moving on to human clinical trials.

4) They can provide insights into disease mechanisms: Studying disease models in animals can provide valuable insights into the underlying mechanisms of a particular disease. This information can then be used to develop new treatments or improve existing ones.

5) Reduces the need for human testing: Using animal disease models reduces the need for human testing, which can be time-consuming, expensive, and ethically challenging. However, it is important to note that animal models are not perfect substitutes for human subjects, and results obtained from animal studies may not always translate to humans.

6) They can be used to study infectious diseases: Animal disease models can be used to study infectious diseases such as HIV, TB, and malaria. These models allow researchers to understand how the disease is transmitted, how it progresses, and how it responds to treatment.

7) They can be used to study complex diseases: Animal disease models can be used to study complex diseases such as cancer, diabetes, and heart disease. These models allow researchers to understand the underlying mechanisms of the disease and test potential treatments.

8) They are cost-effective: Animal disease models are often less expensive than human clinical trials, making them a cost-effective way to conduct research.

9) They can be used to study drug delivery: Animal disease models can be used to study drug delivery and pharmacokinetics, which is important for developing new drugs and drug delivery systems.

10) They can be used to study aging: Animal disease models can be used to study the aging process and age-related diseases such as Alzheimer's and Parkinson's. This allows researchers to understand how aging contributes to disease and develop potential treatments.

www.medicinenet.com/sudden_death/article.htm
Sudden death is death that occurs unexpectedly and without warning, often due to a cardiac arrest or other underlying medical condition.

In the medical field, sudden death is defined as death that occurs within one hour of the onset of symptoms, with no prior knowledge of any serious medical condition. It is often caused by a cardiac arrhythmia, such as ventricular fibrillation or tachycardia, which can lead to cardiac arrest and sudden death if not treated promptly.

Other possible causes of sudden death include:

1. Heart disease: Coronary artery disease, heart failure, and other heart conditions can increase the risk of sudden death.
2. Stroke: A stroke can cause sudden death by disrupting blood flow to the brain or other vital organs.
3. Pulmonary embolism: A blood clot in the lungs can block blood flow and cause sudden death.
4. Trauma: Sudden death can occur as a result of injuries sustained in an accident or other traumatic event.
5. Drug overdose: Taking too much of certain medications or drugs can cause sudden death due to cardiac arrest or respiratory failure.
6. Infections: Sepsis, meningitis, and other severe infections can lead to sudden death if left untreated.
7. Genetic conditions: Certain inherited disorders, such as Long QT syndrome, can increase the risk of sudden death due to cardiac arrhythmias.

The diagnosis of sudden death often requires an autopsy and a thorough investigation into the individual's medical history and circumstances surrounding their death. Treatment and prevention strategies may include defibrillation, CPR, medications to regulate heart rhythm, and lifestyle modifications to reduce risk factors such as obesity, smoking, and high blood pressure.

There are several potential causes of LVD, including:

1. Coronary artery disease: The buildup of plaque in the coronary arteries can lead to a heart attack, which can damage the left ventricle and impair its ability to function properly.
2. Heart failure: When the heart is unable to pump enough blood to meet the body's needs, it can lead to LVD.
3. Cardiomyopathy: This is a condition where the heart muscle becomes weakened or enlarged, leading to impaired function of the left ventricle.
4. Heart valve disease: Problems with the heart valves can disrupt the normal flow of blood and cause LVD.
5. Hypertension: High blood pressure can cause damage to the heart muscle and lead to LVD.
6. Genetic factors: Some people may be born with genetic mutations that predispose them to developing LVD.
7. Viral infections: Certain viral infections, such as myocarditis, can inflame and damage the heart muscle, leading to LVD.
8. Alcohol or drug abuse: Substance abuse can damage the heart muscle and lead to LVD.
9. Nutritional deficiencies: A diet lacking essential nutrients can lead to damage to the heart muscle and increase the risk of LVD.

Diagnosis of LVD typically involves a physical exam, medical history, and results of diagnostic tests such as electrocardiograms (ECGs), echocardiograms, and stress tests. Treatment options for LVD depend on the underlying cause, but may include medications to improve cardiac function, lifestyle changes, and in severe cases, surgery or other procedures.

Preventing LVD involves taking steps to maintain a healthy heart and reducing risk factors such as high blood pressure, smoking, and obesity. This can be achieved through a balanced diet, regular exercise, stress management, and avoiding substance abuse. Early detection and treatment of underlying conditions that increase the risk of LVD can also help prevent the condition from developing.

OHCA is a life-threatening medical emergency that requires immediate attention and treatment. If not treated promptly, OHCA can lead to brain damage, disability, or even death.

The symptoms of OHCA are similar to those of in-hospital cardiac arrest, and may include:

* Loss of consciousness (fainting)
* No breathing or abnormal breathing (gasping or gurgling sounds)
* No pulse or a very weak pulse
* Blue lips and skin (cyanosis)

If you suspect someone has experienced OHCA, it is important to call emergency services immediately. While waiting for help to arrive, follow these steps:

1. Check the person's airway, breathing, and pulse. If the person is not breathing or has no pulse, begin CPR (cardiopulmonary resuscitation) immediately.
2. Provide rescue breaths and chest compressions until emergency medical services arrive.
3. Use an automated external defibrillator (AED) if one is available and the person is in cardiac arrest.
4. Keep the person warm and comfortable, as hypothermia can worsen the condition.
5. Provide reassurance and support to the person's family and loved ones.

OHCA is a medical emergency that requires prompt treatment and attention. If you suspect someone has experienced OHCA, call emergency services immediately and provide appropriate care until help arrives.

Some common causes of syncope include:

1. Vasovagal response: This is the most common cause of syncope and is triggered by a sudden drop in blood pressure, usually due to sight of blood or injury.
2. Cardiac arrhythmias: Abnormal heart rhythms can lead to a decrease in blood flow to the brain, causing syncope.
3. Heart failure: When the heart is unable to pump enough blood to meet the body's needs, syncope can occur.
4. Anemia: A low red blood cell count can cause decreased oxygen delivery to the brain, leading to syncope.
5. Dehydration: Lack of fluids and electrolytes can lead to a decrease in blood pressure, causing syncope.
6. Medication side effects: Certain medications can cause syncope as a side effect, such as vasodilators and beta-blockers.
7. Neurological disorders: Syncope can be a symptom of neurological conditions such as seizures, migraines, and stroke.
8. Psychological factors: Stress, anxiety, and panic attacks can also cause syncope.

Diagnosis of syncope is based on a thorough medical history and physical examination, as well as diagnostic tests such as electrocardiogram (ECG), echocardiogram, and blood tests. Treatment of syncope depends on the underlying cause and may include lifestyle modifications, medication, and in some cases, surgical intervention.

In summary, syncope is a symptom of a wide range of medical conditions that can be caused by cardiovascular, neurological, and psychological factors. A thorough diagnosis and appropriate treatment are necessary to determine the underlying cause and prevent complications.

1. Infection: Bacterial or viral infections can develop after surgery, potentially leading to sepsis or organ failure.
2. Adhesions: Scar tissue can form during the healing process, which can cause bowel obstruction, chronic pain, or other complications.
3. Wound complications: Incisional hernias, wound dehiscence (separation of the wound edges), and wound infections can occur.
4. Respiratory problems: Pneumonia, respiratory failure, and atelectasis (collapsed lung) can develop after surgery, particularly in older adults or those with pre-existing respiratory conditions.
5. Cardiovascular complications: Myocardial infarction (heart attack), cardiac arrhythmias, and cardiac failure can occur after surgery, especially in high-risk patients.
6. Renal (kidney) problems: Acute kidney injury or chronic kidney disease can develop postoperatively, particularly in patients with pre-existing renal impairment.
7. Neurological complications: Stroke, seizures, and neuropraxia (nerve damage) can occur after surgery, especially in patients with pre-existing neurological conditions.
8. Pulmonary embolism: Blood clots can form in the legs or lungs after surgery, potentially causing pulmonary embolism.
9. Anesthesia-related complications: Respiratory and cardiac complications can occur during anesthesia, including respiratory and cardiac arrest.
10. delayed healing: Wound healing may be delayed or impaired after surgery, particularly in patients with pre-existing medical conditions.

It is important for patients to be aware of these potential complications and to discuss any concerns with their surgeon and healthcare team before undergoing surgery.

Fibrosis can occur in response to a variety of stimuli, including inflammation, infection, injury, or chronic stress. It is a natural healing process that helps to restore tissue function and structure after damage or trauma. However, excessive fibrosis can lead to the loss of tissue function and organ dysfunction.

There are many different types of fibrosis, including:

* Cardiac fibrosis: the accumulation of scar tissue in the heart muscle or walls, leading to decreased heart function and potentially life-threatening complications.
* Pulmonary fibrosis: the accumulation of scar tissue in the lungs, leading to decreased lung function and difficulty breathing.
* Hepatic fibrosis: the accumulation of scar tissue in the liver, leading to decreased liver function and potentially life-threatening complications.
* Neurofibromatosis: a genetic disorder characterized by the growth of benign tumors (neurofibromas) made up of fibrous connective tissue.
* Desmoid tumors: rare, slow-growing tumors that are made up of fibrous connective tissue and can occur in various parts of the body.

Fibrosis can be diagnosed through a variety of methods, including:

* Biopsy: the removal of a small sample of tissue for examination under a microscope.
* Imaging tests: such as X-rays, CT scans, or MRI scans to visualize the accumulation of scar tissue.
* Blood tests: to assess liver function or detect specific proteins or enzymes that are elevated in response to fibrosis.

There is currently no cure for fibrosis, but various treatments can help manage the symptoms and slow the progression of the condition. These may include:

* Medications: such as corticosteroids, immunosuppressants, or chemotherapy to reduce inflammation and slow down the growth of scar tissue.
* Lifestyle modifications: such as quitting smoking, exercising regularly, and maintaining a healthy diet to improve overall health and reduce the progression of fibrosis.
* Surgery: in some cases, surgical removal of the affected tissue or organ may be necessary.

It is important to note that fibrosis can progress over time, leading to further scarring and potentially life-threatening complications. Regular monitoring and follow-up with a healthcare professional are crucial to managing the condition and detecting any changes or progression early on.

Heart neoplasms, also known as cardiac tumors, are abnormal growths that occur within the heart muscle or on the surface of the heart. These tumors can be benign (non-cancerous) or malignant (cancerous). Malignant heart tumors are rare but can be aggressive and potentially life-threatening.

Types of Heart Neoplasms:

1. Benign tumors: These include fibromas, lipomas, and teratomas, which are usually slow-growing and do not spread to other parts of the body.
2. Malignant tumors: These include sarcomas, carcinomas, and lymphomas, which can be more aggressive and may spread to other parts of the body.

Causes and Risk Factors:

The exact cause of heart neoplasms is not fully understood, but several factors have been linked to an increased risk of developing these tumors. These include:

1. Genetic mutations: Some heart neoplasms may be caused by inherited genetic mutations.
2. Viral infections: Some viruses, such as human T-lymphotropic virus (HTLV-1), have been linked to an increased risk of developing heart tumors.
3. Radiation exposure: Radiation therapy to the chest area can increase the risk of developing heart tumors.
4. Previous heart surgery: People who have had previous heart surgery may be at higher risk of developing heart neoplasms.

Symptoms and Diagnosis:

The symptoms of heart neoplasms can vary depending on the size and location of the tumor. They may include:

1. Chest pain or discomfort
2. Shortness of breath
3. Fatigue
4. Palpitations
5. Swelling in the legs, ankles, or feet

Diagnosis is typically made through a combination of physical examination, medical history, and diagnostic tests such as electrocardiograms (ECGs), echocardiograms, and cardiac imaging studies. A biopsy may be necessary to confirm the diagnosis.

Treatment and Prognosis:

The treatment of heart neoplasms depends on the type, size, and location of the tumor, as well as the patient's overall health. Treatment options may include:

1. Watchful waiting: Small, benign tumors may not require immediate treatment and can be monitored with regular check-ups.
2. Surgery: Surgical removal of the tumor may be necessary for larger or more aggressive tumors.
3. Chemotherapy: Chemotherapy drugs may be used to shrink the tumor before surgery or to treat any remaining cancer cells after surgery.
4. Radiation therapy: Radiation therapy may be used to treat heart neoplasms that are difficult to remove with surgery or that have returned after previous treatment.

The prognosis for heart neoplasms varies depending on the type and location of the tumor, as well as the patient's overall health. In general, the earlier the diagnosis and treatment, the better the prognosis. However, some heart neoplasms can be aggressive and may have a poor prognosis despite treatment.

Complications:

Heart neoplasms can cause a variety of complications, including:

1. Heart failure: Tumors that obstruct the heart's pumping activity can lead to heart failure.
2. Arrhythmias: Tumors can disrupt the heart's electrical activity and cause arrhythmias (abnormal heart rhythms).
3. Thrombus formation: Tumors can increase the risk of blood clots forming within the heart.
4. Septicemia: Bacterial infections can occur within the tumor, leading to septicemia (blood poisoning).
5. Respiratory failure: Large tumors can compress the lungs and lead to respiratory failure.

Conclusion:

Heart neoplasms are rare but potentially life-threatening conditions that require prompt diagnosis and treatment. While some heart neoplasms are benign, others can be aggressive and may have a poor prognosis despite treatment. It is essential to seek medical attention if symptoms persist or worsen over time, as early detection and treatment can improve outcomes.

APCs can be diagnosed with an electrocardiogram (ECG), which records the electrical activity of the heart. The ECG will show a premature beat in the atria, followed by a normal heartbeat. APCs can also be detected using other tests such as Holter monitor or event monitor, which record the heart's rhythm over a longer period of time.

Treatment for APCs depends on the underlying cause and can range from medications to control the heart rate, cardioversion to restore a normal heart rhythm, or catheter ablation to destroy the abnormal electrical pathway causing the premature beats. In some cases, no treatment may be necessary if the APCs are benign and not causing any symptoms.

The exact cause of HCM is not fully understood, but it is thought to be related to a combination of genetic and environmental factors. Some people with HCM have a family history of the condition, and it is also more common in certain populations such as athletes and individuals with a history of hypertension or diabetes.

Symptoms of HCM can vary from person to person and may include shortness of breath, fatigue, palpitations, and chest pain. In some cases, HCM may not cause any symptoms at all and may be detected only through a physical examination or diagnostic tests such as an echocardiogram or electrocardiogram (ECG).

Treatment for HCM typically focuses on managing symptoms and reducing the risk of complications. This may include medications to reduce blood pressure, control arrhythmias, or improve heart function, as well as lifestyle modifications such as regular exercise and a healthy diet. In some cases, surgery or other procedures may be necessary to treat HCM.

Prognosis for individuals with HCM varies depending on the severity of the condition and the presence of any complications. With appropriate treatment and management, many people with HCM can lead active and fulfilling lives, but it is important to receive regular monitoring and care from a healthcare provider to manage the condition effectively.

There are several types of heart injuries that can occur, including:

1. Myocardial infarction (heart attack): This occurs when the blood flow to the heart is blocked, causing damage to the heart muscle.
2. Cardiac tamponade: This occurs when fluid accumulates in the space between the heart and the sac that surrounds it, putting pressure on the heart and impeding its ability to function properly.
3. Myocarditis: This is an inflammation of the heart muscle that can be caused by a virus or bacteria.
4. Pericardial tamponade: This occurs when fluid accumulates in the space between the heart and the sac that surrounds it, putting pressure on the heart and impeding its ability to function properly.
5. Heart failure: This occurs when the heart is unable to pump enough blood to meet the body's needs.
6. Coronary artery disease: This occurs when the coronary arteries, which supply blood to the heart, become narrowed or blocked, leading to damage to the heart muscle.
7. Cardiac rupture: This is a rare and severe injury that occurs when the heart muscle tears or ruptures.

Symptoms of heart injuries can include chest pain, shortness of breath, fatigue, and irregular heartbeat. Treatment options for heart injuries depend on the severity of the injury and can range from medications to surgery. In some cases, heart injuries may be fatal if not properly treated.

In conclusion, heart injuries are a serious medical condition that can have long-term consequences if not properly treated. It is important to seek medical attention immediately if symptoms of a heart injury are present.

1. Ventricular septal defect (VSD): an opening in the wall between the two lower chambers of the heart, which allows oxygen-poor blood to mix with oxygen-rich blood.
2. Pulmonary stenosis: a narrowing of the pulmonary valve and pulmonary artery, which restricts blood flow to the lungs.
3. Overriding aorta: an aorta that grows over the ventricular septal defect, blocking the flow of oxygen-rich blood from the left ventricle to the rest of the body.
4. Right ventricular hypertrophy: enlargement of the right ventricle due to increased pressure caused by the backflow of blood through the VSD.

These abnormalities combine to reduce the amount of oxygen that reaches the body's tissues, leading to cyanosis (blue discoloration of the skin) and fatigue. Tetralogy of Fallot is usually diagnosed at birth or soon after, and treatment typically involves a combination of medications, surgery, and other interventions to repair the defects and improve blood flow to the body.

Coronary disease is often caused by a combination of genetic and lifestyle factors, such as high blood pressure, high cholesterol levels, smoking, obesity, and a lack of physical activity. It can also be triggered by other medical conditions, such as diabetes and kidney disease.

The symptoms of coronary disease can vary depending on the severity of the condition, but may include:

* Chest pain or discomfort (angina)
* Shortness of breath
* Fatigue
* Swelling of the legs and feet
* Pain in the arms and back

Coronary disease is typically diagnosed through a combination of physical examination, medical history, and diagnostic tests such as electrocardiograms (ECGs), stress tests, and cardiac imaging. Treatment for coronary disease may include lifestyle changes, medications to control symptoms, and surgical procedures such as angioplasty or bypass surgery to improve blood flow to the heart.

Preventative measures for coronary disease include:

* Maintaining a healthy diet and exercise routine
* Quitting smoking and limiting alcohol consumption
* Managing high blood pressure, high cholesterol levels, and other underlying medical conditions
* Reducing stress through relaxation techniques or therapy.

There are three types of AV block:

1. First-degree AV block: This is the mildest form of AV block, where the electrical signals are delayed but still allow for a normal heartbeat.
2. Second-degree AV block: This type of block is more severe and can cause irregular heartbeats. The electrical signals may be blocked or delayed, which can lead to a slow or irregular heart rate.
3. Third-degree AV block (complete heart block): This is the most severe form of AV block, where the electrical signals are completely blocked, resulting in a halted heartbeat. This is a life-threatening condition that requires immediate medical attention.

Symptoms of AV block may include:

* Palpitations or irregular heartbeat
* Slow or fast heart rate
* Dizziness or lightheadedness
* Fatigue or shortness of breath

Diagnosis of AV block is typically made through an electrocardiogram (ECG) test, which measures the electrical activity of the heart. Treatment options for AV block depend on the severity of the condition and may include medications, pacemakers, or cardiac ablation. In some cases, surgery may be necessary to repair or replace damaged heart tissue.

In summary, atrioventricular block is a condition where there is a delay or interruption in the electrical signals that regulate the heartbeat, which can lead to irregular heartbeats and potentially life-threatening complications. It is important to seek medical attention if symptoms of AV block are present to receive proper diagnosis and treatment.

LVH can lead to a number of complications, including:

1. Heart failure: The enlarged left ventricle can become less efficient at pumping blood throughout the body, leading to heart failure.
2. Arrhythmias: The abnormal electrical activity in the heart can lead to irregular heart rhythms.
3. Sudden cardiac death: In some cases, LVH can increase the risk of sudden cardiac death.
4. Atrial fibrillation: The enlarged left atrium can lead to atrial fibrillation, a common type of arrhythmia.
5. Mitral regurgitation: The enlargement of the left ventricle can cause the mitral valve to become incompetent, leading to mitral regurgitation.
6. Heart valve problems: The enlarged left ventricle can lead to heart valve problems, such as mitral regurgitation or aortic stenosis.
7. Coronary artery disease: LVH can increase the risk of coronary artery disease, which can lead to a heart attack.
8. Pulmonary hypertension: The enlarged left ventricle can lead to pulmonary hypertension, which can further strain the heart and increase the risk of complications.

Evaluation of LVH typically involves a physical examination, medical history, electrocardiogram (ECG), echocardiography, and other diagnostic tests such as stress test or cardiac MRI. Treatment options for LVH depend on the underlying cause and may include medications, lifestyle changes, and in some cases, surgery or other interventions.

The symptoms of myocarditis can vary depending on the severity of the inflammation and the location of the affected areas of the heart muscle. Common symptoms include chest pain, shortness of breath, fatigue, and swelling in the legs and feet.

Myocarditis can be difficult to diagnose, as its symptoms are similar to those of other conditions such as coronary artery disease or heart failure. Diagnosis is typically made through a combination of physical examination, medical history, and results of diagnostic tests such as electrocardiogram (ECG), echocardiogram, and blood tests.

Treatment of myocarditis depends on the underlying cause and severity of the condition. Mild cases may require only rest and over-the-counter pain medication, while more severe cases may require hospitalization and intravenous medications to manage inflammation and cardiac function. In some cases, surgery may be necessary to repair or replace damaged heart tissue.

Prevention of myocarditis is important, as it can lead to serious complications such as heart failure and arrhythmias if left untreated. Prevention strategies include avoiding exposure to viruses and other infections, managing underlying medical conditions such as diabetes and high blood pressure, and getting regular check-ups with a healthcare provider to monitor cardiac function.

In summary, myocarditis is an inflammatory condition that affects the heart muscle, causing symptoms such as chest pain, shortness of breath, and fatigue. Diagnosis can be challenging, but treatment options range from rest and medication to hospitalization and surgery. Prevention is key to avoiding serious complications and maintaining good cardiac health.

In TEA, the abnormal electrical focus in the atria can be caused by various factors, including damage to the heart tissue due to coronary artery disease, high blood pressure, or other underlying conditions. The condition can be diagnosed using electrocardiography (ECG) and can be treated with medications such as beta blockers or antiarrhythmics, or in some cases, catheter ablation may be necessary to destroy the abnormal electrical focus in the atria.

The term "ectopic" refers to the fact that the abnormal electrical activity originates from an unusual location within the heart, specifically in the atria near the cavo-tricuspid isthmus. The term "tachycardia" refers to the rapid and irregular heartbeat.

In summary, Tachycardia, Ectopic Atrial (TEA) is a type of arrhythmia that originates from an abnormal electrical focus in the atria near the cavo-tricuspid isthmus, leading to rapid and irregular atrial contractions and potentially causing symptoms such as palpitations and shortness of breath.

Symptoms of ARVD can include palpitations, shortness of breath, and fatigue, and may be accompanied by chest pain or pressure. Diagnosis is typically made through a combination of physical examination, electrocardiogram (ECG), echocardiogram, and cardiac MRI.

Treatment for ARVD is often focused on managing symptoms and preventing complications, and may include medications to control arrhythmias, implantable devices such as pacemakers or defibrillators, and in severe cases, heart transplantation. Prevention of sudden cardiac death is a critical aspect of management, and individuals with ARVD are often advised to avoid intense physical activity and take precautions to prevent injuries or trauma to the heart.

ARVD is a rare condition, affecting approximately 1 in 100,000 individuals worldwide. It can occur in individuals of all ages, but is most commonly diagnosed in young adults and children. While there is currently no cure for ARVD, advances in diagnostic techniques and treatment options have improved outcomes for individuals with this condition.

Note: Sinus tachycardia is different from atrial fibrillation, which is another type of arrhythmia that can also cause a rapid heart rate. In atrial fibrillation, the heart's upper chambers (atria) contract in a disorganized and irregular manner, rather than in a regular and coordinated pattern like in sinus tachycardia.

Recurrence can also refer to the re-emergence of symptoms in a previously treated condition, such as a chronic pain condition that returns after a period of remission.

In medical research, recurrence is often studied to understand the underlying causes of disease progression and to develop new treatments and interventions to prevent or delay its return.

The disorder is named after the three physicians who first described it in the early 20th century: Louis Wolff, John Parkinson, and Paul White. WPW syndrome can be diagnosed using a variety of tests, including electrocardiogram (ECG), echocardiogram, and stress test. Treatment options for WPW syndrome include medications to control heart rate and rhythm, catheter ablation (a minimally invasive procedure that destroys the extra electrical pathway), and in some cases, surgery.

WPW syndrome can be caused by a variety of genetic mutations, as well as by other factors such as coronary artery disease or hypertension. The condition is typically diagnosed in children or young adults, but it can also occur in older adults. WPW syndrome can be a serious condition, as the abnormal heart rhythms can lead to cardiac arrest and sudden death if left untreated. However, with proper treatment, most people with WPW syndrome can lead normal lives and have a good prognosis.

There are three main types of bundle branch blocks:

1. Right bundle branch block (RBBB): This occurs when the electrical conduction bundle that carries the heart's rhythm from the right atrium to the right ventricle is damaged or diseased.
2. Left bundle branch block (LBBB): This occurs when the electrical conduction bundle that carries the heart's rhythm from the left atrium to the left ventricle is damaged or diseased.
3. Bifascicular bundle branch block: This occurs when two of the electrical conduction bundles are damaged or diseased.

Symptoms of bundle branch block may include:

* Heart palpitations
* Slow or irregular heartbeat
* Shortness of breath
* Fatigue
* Dizziness or lightheadedness
* Chest pain or discomfort

Diagnosis of bundle branch block is typically made using an electrocardiogram (ECG) test, which measures the electrical activity of the heart. Treatment options for BBB may include medications to regulate the heartbeat, cardiac resynchronization therapy (CRT) to help both ventricles beat together, or implantable cardioverter-defibrillator (ICD) to prevent life-threatening arrhythmias. In some cases, surgery may be necessary to repair or replace damaged heart tissue.

It is important to note that bundle branch block can increase the risk of developing other cardiac conditions such as heart failure, atrial fibrillation, and ventricular tachycardia. Therefore, it is essential for individuals with BBB to work closely with their healthcare provider to manage their condition and reduce the risk of complications.

Rhabdomyomas are typically benign (non-cancerous) and slow-growing, but they can sometimes be malignant (cancerous). They can cause symptoms such as pain, swelling, and limited mobility in the affected area.

There are several types of rhabdomyoma, including:

1. Embryonal rhabdomyoma: This is the most common type of rhabdomyoma and typically occurs in the soft tissues of the body.
2. Alveolar rhabdomyoma: This type of rhabdomyoma is more aggressive than embryonal rhabdomyoma and can occur in both soft tissues and internal organs.
3. Pleomorphic rhabdomyoma: This type of rhabdomyoma is the least common and can occur in any part of the body. It has a more complex appearance under a microscope than the other types of rhabdomyoma.

The exact cause of rhabdomyomas is not fully understood, but they are thought to be related to genetic mutations that occur during fetal development. These tumors can be diagnosed through a combination of imaging tests such as ultrasound, CT scan, and MRI, and a biopsy to confirm the presence of cancer cells.

Treatment for rhabdomyoma depends on the size, location, and malignant potential of the tumor. Small, benign tumors may not require treatment and can be monitored with regular imaging studies. Larger or more aggressive tumors may require surgery to remove the tumor, and in some cases, radiation therapy or chemotherapy may be necessary to treat any remaining cancer cells.

Overall, rhabdomyomas are rare and relatively uncommon tumors that can occur in various parts of the body. They can cause symptoms such as pain and limited mobility, and can be diagnosed through a combination of imaging tests and biopsies. Treatment for these tumors depends on their size, location, and malignant potential, and may involve surgery and/or radiation therapy or chemotherapy.

The exact cause of endomyocardial fibrosis is not known, but it is believed to be related to inflammation and scarring within the heart. The condition is more common in men than women, and typically affects people between the ages of 20 and 50. Symptoms of endomyocardial fibrosis can include shortness of breath, fatigue, swelling in the legs and feet, and chest pain.

There is no cure for endomyocardial fibrosis, but treatment options may include medications to manage symptoms, surgery to repair or replace damaged heart tissue, and lifestyle changes such as a healthy diet and regular exercise. In severe cases, heart transplantation may be necessary. Early diagnosis and treatment can help slow the progression of the condition and improve quality of life for those affected.

Synonyms: RV dysfunction

See also: Left Ventricular Dysfunction, Cardiac Dysfunction, Heart Failure

Note: This term is not a formal medical diagnosis but rather a descriptive term used to indicate the specific location of cardiac dysfunction. A more comprehensive diagnosis would require further evaluation and testing by a healthcare provider.

Examples of syndromes include:

1. Down syndrome: A genetic disorder caused by an extra copy of chromosome 21 that affects intellectual and physical development.
2. Turner syndrome: A genetic disorder caused by a missing or partially deleted X chromosome that affects physical growth and development in females.
3. Marfan syndrome: A genetic disorder affecting the body's connective tissue, causing tall stature, long limbs, and cardiovascular problems.
4. Alzheimer's disease: A neurodegenerative disorder characterized by memory loss, confusion, and changes in personality and behavior.
5. Parkinson's disease: A neurological disorder characterized by tremors, rigidity, and difficulty with movement.
6. Klinefelter syndrome: A genetic disorder caused by an extra X chromosome in males, leading to infertility and other physical characteristics.
7. Williams syndrome: A rare genetic disorder caused by a deletion of genetic material on chromosome 7, characterized by cardiovascular problems, developmental delays, and a distinctive facial appearance.
8. Fragile X syndrome: The most common form of inherited intellectual disability, caused by an expansion of a specific gene on the X chromosome.
9. Prader-Willi syndrome: A genetic disorder caused by a defect in the hypothalamus, leading to problems with appetite regulation and obesity.
10. Sjogren's syndrome: An autoimmune disorder that affects the glands that produce tears and saliva, causing dry eyes and mouth.

Syndromes can be diagnosed through a combination of physical examination, medical history, laboratory tests, and imaging studies. Treatment for a syndrome depends on the underlying cause and the specific symptoms and signs presented by the patient.

Pericardial effusion can be caused by a variety of factors, including infection, inflammation, tumors, or trauma. It can also be a complication of other medical conditions such as heart failure or kidney disease.

Symptoms of pericardial effusion may include chest pain, shortness of breath, fatigue, and fever. If the effusion is severe, it can lead to cardiac tamponade, which is a life-threatening condition that requires immediate medical attention.

Diagnosis of pericardial effusion typically involves physical examination, imaging tests such as chest X-rays or echocardiography, and laboratory tests to determine the cause of the effusion. Treatment may involve drainage of the fluid, antibiotics for infection, or other medications to reduce inflammation. In severe cases, surgery may be necessary to remove the fluid and repair any damage to the heart or pericardial sac.

There are several types of SSS, including:

1. Sinus bradycardia: a slow heart rate due to sinus node dysfunction.
2. Sinus pauses: periods of complete cessation of sinus node activity.
3. Sinus arrhythmias: irregular heart rhythms caused by sinus node dysfunction.
4. Atrioventricular (AV) block: a delay or blockage in the electrical signal passing from the atria to the ventricles due to sinus node dysfunction.

Symptoms of SSS can include fatigue, weakness, dizziness, and fainting. In severe cases, SSS can lead to heart failure, atrial fibrillation, or ventricular tachycardia.

Diagnosis of SSS is typically made through a combination of physical examination, electrocardiogram (ECG), and echocardiography. Treatment options for SSS include medications to regulate the heart rhythm, cardioversion (electrical shock to restore a normal heart rhythm), and in some cases, implantation of a pacemaker or implantable cardioverter-defibrillator (ICD).

Prognosis for SSS is generally good if the underlying cause is identified and treated appropriately. However, if left untreated, SSS can lead to serious complications, such as heart failure, atrial fibrillation, or ventricular tachycardia, which can be life-threatening.

In summary, sick sinus syndrome is a group of heart rhythm disorders that affect the sinus node and can lead to abnormal heart rhythms, fatigue, weakness, dizziness, and fainting. Early diagnosis and treatment are important to prevent serious complications and improve prognosis.

The buildup of plaque in the coronary arteries is often caused by high levels of low-density lipoprotein (LDL) cholesterol, smoking, high blood pressure, diabetes, and a family history of heart disease. The plaque can also rupture, causing a blood clot to form, which can completely block the flow of blood to the heart muscle, leading to a heart attack.

CAD is the most common type of heart disease and is often asymptomatic until a serious event occurs. Risk factors for CAD include:

* Age (men over 45 and women over 55)
* Gender (men are at greater risk than women, but women are more likely to die from CAD)
* Family history of heart disease
* High blood pressure
* High cholesterol
* Diabetes
* Smoking
* Obesity
* Lack of exercise

Diagnosis of CAD typically involves a physical exam, medical history, and results of diagnostic tests such as:

* Electrocardiogram (ECG or EKG)
* Stress test
* Echocardiogram
* Coronary angiography

Treatment for CAD may include lifestyle changes such as a healthy diet, regular exercise, stress management, and quitting smoking. Medications such as beta blockers, ACE inhibitors, and statins may also be prescribed to manage symptoms and slow the progression of the disease. In severe cases, surgical intervention such as coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) may be necessary.

Prevention of CAD includes managing risk factors such as high blood pressure, high cholesterol, and diabetes, quitting smoking, maintaining a healthy weight, and getting regular exercise. Early detection and treatment of CAD can help to reduce the risk of complications and improve quality of life for those affected by the disease.

There are several types of heart valve diseases, including:

1. Mitral regurgitation: This occurs when the mitral valve does not close properly, allowing blood to flow backward into the left atrium.
2. Aortic stenosis: This occurs when the aortic valve becomes narrowed or blocked, restricting blood flow from the left ventricle into the aorta.
3. Pulmonary stenosis: This occurs when the pulmonary valve becomes narrowed or blocked, restricting blood flow from the right ventricle into the pulmonary artery.
4. Tricuspid regurgitation: This occurs when the tricuspid valve does not close properly, allowing blood to flow backward into the right atrium.
5. Heart valve thickening or calcification: This can occur due to aging, rheumatic fever, or other conditions that cause inflammation in the heart.
6. Endocarditis: This is an infection of the inner lining of the heart, which can damage the heart valves.
7. Rheumatic heart disease: This is a condition caused by rheumatic fever, which can damage the heart valves and cause scarring.
8. Congenital heart defects: These are heart defects that are present at birth, and can affect the heart valves as well as other structures of the heart.

Symptoms of heart valve disease can include shortness of breath, fatigue, swelling in the legs or feet, and chest pain. Treatment options for heart valve disease depend on the specific condition and can range from medication to surgery or other procedures.

The symptoms of PAT can vary in severity and may include:

* Rapid heartbeats (tachycardia)
* Palpitations or pounding sensation in the chest
* Shortness of breath (dyspnea)
* Dizziness or lightheadedness
* Chest pain or discomfort

During an episode of PAT, the heart rate may exceed 100 beats per minute and can reach as high as 200-300 beats per minute. The episodes can last from a few seconds to several hours and may occur randomly throughout the day.

PAT is often diagnosed through a physical examination, electrocardiogram (ECG), or holter monitor. Treatment options for PAT may include medications to control heart rate and rhythm, lifestyle changes such as avoiding triggers, and in severe cases, implantable devices such as pacemakers or cardioverter-defibrillators.

In summary, paroxysmal tachycardia is a type of arrhythmia that is characterized by rapid heartbeats that come and go in episodes, and it can be triggered by various factors. It can cause symptoms such as palpitations, shortness of breath, and chest pain, and may require treatment with medications or implantable devices.

Chagas cardiomyopathy is a type of heart disease that is caused by the parasitic infection Trypanosoma cruzi, which is transmitted through the feces of infected triatomine bugs. It is also known as American trypanosomiasis or Latin American trypanosomiasis.

The infection can cause inflammation and damage to the heart muscle, leading to cardiomyopathy, which is a condition where the heart muscle becomes weakened and cannot pump blood effectively. This can lead to symptoms such as shortness of breath, fatigue, swelling, and irregular heartbeat.

Chagas cardiomyopathy is most commonly found in countries in Central and South America, where the disease is transmitted by triatomine bugs that are found in rural areas. It is estimated that around 8 million people are infected with Chagas disease worldwide, with the majority of cases occurring in Latin America.

There is no cure for Chagas cardiomyopathy, but medications and other treatments can help manage symptoms and slow the progression of the disease. Prevention is key to avoiding Chagas cardiomyopathy, and this includes avoiding triatomine bug bites, using insecticides to kill bugs in homes, and screening blood donors for the disease.

Overall, Chagas cardiomyopathy is a serious and debilitating condition that can have significant implications for quality of life and survival. It is important to be aware of the risk of infection and take steps to prevent it, particularly if you live in or travel to areas where the disease is common.

The symptoms of AVNRT may include palpitations, shortness of breath, chest pain, and dizziness or lightheadedness. The arrhythmia can be triggered by stress, caffeine, exercise, or certain medications. It is important to seek medical attention if these symptoms persist or worsen over time, as AVNRT can increase the risk of more serious complications such as stroke or heart failure.

Diagnosis of AVNRT typically involves a physical examination, electrocardiogram (ECG), and other diagnostic tests such as echocardiography or stress testing. Treatment options for AVNRT include medications to regulate the heart rhythm, cardioversion, catheter ablation, or implantation of a cardioverter-defibrillator (ICD).

In summary, Tachycardia, Atrioventricular Nodal Reentry (AVNRT) is an arrhythmia that originates in the AV node and causes an abnormal and rapid heart rate. It can be triggered by various factors and can lead to more serious complications if left untreated. Accurate diagnosis and appropriate treatment are essential to managing this condition and preventing potential complications.

The normal range for potassium levels in the blood varies depending on age, gender, and other factors, but generally it is between 3.5 and 5.5 mEq/L (milliequivalents per liter).

Hypokalemia can be caused by a variety of factors such as diarrhea, vomiting, certain medications (diuretics, laxatives), kidney disease or malfunctioning of the parathyroid glands.

A condition characterized by swelling of the heart and surrounding tissues due to an accumulation of fluid. This can occur as a result of various conditions such as heart failure, coronary artery disease, or cardiomyopathy. The swelling can lead to symptoms such as shortness of breath, fatigue, and difficulty exercising. Treatment options include diuretics, ACE inhibitors, and other medications to manage the underlying condition causing the edema.

Example sentence: "The patient was diagnosed with cardiac edema and started on a regimen of diuretics and ACE inhibitors to help reduce the swelling and improve their symptoms."

There are two types of hypertension:

1. Primary Hypertension: This type of hypertension has no identifiable cause and is also known as essential hypertension. It accounts for about 90% of all cases of hypertension.
2. Secondary Hypertension: This type of hypertension is caused by an underlying medical condition or medication. It accounts for about 10% of all cases of hypertension.

Some common causes of secondary hypertension include:

* Kidney disease
* Adrenal gland disorders
* Hormonal imbalances
* Certain medications
* Sleep apnea
* Cocaine use

There are also several risk factors for hypertension, including:

* Age (the risk increases with age)
* Family history of hypertension
* Obesity
* Lack of exercise
* High sodium intake
* Low potassium intake
* Stress

Hypertension is often asymptomatic, and it can cause damage to the blood vessels and organs over time. Some potential complications of hypertension include:

* Heart disease (e.g., heart attacks, heart failure)
* Stroke
* Kidney disease (e.g., chronic kidney disease, end-stage renal disease)
* Vision loss (e.g., retinopathy)
* Peripheral artery disease

Hypertension is typically diagnosed through blood pressure readings taken over a period of time. Treatment for hypertension may include lifestyle changes (e.g., diet, exercise, stress management), medications, or a combination of both. The goal of treatment is to reduce the risk of complications and improve quality of life.

Myxomas are usually slow-growing and may not cause any symptoms until they reach a significant size. They can be painful and tender to the touch, and may be associated with swelling and redness in the affected area.

There are several types of myxoma, including:

1. Cutaneous myxoma: This type of myxoma occurs in the skin and is usually seen on the arms, legs, or trunk. It is a small, firm nodule that may be painful to the touch.
2. Subcutaneous myxoma: This type of myxoma occurs just beneath the skin and can cause swelling and bruising in the affected area.
3. Soft tissue myxoma: This type of myxoma occurs in the soft tissues of the body, such as muscles, tendons, and ligaments. It is usually painless and may not cause any symptoms until it reaches a significant size.
4. Intestinal myxoma: This type of myxoma occurs in the intestines and is rare. It can cause abdominal pain, bleeding, and other gastrointestinal symptoms.

Myxomas are usually diagnosed by a biopsy, which involves taking a sample of the tumor tissue and examining it under a microscope. Treatment for myxoma typically involves surgical removal of the tumor, and in some cases, radiation therapy may be recommended to prevent recurrence.

In summary, myxoma is a rare benign tumor that can occur anywhere in the body where there is connective tissue. It is usually slow-growing and may not cause any symptoms until it reaches a significant size. Treatment typically involves surgical removal of the tumor and, in some cases, radiation therapy to prevent recurrence.

The symptoms of Andersen Syndrome can vary in severity and may include:

1. Heart rhythm disturbances (arrhythmias)
2. Abnormal heart rate
3. Fainting spells (syncope)
4. Seizures
5. Weakness or paralysis of the face, arms, or legs
6. Vision problems
7. Hearing loss
8. Developmental delays and intellectual disability
9. Craniofacial abnormalities
10. Short stature

Andersen Syndrome is usually diagnosed through a combination of clinical evaluation, electrophysiology studies, and genetic testing. Treatment is aimed at managing the symptoms and may include medications to regulate the heart rhythm, anticonvulsants for seizure control, and physical therapy to improve muscle strength and coordination. In some cases, implantation of a cardioverter-defibrillator (ICD) may be necessary to prevent sudden death.

Andersen Syndrome is an autosomal dominant disorder, which means that a single copy of the mutated gene is enough to cause the condition. It can be inherited from one affected parent or can occur spontaneously due to a new mutation. The syndrome affects both males and females equally and can affect individuals of all ages, including children and adults.

Overall, Andersen Syndrome is a rare and complex disorder that requires careful management and monitoring by a team of healthcare professionals. With appropriate treatment, individuals with this condition can lead fulfilling lives despite the challenges posed by the syndrome.

Examples of fetal diseases include:

1. Down syndrome: A genetic disorder caused by an extra copy of chromosome 21, which can cause delays in physical and intellectual development, as well as increased risk of heart defects and other health problems.
2. Spina bifida: A birth defect that affects the development of the spine and brain, resulting in a range of symptoms from mild to severe.
3. Cystic fibrosis: A genetic disorder that affects the respiratory and digestive systems, causing thick mucus buildup and recurring lung infections.
4. Anencephaly: A condition where a portion of the brain and skull are missing, which is usually fatal within a few days or weeks of birth.
5. Clubfoot: A deformity of the foot and ankle that can be treated with casts or surgery.
6. Hirschsprung's disease: A condition where the nerve cells that control bowel movements are missing, leading to constipation and other symptoms.
7. Diaphragmatic hernia: A birth defect that occurs when there is a hole in the diaphragm, allowing organs from the abdomen to move into the chest cavity.
8. Gastroschisis: A birth defect where the intestines protrude through a opening in the abdominal wall.
9. Congenital heart disease: Heart defects that are present at birth, such as holes in the heart or narrowed blood vessels.
10. Neural tube defects: Defects that affect the brain and spine, such as spina bifida and anencephaly.

Early detection and diagnosis of fetal diseases can be crucial for ensuring proper medical care and improving outcomes for affected babies. Prenatal testing, such as ultrasound and blood tests, can help identify fetal anomalies and genetic disorders during pregnancy.

1. Coronary artery disease: The narrowing or blockage of the coronary arteries, which supply blood to the heart.
2. Heart failure: A condition in which the heart is unable to pump enough blood to meet the body's needs.
3. Arrhythmias: Abnormal heart rhythms that can be too fast, too slow, or irregular.
4. Heart valve disease: Problems with the heart valves that control blood flow through the heart.
5. Heart muscle disease (cardiomyopathy): Disease of the heart muscle that can lead to heart failure.
6. Congenital heart disease: Defects in the heart's structure and function that are present at birth.
7. Peripheral artery disease: The narrowing or blockage of blood vessels that supply oxygen and nutrients to the arms, legs, and other organs.
8. Deep vein thrombosis (DVT): A blood clot that forms in a deep vein, usually in the leg.
9. Pulmonary embolism: A blockage in one of the arteries in the lungs, which can be caused by a blood clot or other debris.
10. Stroke: A condition in which there is a lack of oxygen to the brain due to a blockage or rupture of blood vessels.

INCVM can occur as an isolated defect or in combination with other congenital heart defects. The symptoms may vary depending on the severity of the condition, but they usually include difficulty breathing, fatigue, and shortness of breath during exercise. INVCM can be diagnosed using various imaging techniques such as echocardiography, cardiac MRI, or cardiac catheterization.

Treatment options for INVCM vary depending on the severity of the condition and may include medications to manage symptoms, surgery to repair or replace damaged heart tissue, or implantation of a pacemaker or defibrillator to regulate heart rhythms. In some cases, INCVM may be treated with cardiac resynchronization therapy (CRT) or cardiac contractility modulation (CCM) to improve the heart's pumping function.

INVCM is a rare condition, and its prevalence is not well established. However, it is believed to affect approximately 1 in 100,000 to 1 in 200,000 individuals worldwide. INVCM can occur in people of all ages but is more commonly diagnosed in infants and children. With appropriate treatment, many individuals with INVCM can lead active and fulfilling lives.

Examples of acute diseases include:

1. Common cold and flu
2. Pneumonia and bronchitis
3. Appendicitis and other abdominal emergencies
4. Heart attacks and strokes
5. Asthma attacks and allergic reactions
6. Skin infections and cellulitis
7. Urinary tract infections
8. Sinusitis and meningitis
9. Gastroenteritis and food poisoning
10. Sprains, strains, and fractures.

Acute diseases can be treated effectively with antibiotics, medications, or other therapies. However, if left untreated, they can lead to chronic conditions or complications that may require long-term care. Therefore, it is important to seek medical attention promptly if symptoms persist or worsen over time.

The burden of chronic diseases is significant, with over 70% of deaths worldwide attributed to them, according to the World Health Organization (WHO). In addition to the physical and emotional toll they take on individuals and their families, chronic diseases also pose a significant economic burden, accounting for a large proportion of healthcare expenditure.

In this article, we will explore the definition and impact of chronic diseases, as well as strategies for managing and living with them. We will also discuss the importance of early detection and prevention, as well as the role of healthcare providers in addressing the needs of individuals with chronic diseases.

What is a Chronic Disease?

A chronic disease is a condition that lasts for an extended period of time, often affecting daily life and activities. Unlike acute diseases, which have a specific beginning and end, chronic diseases are long-term and persistent. Examples of chronic diseases include:

1. Diabetes
2. Heart disease
3. Arthritis
4. Asthma
5. Cancer
6. Chronic obstructive pulmonary disease (COPD)
7. Chronic kidney disease (CKD)
8. Hypertension
9. Osteoporosis
10. Stroke

Impact of Chronic Diseases

The burden of chronic diseases is significant, with over 70% of deaths worldwide attributed to them, according to the WHO. In addition to the physical and emotional toll they take on individuals and their families, chronic diseases also pose a significant economic burden, accounting for a large proportion of healthcare expenditure.

Chronic diseases can also have a significant impact on an individual's quality of life, limiting their ability to participate in activities they enjoy and affecting their relationships with family and friends. Moreover, the financial burden of chronic diseases can lead to poverty and reduce economic productivity, thus having a broader societal impact.

Addressing Chronic Diseases

Given the significant burden of chronic diseases, it is essential that we address them effectively. This requires a multi-faceted approach that includes:

1. Lifestyle modifications: Encouraging healthy behaviors such as regular physical activity, a balanced diet, and smoking cessation can help prevent and manage chronic diseases.
2. Early detection and diagnosis: Identifying risk factors and detecting diseases early can help prevent or delay their progression.
3. Medication management: Effective medication management is crucial for controlling symptoms and slowing disease progression.
4. Multi-disciplinary care: Collaboration between healthcare providers, patients, and families is essential for managing chronic diseases.
5. Health promotion and disease prevention: Educating individuals about the risks of chronic diseases and promoting healthy behaviors can help prevent their onset.
6. Addressing social determinants of health: Social determinants such as poverty, education, and employment can have a significant impact on health outcomes. Addressing these factors is essential for reducing health disparities and improving overall health.
7. Investing in healthcare infrastructure: Investing in healthcare infrastructure, technology, and research is necessary to improve disease detection, diagnosis, and treatment.
8. Encouraging policy change: Policy changes can help create supportive environments for healthy behaviors and reduce the burden of chronic diseases.
9. Increasing public awareness: Raising public awareness about the risks and consequences of chronic diseases can help individuals make informed decisions about their health.
10. Providing support for caregivers: Chronic diseases can have a significant impact on family members and caregivers, so providing them with support is essential for improving overall health outcomes.

Conclusion

Chronic diseases are a major public health burden that affect millions of people worldwide. Addressing these diseases requires a multi-faceted approach that includes lifestyle changes, addressing social determinants of health, investing in healthcare infrastructure, encouraging policy change, increasing public awareness, and providing support for caregivers. By taking a comprehensive approach to chronic disease prevention and management, we can improve the health and well-being of individuals and communities worldwide.

There are different types of heart aneurysms, including:

1. Left ventricular aneurysm: This is the most common type and occurs in the left lower chamber of the heart (left ventricle).
2. Right ventricular aneurysm: This type occurs in the right lower chamber of the heart (right ventricle).
3. Mitral valve aneurysm: This type occurs near the mitral valve, which separates the left atrium and left ventricle.
4. Tricuspid valve aneurysm: This type occurs near the tricuspid valve, which separates the right atrium and right ventricle.

Heart aneurysms can cause symptoms such as chest pain, shortness of breath, and fatigue. In some cases, they may not cause any symptoms until they rupture, leading to life-threatening complications.

Diagnosis of a heart aneurysm is typically made through imaging tests such as echocardiography, cardiac MRI, or CT scans. Treatment options for heart aneurysms depend on the size and location of the aneurysm, as well as the patient's overall health. Treatment may involve medications to control blood pressure and prevent further enlargement of the aneurysm, or in some cases, surgery may be necessary to repair or replace the affected heart muscle or valve.

Prognosis for heart aneurysms varies depending on the size and location of the aneurysm, as well as the patient's overall health. In general, early detection and treatment can improve outcomes and reduce the risk of complications.

Pericarditis is diagnosed through a combination of physical examination, medical history, and diagnostic tests such as electrocardiogram (ECG), echocardiogram, or blood tests. Treatment for pericarditis usually involves antibiotics if the condition is caused by an infection, as well as medication to manage pain and inflammation. In severe cases, surgery may be necessary to drain fluid from the pericardium or repair any damage to the heart muscle.

Pericarditis can have long-term effects on the heart if left untreated, such as scarring or thickening of the pericardium, which can lead to chronic inflammation and impaired heart function. Therefore, prompt diagnosis and treatment are important to prevent complications and improve outcomes for patients with pericarditis.

There are several types of disease susceptibility, including:

1. Genetic predisposition: This refers to the inherent tendency of an individual to develop a particular disease due to their genetic makeup. For example, some families may have a higher risk of developing certain diseases such as cancer or heart disease due to inherited genetic mutations.
2. Environmental susceptibility: This refers to the increased risk of developing a disease due to exposure to environmental factors such as pollutants, toxins, or infectious agents. For example, someone who lives in an area with high levels of air pollution may be more susceptible to developing respiratory problems.
3. Lifestyle susceptibility: This refers to the increased risk of developing a disease due to unhealthy lifestyle choices such as smoking, lack of exercise, or poor diet. For example, someone who smokes and is overweight may be more susceptible to developing heart disease or lung cancer.
4. Immune system susceptibility: This refers to the increased risk of developing a disease due to an impaired immune system. For example, people with autoimmune disorders such as HIV/AIDS or rheumatoid arthritis may be more susceptible to opportunistic infections.

Understanding disease susceptibility can help healthcare providers identify individuals who are at risk of developing certain diseases and provide preventive measures or early intervention to reduce the risk of disease progression. Additionally, genetic testing can help identify individuals with a high risk of developing certain diseases, allowing for earlier diagnosis and treatment.

In summary, disease susceptibility refers to the predisposition of an individual to develop a particular disease or condition due to various factors such as genetics, environment, lifestyle choices, and immune system function. Understanding disease susceptibility can help healthcare providers identify individuals at risk and provide appropriate preventive measures or early intervention to reduce the risk of disease progression.

The term "pre-excitation" refers to the fact that the electrical activity that triggers each heartbeat occurs before the actual contraction of the heart muscle. This can cause the heart to beat abnormally fast or irregularly, leading to a range of symptoms and complications.

There are several different types of pre-excitation syndromes, including:

1. Wolff-Parkinson-White (WPW) syndrome: This is the most common type of pre-excitation syndrome, and it is caused by an extra electrical pathway in the heart. This pathway can cause the heart to beat abnormally fast, leading to symptoms such as palpitations, shortness of breath, and dizziness.
2. Pre-excited atrial fibrillation: This is a type of atrial fibrillation (a common heart rhythm disorder) that is caused by an extra electrical pathway in the heart. Like WPW syndrome, this pathway can cause the heart to beat abnormally fast and lead to symptoms such as palpitations, shortness of breath, and dizziness.
3. Pre-excited ventricular tachycardia: This is a type of ventricular tachycardia (a rapid heart rhythm) that is caused by an extra electrical pathway in the heart. Like WPW syndrome and pre-excited atrial fibrillation, this pathway can cause the heart to beat abnormally fast and lead to symptoms such as palpitations, shortness of breath, and dizziness.
4. Other rare forms of pre-excitation syndromes: There are several other rare forms of pre-excitation syndromes, including idiopathic ventricular tachycardia, exercise-induced arrhythmias, and others. These syndromes can also cause abnormal heart rhythms and symptoms such as palpitations, shortness of breath, and dizziness.

In summary, pre-excitation syndromes are a group of rare heart rhythm disorders that are caused by extra electrical pathways in the heart. These pathways can cause the heart to beat abnormally fast and lead to symptoms such as palpitations, shortness of breath, and dizziness. The most common form of pre-excitation syndrome is WPW syndrome, but there are several other rare forms of these disorders as well.

In EJ tachycardia, the heartbeats are initiated by abnormal electrical impulses that arise from the junctional tissue near the atrioventricular (AV) node. These impulses then spread to the rest of the heart, causing a rapid and irregular heartbeat.

EJ tachycardia can be caused by a variety of factors, including:

* Coronary artery disease
* Heart failure
* Cardiomyopathy
* Hypertension
* Certain medications
* Abnormal electrical pathways in the heart

Symptoms of EJ tachycardia can include palpitations, shortness of breath, and dizziness. In some cases, the arrhythmia may be asymptomatic and only detected during a physical examination or electrocardiogram (ECG).

Diagnosis of EJ tachycardia is typically made based on symptoms, physical examination findings, and results of diagnostic tests such as an ECG, echocardiogram, or stress test. Treatment options for EJ tachycardia depend on the underlying cause of the arrhythmia and may include medications to control heart rate and rhythm, cardioversion (electrical shock therapy) to restore a normal heart rhythm, or catheter ablation to destroy the abnormal electrical pathways in the heart. In some cases, implantation of a cardioverter-defibrillator (ICD) may be recommended to prevent sudden death.

Types of Electric Injuries There are several types of electric injuries that can occur, including:

1. Electrical shock: This occurs when a person's body is exposed to an electric current, which can cause muscle contractions, nerve damage, and other systemic effects.
2. Electrical burns: These are burns caused by the heat generated by electrical currents flowing through the body. They can be superficial or deep, and may require surgical intervention.
3. Lightning strikes: This is a type of electric injury caused by direct exposure to lightning. It can cause a range of symptoms, including burns, cardiac arrest, and neurological damage.
4. Arc flash burns: These are burns caused by the intense heat generated when electrical currents flow through the body in an enclosed space. They can be severe and may require prolonged treatment.

Symptoms of Electric Injuries The symptoms of electric injuries can vary depending on the severity of the injury, but may include:

1. Muscle contractions or spasms
2. Numbness or tingling in the affected area
3. Burns or redness of the skin
4. Cardiac arrest or arrhythmias
5. Neurological damage or seizures
6. Respiratory distress or difficulty breathing
7. Weakness or fatigue
8. Dizziness or loss of consciousness

Treatment of Electric Injuries The treatment of electric injuries depends on the severity of the injury and may include:

1. Cardiopulmonary resuscitation (CPR) if the patient has cardiac arrest or is unresponsive
2. Burn care, including debridement and wound dressing
3. Electrolyte replacement to maintain fluid balance and prevent dehydration
4. Pain management with analgesics and sedatives
5. Physical therapy to restore strength and mobility
6. Monitoring of neurological function and seizure control
7. Psychological support to cope with the injury and its effects

Prevention of Electric Injuries Prevention of electric injuries is important, especially in workplaces where electrical hazards are present. Some measures for prevention include:

1. Proper training on electrical safety and equipment use
2. Regular inspection and maintenance of electrical equipment
3. Use of protective gear such as gloves, safety glasses, and hard hats
4. Avoiding direct contact with electrical sources
5. Use of ground fault circuit interrupters (GFCIs) to prevent electrical shock
6. Proper storage of electrical equipment when not in use
7. Emergency preparedness and response plans in place

In conclusion, electric injuries can be severe and potentially life-threatening. Prompt medical attention is essential for proper treatment and prevention of complications. It is important to be aware of the hazards of electricity and take measures to prevent electrical injuries in the workplace and at home. Proper training, equipment maintenance, and safety precautions can go a long way in preventing these types of injuries.

Angina pectoris is a medical condition that is characterized by recurring chest pain or discomfort due to reduced blood flow and oxygen supply to the heart muscle, specifically the myocardium. It is also known as stable angina or effort angina. The symptoms of angina pectoris typically occur during physical activity or emotional stress and are relieved by rest.

The term "angina" comes from the Latin word for "strangulation," which refers to the feeling of tightness or constriction in the chest that is associated with the condition. Angina pectoris can be caused by atherosclerosis, or the buildup of plaque in the coronary arteries, which supply blood to the heart muscle. This buildup can lead to the formation of atherosclerotic plaques that can narrow the coronary arteries and reduce blood flow to the heart muscle, causing chest pain.

There are several types of angina pectoris, including:

1. Stable angina: This is the most common type of angina and is characterized by predictable and reproducible symptoms that occur during specific situations or activities, such as exercise or emotional stress.
2. Unstable angina: This type of angina is characterized by unpredictable and changing symptoms that can occur at rest or with minimal exertion. It is often a sign of a more severe underlying condition, such as a heart attack.
3. Variant angina: This type of angina occurs during physical activity, but the symptoms are not relieved by rest.
4. Prinzmetal's angina: This is a rare type of angina that occurs at rest and is characterized by a feeling of tightness or constriction in the chest.

The diagnosis of angina pectoris is typically made based on a combination of physical examination, medical history, and diagnostic tests such as electrocardiogram (ECG), stress test, and imaging studies. Treatment for angina pectoris usually involves lifestyle modifications, such as regular exercise, a healthy diet, and stress management, as well as medications to relieve symptoms and reduce the risk of complications. In some cases, surgery or other procedures may be necessary to treat the underlying condition causing the angina.

There are many different types of ANS diseases, including:

1. Dysautonomia: a general term that refers to dysfunction of the autonomic nervous system.
2. Postural orthostatic tachycardia syndrome (POTS): a condition characterized by rapid heart rate and other symptoms that occur upon standing.
3. Neurocardiogenic syncope: a form of fainting caused by a sudden drop in blood pressure.
4. Multiple system atrophy (MSA): a progressive neurodegenerative disorder that affects the autonomic nervous system and other parts of the brain.
5. Parkinson's disease: a neurodegenerative disorder that can cause autonomic dysfunction, including constipation, urinary incontinence, and erectile dysfunction.
6. Dopamine deficiency: a condition characterized by low levels of the neurotransmitter dopamine, which can affect the ANS and other body systems.
7. Autonomic nervous system disorders associated with autoimmune diseases, such as Guillain-Barré syndrome and lupus.
8. Trauma: physical or emotional trauma can sometimes cause dysfunction of the autonomic nervous system.
9. Infections: certain infections, such as Lyme disease, can affect the autonomic nervous system.
10. Genetic mutations: some genetic mutations can affect the functioning of the autonomic nervous system.

Treatment for ANS diseases depends on the specific condition and its underlying cause. In some cases, medication may be prescribed to regulate heart rate, blood pressure, or other bodily functions. Lifestyle changes, such as regular exercise and stress management techniques, can also be helpful in managing symptoms. In severe cases, surgery may be necessary to correct anatomical abnormalities or repair damaged nerves.

In medical terms, death is defined as the irreversible cessation of all bodily functions that are necessary for life. This includes the loss of consciousness, the absence of breathing, heartbeat, and other vital signs. Brain death, which occurs when the brain no longer functions, is considered a definitive sign of death.

The medical professionals use various criteria to determine death, such as:

1. Cessation of breathing: When an individual stops breathing for more than 20 minutes, it is considered a sign of death.
2. Cessation of heartbeat: The loss of heartbeat for more than 20 minutes is another indicator of death.
3. Loss of consciousness: If an individual is unresponsive and does not react to any stimuli, it can be assumed that they have died.
4. Brain death: When the brain no longer functions, it is considered a definitive sign of death.
5. Decay of body temperature: After death, the body's temperature begins to decrease, which is another indicator of death.

In some cases, medical professionals may use advanced technologies such as electroencephalography (EEG) or functional magnetic resonance imaging (fMRI) to confirm brain death. These tests can help determine whether the brain has indeed ceased functioning and if there is no hope of reviving the individual.

It's important to note that while death is a natural part of life, it can be a difficult and emotional experience for those who are left behind. It's essential to provide support and care to the family members and loved ones of the deceased during this challenging time.

Cicatrix is a term used to describe the scar tissue that forms after an injury or surgery. It is made up of collagen fibers and other cells, and its formation is a natural part of the healing process. The cicatrix can be either hypertrophic (raised) or atrophic (depressed), depending on the severity of the original wound.

The cicatrix serves several important functions in the healing process, including:

1. Protection: The cicatrix helps to protect the underlying tissue from further injury and provides a barrier against infection.
2. Strength: The collagen fibers in the cicatrix give the scar tissue strength and flexibility, allowing it to withstand stress and strain.
3. Support: The cicatrix provides support to the surrounding tissue, helping to maintain the shape of the affected area.
4. Cosmetic appearance: The appearance of the cicatrix can affect the cosmetic outcome of a wound or surgical incision. Hypertrophic scars are typically red and raised, while atrophic scars are depressed and may be less noticeable.

While the formation of cicatrix is a normal part of the healing process, there are some conditions that can affect its development or appearance. For example, keloid scars are raised, thick scars that can form as a result of an overactive immune response to injury. Acne scars can also be difficult to treat and may leave a lasting impression on the skin.

In conclusion, cicatrix is an important part of the healing process after an injury or surgery. It provides protection, strength, support, and can affect the cosmetic appearance of the affected area. Understanding the formation and functions of cicatrix can help medical professionals to better manage wound healing and improve patient outcomes.

Some common examples of intraoperative complications include:

1. Bleeding: Excessive bleeding during surgery can lead to hypovolemia (low blood volume), anemia (low red blood cell count), and even death.
2. Infection: Surgical wounds can become infected, leading to sepsis or bacteremia (bacterial infection of the bloodstream).
3. Nerve damage: Surgery can sometimes result in nerve damage, leading to numbness, weakness, or paralysis.
4. Organ injury: Injury to organs such as the liver, lung, or bowel can occur during surgery, leading to complications such as bleeding, infection, or organ failure.
5. Anesthesia-related complications: Problems with anesthesia can include respiratory or cardiac depression, allergic reactions, or awareness during anesthesia (a rare but potentially devastating complication).
6. Hypotension: Low blood pressure during surgery can lead to inadequate perfusion of vital organs and tissues, resulting in organ damage or death.
7. Thromboembolism: Blood clots can form during surgery and travel to other parts of the body, causing complications such as stroke, pulmonary embolism, or deep vein thrombosis.
8. Postoperative respiratory failure: Respiratory complications can occur after surgery, leading to respiratory failure, pneumonia, or acute respiratory distress syndrome (ARDS).
9. Wound dehiscence: The incision site can separate or come open after surgery, leading to infection, fluid accumulation, or hernia.
10. Seroma: A collection of serous fluid that can develop at the surgical site, which can become infected and cause complications.
11. Nerve damage: Injury to nerves during surgery can result in numbness, weakness, or paralysis, sometimes permanently.
12. Urinary retention or incontinence: Surgery can damage the bladder or urinary sphincter, leading to urinary retention or incontinence.
13. Hematoma: A collection of blood that can develop at the surgical site, which can become infected and cause complications.
14. Pneumonia: Inflammation of the lungs after surgery can be caused by bacteria, viruses, or fungi and can lead to serious complications.
15. Sepsis: A systemic inflammatory response to infection that can occur after surgery, leading to organ dysfunction and death if not treated promptly.

It is important to note that these are potential complications, and not all patients will experience them. Additionally, many of these complications are rare, and the vast majority of surgeries are successful with minimal or no complications. However, it is important for patients to be aware of the potential risks before undergoing surgery so they can make an informed decision about their care.

There are different types of anoxia, including:

1. Cerebral anoxia: This occurs when the brain does not receive enough oxygen, leading to cognitive impairment, confusion, and loss of consciousness.
2. Pulmonary anoxia: This occurs when the lungs do not receive enough oxygen, leading to shortness of breath, coughing, and chest pain.
3. Cardiac anoxia: This occurs when the heart does not receive enough oxygen, leading to cardiac arrest and potentially death.
4. Global anoxia: This is a complete lack of oxygen to the entire body, leading to widespread tissue damage and death.

Treatment for anoxia depends on the underlying cause and the severity of the condition. In some cases, hospitalization may be necessary to provide oxygen therapy, pain management, and other supportive care. In severe cases, anoxia can lead to long-term disability or death.

Prevention of anoxia is important, and this includes managing underlying medical conditions such as heart disease, diabetes, and respiratory problems. It also involves avoiding activities that can lead to oxygen deprivation, such as scuba diving or high-altitude climbing, without proper training and equipment.

In summary, anoxia is a serious medical condition that occurs when there is a lack of oxygen in the body or specific tissues or organs. It can cause cell death and tissue damage, leading to serious health complications and even death if left untreated. Early diagnosis and treatment are crucial to prevent long-term disability or death.

In a normal heart, the aorta arises from the left ventricle and the pulmonary artery arises from the right ventricle. In TGV, the positions of these vessels are reversed, with the aorta arising from the right ventricle and the pulmonary artery arising from the left ventricle. This can lead to a variety of complications, including cyanosis (blue discoloration of the skin), tachycardia (rapid heart rate), and difficulty breathing.

TGV is often diagnosed during infancy or early childhood, and treatment typically involves surgery to repair the defect. In some cases, a procedure called an arterial switch may be performed, in which the aorta and pulmonary artery are surgically reversed to their normal positions. In other cases, a heart transplant may be necessary. With proper treatment, many individuals with TGV can lead active and healthy lives. However, they may require ongoing monitoring and care throughout their lives to manage any potential complications.

Note: This definition is based on the current medical knowledge and may change as new research and discoveries are made.

During myocardial stunning, the heart muscle cells experience a temporary reduction in contractility and an increase in the amount of lactic acid produced. This can lead to symptoms such as chest pain, shortness of breath, and fatigue. In severe cases, myocardial stunning can progress to myocardial infarction (heart attack) or cardiac arrest.

Myocardial stunning is often seen in athletes who engage in intense exercise, such as marathon runners or professional football players. It can also occur in people with pre-existing heart conditions, such as coronary artery disease or hypertension.

Treatment of myocardial stunning typically involves addressing the underlying cause, such as reducing stress on the heart or improving blood flow to the myocardium. In severe cases, medications such as nitrates or beta blockers may be used to reduce the workload on the heart and improve contractility. In some cases, hospitalization may be necessary to monitor the condition and provide appropriate treatment.

Prevention of myocardial stunning involves taking steps to reduce the risk factors for heart disease, such as maintaining a healthy diet, exercising regularly, and managing stress. It is also important to seek medical attention if symptoms of myocardial stunning are present, as prompt treatment can help prevent more severe complications.

There are several types of channelopathies, including:

1. Long QT syndrome: This is a condition that affects the ion channels in the heart, leading to abnormal heart rhythms and increased risk of sudden death.
2. Short QT syndrome: This is a rare condition that has the opposite effect of long QT syndrome, causing the heart to beat too quickly.
3. Catecholaminergic polymorphic ventricular tachycardia (CPVT): This is a rare disorder that affects the ion channels in the heart, leading to abnormal heart rhythms and increased risk of sudden death.
4. Brugada syndrome: This is a condition that affects the ion channels in the heart, leading to abnormal heart rhythms and increased risk of sudden death.
5. Wolff-Parkinson-White (WPW) syndrome: This is a condition that affects the ion channels in the heart, leading to abnormal heart rhythms and increased risk of sudden death.
6. Neuromuscular disorders: These are disorders that affect the nerve-muscle junction, leading to muscle weakness and wasting. Examples include muscular dystrophy and myasthenia gravis.
7. Dystrophinopathies: These are a group of disorders that affect the structure of muscle cells, leading to muscle weakness and wasting. Examples include Duchenne muscular dystrophy and Becker muscular dystrophy.
8. Myotonia: This is a condition that affects the muscles, causing them to become stiff and rigid.
9. Hyperkalemic periodic paralysis: This is a rare condition that causes muscle weakness and paralysis due to abnormal potassium levels in the body.
10. Hypokalemic periodic paralysis: This is a rare condition that causes muscle weakness and paralysis due to low potassium levels in the body.
11. Thyrotoxic periodic paralysis: This is a rare condition that causes muscle weakness and paralysis due to an overactive thyroid gland.
12. Hyperthyroidism: This is a condition where the thyroid gland becomes overactive, leading to increased heart rate, weight loss, and muscle weakness.
13. Hypothyroidism: This is a condition where the thyroid gland becomes underactive, leading to fatigue, weight gain, and muscle weakness.
14. Pituitary tumors: These are tumors that affect the pituitary gland, which regulates hormone production in the body.
15. Adrenal tumors: These are tumors that affect the adrenal glands, which produce hormones such as cortisol and aldosterone.
16. Carcinoid syndrome: This is a condition where cancer cells in the digestive system produce hormones that can cause muscle weakness and wasting.
17. Multiple endocrine neoplasia (MEN): This is a genetic disorder that affects the endocrine system and can cause tumors to grow in the thyroid, adrenal, and parathyroid glands.

These are just some of the many potential causes of muscle weakness. It's important to see a healthcare professional for an accurate diagnosis and appropriate treatment.

In medicine, cyanosis is often used as an indication of the severity of a patient's condition. For example, a patient with severe cyanosis may have a more serious underlying condition than a patient with mild cyanosis. Additionally, cyanosis can be used to monitor the effectiveness of treatment and to determine when further interventions are necessary.

Cyanosis can be diagnosed through physical examination, blood tests, and other diagnostic procedures such as pulse oximetry or arterial blood gas analysis. Treatment for cyanosis depends on the underlying cause and may include oxygen therapy, medication, or surgical intervention.

In summary, cyanosis is a condition characterized by a bluish discoloration of the skin and mucous membranes due to inadequate oxygenation of the body's tissues. It is an important sign of underlying disease and can be used to assess the severity of a patient's condition and monitor the effectiveness of treatment.

There are several types of hypertrophy, including:

1. Muscle hypertrophy: The enlargement of muscle fibers due to increased protein synthesis and cell growth, often seen in individuals who engage in resistance training exercises.
2. Cardiac hypertrophy: The enlargement of the heart due to an increase in cardiac workload, often seen in individuals with high blood pressure or other cardiovascular conditions.
3. Adipose tissue hypertrophy: The excessive growth of fat cells, often seen in individuals who are obese or have insulin resistance.
4. Neurological hypertrophy: The enlargement of neural structures such as brain or spinal cord due to an increase in the number of neurons or glial cells, often seen in individuals with neurodegenerative diseases such as Alzheimer's or Parkinson's.
5. Hepatic hypertrophy: The enlargement of the liver due to an increase in the number of liver cells, often seen in individuals with liver disease or cirrhosis.
6. Renal hypertrophy: The enlargement of the kidneys due to an increase in blood flow and filtration, often seen in individuals with kidney disease or hypertension.
7. Ovarian hypertrophy: The enlargement of the ovaries due to an increase in the number of follicles or hormonal imbalances, often seen in individuals with polycystic ovary syndrome (PCOS).

Hypertrophy can be diagnosed through various medical tests such as imaging studies (e.g., CT scans, MRI), biopsies, and blood tests. Treatment options for hypertrophy depend on the underlying cause and may include medications, lifestyle changes, and surgery.

In conclusion, hypertrophy is a growth or enlargement of cells, tissues, or organs in response to an excessive stimulus. It can occur in various parts of the body, including the brain, liver, kidneys, heart, muscles, and ovaries. Understanding the underlying causes and diagnosis of hypertrophy is crucial for effective treatment and management of related health conditions.

The name "Romano-Ward" refers to the first two patients described with the condition, who were named Romano and Ward. The syndrome was first identified in the early 2000s by a team of researchers led by Dr. David Adams at the University of California, Los Angeles (UCLA).

People with Romano-Ward syndrome often have distinctive physical features, such as large ears, a prominent forehead, and a narrow face. They may also have difficulty with coordination and balance, and may experience joint pain and stiffness. The condition is typically diagnosed in early childhood, and there is currently no cure or standard treatment.

Research into Romano-Ward syndrome is ongoing, and scientists are working to better understand the genetic causes of the condition and to develop new treatments for affected individuals.

There are several causes of hypotension, including:

1. Dehydration: Loss of fluids and electrolytes can cause a drop in blood pressure.
2. Blood loss: Losing too much blood can lead to hypotension.
3. Medications: Certain medications, such as diuretics and beta-blockers, can lower blood pressure.
4. Heart conditions: Heart failure, cardiac tamponade, and arrhythmias can all cause hypotension.
5. Endocrine disorders: Hypothyroidism (underactive thyroid) and adrenal insufficiency can cause low blood pressure.
6. Vasodilation: A condition where the blood vessels are dilated, leading to low blood pressure.
7. Sepsis: Severe infection can cause hypotension.

Symptoms of hypotension can include:

1. Dizziness and lightheadedness
2. Fainting or passing out
3. Weakness and fatigue
4. Confusion and disorientation
5. Pale, cool, or clammy skin
6. Fast or weak pulse
7. Shortness of breath
8. Nausea and vomiting

If you suspect that you or someone else is experiencing hypotension, it is important to seek medical attention immediately. Treatment will depend on the underlying cause of the condition, but may include fluids, electrolytes, and medication to raise blood pressure. In severe cases, hospitalization may be necessary.

There are several types of MVP, including:

1. Primary MVP: This is the most common type of MVP and occurs when the mitral valve leaflets are too long and prolapse into the left atrium.
2. Secondary MVP: This type of MVP occurs when another condition, such as a heart murmur or an enlarged heart, causes the mitral valve to prolapse.
3. Functional MVP: This type of MVP is caused by abnormal functioning of the mitral valve rather than any physical defect.
4. Rheumatic MVP: This type of MVP is caused by inflammation of the mitral valve due to rheumatic fever.

The symptoms of MVP can vary in severity and may include:

* Chest pain or discomfort
* Shortness of breath
* Palpitations or fluttering in the chest
* Fatigue
* Dizziness or lightheadedness
* Coughing up pink, foamy fluid (in severe cases)

If you experience any of these symptoms, it is important to see a doctor for proper diagnosis and treatment. MVP can be diagnosed with an echocardiogram, which uses sound waves to create images of the heart. Treatment options for MVP include medications to control symptoms, lifestyle changes such as regular exercise and a healthy diet, and in severe cases, surgery to repair or replace the mitral valve.

In conclusion, mitral valve prolapse is a relatively common condition that can cause a range of symptoms. It is important to seek medical attention if you experience any of these symptoms so that proper diagnosis and treatment can be provided. With appropriate treatment, most people with MVP can lead normal, active lives.

Causes of Hyperkalemia:

1. Kidney dysfunction: When the kidneys are not able to excrete excess potassium, it can build up in the bloodstream and lead to hyperkalemia.
2. Medications: Certain drugs, such as ACE inhibitors, potassium-sparing diuretics, and NSAIDs, can increase potassium levels by blocking the excretion of potassium in the urine.
3. Diabetic ketoacidosis: High levels of potassium can occur in people with uncontrolled diabetes who have diabetic ketoacidosis.
4. Acute kidney injury: This condition can cause a rapid increase in potassium levels as the kidneys are unable to remove excess potassium from the blood.
5. Heart disease: Potassium levels can rise in people with heart failure or other cardiac conditions, leading to hyperkalemia.

Symptoms of Hyperkalemia:

1. Muscle weakness and fatigue
2. Abnormal heart rhythms (arrhythmias)
3. Palpitations
4. Constipation
5. Nausea and vomiting
6. Abdominal cramps
7. Fatigue
8. Confusion
9. Headaches
10. Weakness in the legs and feet

Treatment of Hyperkalemia:

The treatment of hyperkalemia depends on the underlying cause and the severity of the condition. Some of the common methods for lowering potassium levels include:

1. Diuretics: These medications help remove excess fluid and electrolytes, including potassium, from the body.
2. Calcium gluconate: This medication can help stabilize cardiac function and reduce the risk of arrhythmias.
3. Insulin and glucose: Giving insulin and glucose to someone with diabetic ketoacidosis can help lower potassium levels by increasing glucose uptake in the cells.
4. Hemodialysis: This is a process that uses a machine to filter waste products, including excess potassium, from the blood.
5. Potassium-binding resins: These medications can bind to potassium ions in the gut and prevent their absorption into the bloodstream.
6. Sodium polystyrene sulfonate (Kayexalate): This medication can help lower potassium levels by binding to excess potassium in the gut and causing it to be eliminated in the stool.
7. Activated charcoal: This medication can help bind to potassium ions in the gut and prevent their absorption into the bloodstream.

In severe cases of hyperkalemia, hospitalization may be necessary to monitor and treat the condition. In some instances, dialysis may be required to remove excess potassium from the blood. It is important to note that the treatment for hyperkalemia should only be done under the guidance of a healthcare professional, as some medications or procedures can worsen the condition if not properly managed.

Types of Diabetic Cardiomyopathies:

1. Diabetic cardiomyopathy: This is the most common type of diabetic cardiomyopathy and is characterized by fibrosis, hypertrophy, and left ventricular dysfunction.
2. Diabetic cardiac syndrome: This condition is characterized by a combination of myocardial stunning, fibrosis, and systolic dysfunction.
3. Diabetic myocarditis: This is an inflammatory condition that affects the heart muscle and can lead to scarring and dysfunction.
4. Diabetic cardiac arrest: This is a rare but life-threatening complication of diabetes that occurs when the heart stops functioning due to severe coronary artery disease or other factors.

Causes and Risk Factors:

1. Hyperglycemia: Elevated blood sugar levels can damage the cardiovascular system, including the heart muscle.
2. Hypertension: High blood pressure can increase the risk of cardiac complications in individuals with diabetes.
3. Dyslipidemia: Abnormal lipid levels, such as high triglycerides and low HDL cholesterol, can contribute to the development of cardiovascular disease.
4. Smoking: Smoking is a significant risk factor for cardiovascular disease in individuals with diabetes.
5. Obesity: Excess weight can increase the risk of cardiovascular disease and worsen glycemic control.
6. Family history: A family history of cardiovascular disease increases the risk of developing diabetic cardiomyopathy.

Symptoms:

1. Chest pain or angina
2. Shortness of breath
3. Fatigue
4. Swelling of the legs and feet
5. Palpitations
6. Dizziness and lightheadedness

Diagnosis:

1. Physical examination
2. Electrocardiogram (ECG)
3. Echocardiography
4. Stress test
5. Blood tests to assess lipid levels, blood sugar, and kidney function

Treatment and Management:

1. Medications: ACE inhibitors or beta-blockers may be prescribed to manage hypertension and angina. Statins may be used to lower cholesterol levels.
2. Lifestyle modifications: Smoking cessation, weight loss, and regular exercise can help improve glycemic control and cardiovascular health.
3. Dietary changes: A healthy, balanced diet low in saturated fats, added sugars, and refined carbohydrates can help manage blood sugar levels and improve overall health.
4. Monitoring: Regular monitoring of blood sugar levels, blood pressure, and lipid profiles is essential to prevent complications and manage the condition effectively.
5. Surgical intervention: In severe cases, bariatric surgery may be considered to help achieve significant weight loss and improve glycemic control.

Prognosis:
The prognosis for patients with metabolic syndrome is generally good if the condition is identified early and managed effectively. However, untreated or poorly managed metabolic syndrome can increase the risk of developing serious health complications such as heart disease, stroke, and type 2 diabetes.

Complications:

1. Heart disease: The increased risk of heart disease is due to high blood pressure, high cholesterol levels, and obesity, which can lead to atherosclerosis (hardening of the arteries) and coronary artery disease.
2. Stroke: The risk of stroke is increased due to high blood pressure, diabetes, and obesity, which can damage the blood vessels in the brain and cause a stroke.
3. Type 2 diabetes: Metabolic syndrome increases the risk of developing type 2 diabetes due to insulin resistance and impaired glucose tolerance.
4. Other health complications: Other potential complications of metabolic syndrome include non-alcoholic fatty liver disease, sleep apnea, and osteoarthritis.

Preventive Measures:

1. Healthy diet: Eating a healthy, balanced diet that is low in saturated fats, added sugars, and refined carbohydrates can help prevent or manage metabolic syndrome.
2. Regular exercise: Engaging in regular physical activity can improve insulin sensitivity, reduce inflammation, and promote weight loss.
3. Weight management: Maintaining a healthy weight through diet and exercise can help prevent or manage metabolic syndrome.
4. Stress management: Chronic stress can contribute to the development of metabolic syndrome by promoting inflammation and decreasing insulin sensitivity. Engaging in stress-reducing activities such as yoga, meditation, or deep breathing exercises may be helpful.
5. Sleep hygiene: Getting adequate sleep is essential for maintaining metabolic health. Aim for 7-8 hours of sleep per night and practice good sleep hygiene by avoiding caffeine and electronic screens before bedtime.
6. Limit alcohol intake: Drinking too much alcohol can contribute to the development of metabolic syndrome by promoting inflammation, increasing triglycerides, and decreasing HDL cholesterol.
7. Quit smoking: Smoking is a significant risk factor for developing metabolic syndrome, as it promotes inflammation, decreases insulin sensitivity, and increases cardiovascular disease risk.
8. Monitoring and treatment of underlying conditions: If you have underlying conditions such as hypertension, high cholesterol, or diabetes, it is essential to monitor and manage them effectively to prevent the development of metabolic syndrome.

In conclusion, metabolic syndrome is a cluster of conditions that increase the risk of developing type 2 diabetes and cardiovascular disease. It is essential to be aware of the risk factors, symptoms, and complications of metabolic syndrome and take preventive measures to manage and prevent it. By making healthy lifestyle choices, such as following a balanced diet, exercising regularly, maintaining a healthy weight, and managing underlying conditions, you can reduce your risk of developing metabolic syndrome and improve your overall health.

HFCM is caused by mutations in genes that encode proteins involved in the structure and function of the heart muscle. These mutations can be inherited from one's parents or can occur spontaneously. The condition typically affects multiple members of a family, and the age of onset and severity of symptoms can vary widely.

HFCM is diagnosed through a combination of physical examination, medical history, and diagnostic tests such as echocardiography, electrocardiography, and cardiac MRI. Treatment options for HFCM include medications to manage symptoms, lifestyle modifications such as regular exercise and a healthy diet, and in some cases, surgery or other procedures to repair or replace damaged heart tissue.

In summary, Cardiomyopathy, Hypertrophic, Familial (HFCM) is a genetic disorder that affects the heart muscle, leading to thickening of the heart muscle and potentially causing heart failure and other complications. It is characterized by an abnormal thickening of the heart muscle, particularly in the left ventricle, and can be inherited or caused by spontaneous mutations in genes that encode proteins involved in heart muscle structure and function.

Some common types of cardiovascular abnormalities include:

1. Hypertension (high blood pressure): This occurs when the force of blood pushing against the artery walls is too high, which can damage the blood vessels and increase the risk of heart disease.
2. Hyperlipidemia (high cholesterol): Elevated levels of low-density lipoprotein (LDL) cholesterol and triglycerides in the blood can contribute to the buildup of plaque in the arteries, leading to blockages and increasing the risk of heart disease.
3. Heart valve problems: Dysfunctional heart valves can disrupt the normal flow of blood, causing symptoms such as fatigue, shortness of breath, and swelling in the legs.
4. Cardiac arrhythmias (abnormal heart rhythms): These can include atrial fibrillation, ventricular tachycardia, and ventricular fibrillation, which can lead to irregular heartbeats and potentially life-threatening complications.
5. Heart failure: This occurs when the heart is unable to pump enough blood to meet the body's needs, leading to fatigue, swelling in the legs, and shortness of breath.
6. Coronary artery disease: The buildup of plaque in the coronary arteries can reduce blood flow to the heart muscle, leading to chest pain or a heart attack.
7. Heart murmurs: These are abnormal sounds heard during a heartbeat that can indicate underlying cardiovascular problems, such as congenital heart defects or heart valve problems.
8. Anemia: This is a condition in which the body does not have enough red blood cells or hemoglobin, which can lead to fatigue, weakness, and shortness of breath.
9. Peripheral artery disease: The narrowing of the blood vessels that supply oxygen and nutrients to the legs, which can cause leg pain when walking (claudication) or numbness in the legs.
10. Venous thromboembolism (VTE): This is a condition in which a blood clot forms in the veins, which can be dangerous and even life-threatening if it breaks loose and travels to the lungs.

It's important to note that this list is not exhaustive and there may be other cardiovascular conditions that are not included here. If you suspect you or someone else is experiencing a cardiovascular problem, it's important to seek medical attention immediately.

Cardiac output (CO) is a measure of the heart's ability to pump blood effectively. A high cardiac output indicates that the heart is pumping a large amount of blood per minute, which can be necessary for meeting the body's increased demands during physical activity or stress.

A cardiac output of more than 10 liters per minute is generally considered high. This can be caused by a variety of factors, including:

* Increased heart rate: A fast heart rate can increase the amount of blood being pumped by the heart.
* Increased stroke volume: When the heart muscle contracts, it can pump more blood with each beat if the stroke volume is increased.
* Increased cardiac power: This refers to the overall force of the heart's contractions, which can be increased in conditions such as hypertension or athetosis.

A high cardiac output can be beneficial in certain situations, such as during exercise or when the body needs more oxygen and nutrients. However, a consistently high cardiac output can also be indicative of a cardiovascular condition that needs to be treated.

Some possible causes of a high cardiac output include:

* Heart failure: This is a condition in which the heart is unable to pump enough blood to meet the body's needs.
* Hypertension: High blood pressure can put extra strain on the heart, causing it to work harder and increase its cardiac output.
* Athetosis: This is a condition characterized by an abnormal heart rhythm, which can cause the heart to beat more quickly and increase its cardiac output.
* Anemia: A lack of red blood cells can lead to a decrease in oxygen delivery to the body's tissues, causing the heart to work harder and increase its cardiac output.

In summary, a high cardiac output is generally considered to be more than 10 liters per minute and can be caused by a variety of factors, including increased heart rate, stroke volume, or cardiac power. While a high cardiac output can be beneficial in certain situations, it can also be indicative of a underlying cardiovascular condition that needs to be treated.

Reperfusion injury can cause inflammation, cell death, and impaired function in the affected tissue or organ. The severity of reperfusion injury can vary depending on the duration and severity of the initial ischemic event, as well as the promptness and effectiveness of treatment to restore blood flow.

Reperfusion injury can be a complicating factor in various medical conditions, including:

1. Myocardial infarction (heart attack): Reperfusion injury can occur when blood flow is restored to the heart muscle after a heart attack, leading to inflammation and cell death.
2. Stroke: Reperfusion injury can occur when blood flow is restored to the brain after an ischemic stroke, leading to inflammation and damage to brain tissue.
3. Organ transplantation: Reperfusion injury can occur when a transplanted organ is subjected to ischemia during harvesting or preservation, and then reperfused with blood.
4. Peripheral arterial disease: Reperfusion injury can occur when blood flow is restored to a previously occluded peripheral artery, leading to inflammation and damage to the affected tissue.

Treatment of reperfusion injury often involves medications to reduce inflammation and oxidative stress, as well as supportive care to manage symptoms and prevent further complications. In some cases, experimental therapies such as stem cell transplantation or gene therapy may be used to promote tissue repair and regeneration.

Also known as: SA block, sinus block, atrioventricular dissociation.

Causes: Can be caused by various factors such as medications, electrolyte imbalances, coronary artery disease, heart failure, and cardiac surgery.

Symptoms: May be asymptomatic or may cause symptoms such as fatigue, weakness, dizziness, lightheadedness, fainting, and chest pain.

Diagnosis: Diagnosed using electrocardiography (ECG) tests such as the P waves, QRS complexes, and PR interval.

Treatment: Treatment depends on the underlying cause of the block and may include medications to regulate the heart rhythm, cardioversion to restore a normal heart rhythm, and in severe cases, implantation of a pacemaker.

Prognosis: The prognosis for sinoatrial block is generally good if the underlying cause is treated effectively. However, if left untreated, it can lead to more serious complications such as atrial fibrillation, ventricular tachycardia, and cardiac arrest.

Here are some of the main points about Jervell-Lange Nielsen Syndrome:

1. Rare genetic disorder: Jervell-Lange Nielsen Syndrome is a rare genetic disorder that affects the development of the nervous system.
2. Progressive muscle weakness: The syndrome is characterized by progressive muscle weakness, which can make it difficult for individuals to walk and perform other daily activities.
3. High risk of sudden death: Individuals with Jervell-Lange Nielsen Syndrome have a high risk of sudden death due to cardiac arrhythmias, which can be triggered by stress, exercise, or other factors.
4. Caused by genetic mutations: The syndrome is caused by mutations in genes that code for proteins involved in the development and maintenance of nerve cells.
5. No cure: There is no cure for Jervell-Lange Nielsen Syndrome, but treatment options are available to manage symptoms and prevent complications.
6. Poor prognosis: The prognosis for individuals with this syndrome is generally poor, with most individuals dying before the age of 20 due to cardiac or respiratory failure.
7. Other names: Jervell-Lange Nielsen Syndrome is also known as type 1 long QT syndrome, which refers to the abnormal heart rhythm that is a hallmark of the condition.
8. Rare: The syndrome is rare, with an estimated prevalence of 1 in 200,000 to 1 in 500,000 individuals worldwide.
9. Inherited in an autosomal recessive pattern: Jervell-Lange Nielsen Syndrome is inherited in an autosomal recessive pattern, meaning that a child must inherit two copies of the mutated gene (one from each parent) to develop the condition.
10. Diagnostic criteria: The diagnosis of Jervell-Lange Nielsen Syndrome is based on a combination of clinical features, including progressive muscle weakness, high risk of sudden death, and characteristic electrocardiogram (ECG) findings. Genetic testing can also be used to confirm the diagnosis.

I hope this list helps you understand Jervell-Lange Nielsen Syndrome better! Let me know if you have any other questions.

Explanation: Genetic predisposition to disease is influenced by multiple factors, including the presence of inherited genetic mutations or variations, environmental factors, and lifestyle choices. The likelihood of developing a particular disease can be increased by inherited genetic mutations that affect the functioning of specific genes or biological pathways. For example, inherited mutations in the BRCA1 and BRCA2 genes increase the risk of developing breast and ovarian cancer.

The expression of genetic predisposition to disease can vary widely, and not all individuals with a genetic predisposition will develop the disease. Additionally, many factors can influence the likelihood of developing a particular disease, such as environmental exposures, lifestyle choices, and other health conditions.

Inheritance patterns: Genetic predisposition to disease can be inherited in an autosomal dominant, autosomal recessive, or multifactorial pattern, depending on the specific disease and the genetic mutations involved. Autosomal dominant inheritance means that a single copy of the mutated gene is enough to cause the disease, while autosomal recessive inheritance requires two copies of the mutated gene. Multifactorial inheritance involves multiple genes and environmental factors contributing to the development of the disease.

Examples of diseases with a known genetic predisposition:

1. Huntington's disease: An autosomal dominant disorder caused by an expansion of a CAG repeat in the Huntingtin gene, leading to progressive neurodegeneration and cognitive decline.
2. Cystic fibrosis: An autosomal recessive disorder caused by mutations in the CFTR gene, leading to respiratory and digestive problems.
3. BRCA1/2-related breast and ovarian cancer: An inherited increased risk of developing breast and ovarian cancer due to mutations in the BRCA1 or BRCA2 genes.
4. Sickle cell anemia: An autosomal recessive disorder caused by a point mutation in the HBB gene, leading to defective hemoglobin production and red blood cell sickling.
5. Type 1 diabetes: An autoimmune disease caused by a combination of genetic and environmental factors, including multiple genes in the HLA complex.

Understanding the genetic basis of disease can help with early detection, prevention, and treatment. For example, genetic testing can identify individuals who are at risk for certain diseases, allowing for earlier intervention and preventive measures. Additionally, understanding the genetic basis of a disease can inform the development of targeted therapies and personalized medicine."


The second Cardiac Arrhythmia Suppression Trial (CAST II) modified the enrollment criteria to include patients at higher risk ... The Cardiac Arrhythmia Suppression Trial (CAST) was a double-blind, randomized, controlled study designed to test the ... Clinical trial number NCT00000526 for "Cardiac Arrhythmia Suppression Trial (CAST)" at ClinicalTrials.gov (CS1 German-language ... A possible explanation for increased mortality in the Cardiac Arrhythmia Suppression Trial (CAST)". Circulation. 90 (6): 2843- ...
This action may reduce the prevalence of malignant cardiac arrhythmias, and the reduction in sudden death reported in large ... 8.4). Aronow, Wilbert S. (2010). "Cardiac Arrhythmias". Brocklehurst's Textbook of Geriatric Medicine and Gerontology. Elsevier ... decrease cardiac output, cardiac index, stroke work, and volume; lower resistance in blood vessels in the kidneys; and lead to ... This leads to cardiac dysfunction and neuromuscular consequences, such as muscle weakness, paresthesia, nausea, diarrhea, and ...
doi:10.1016/c2012-0-06151-0. ISBN 978-0-323-49798-5. Aronow, Wilbert S. (2010). "Cardiac Arrhythmias". Brocklehurst's Textbook ... Angiotensin-converting enzyme inhibitors ACE inhibitors have been demonstrated to reduce sudden cardiac death in some studies ...
Heart arrhythmia is not the most common cause in children. When there is a cardiac arrhythmia, it is most often asystole or ... Non-cardiac causes account for 15 to 25% of cardiac arrests. The most common non-cardiac causes are trauma, major bleeding ( ... nonischemic causes).: 831 Sudden cardiac arrest can result from cardiac and non-cardiac causes including the following: ... is sudden death from cardiac causes. However, sometimes physicians call cardiac arrest "sudden cardiac death" even if the ...
Mechanisms of Cardiac Arrhythmias and Conduction Disturbances. In V. Fuster, R.A. Walsh, R.A. Harrington (Eds) (Articles with ... "Cardiac Arrhythmias". Retrieved 2007-07-21. Am J Cardiol. 1984 Jul 30;54(2):1A-6A. Cardiovascular Physiology & Anesthesia. ... Re-entry ventricular arrhythmia is a type of paroxysmal tachycardia occurring in the ventricle where the cause of the ... or bradycardia are potential causes of functionally defined re-entry due to changes in the properties of the cardiac tissue's ...
Inherited Cardiac Arrhythmias. Nature Reviews Disease Primers, Jul 16;6(1):58, 2020. PMID 32678103. Chen P-S, Antzelevitch C, ... Cardiac Electrophysiology, Arrhythmias and Sudden Death Section, Vasan Ramachandran and Douglas Sawyer, Editors-in-Chief and In ... Chen PS, Antzelevitch C. Mechanisms of cardiac arrhythmias and conduction disturbances. In: Hurst's The Heart 14th ed. Fuster V ... "CES Past Presidents - Cardiac Electrophysiology Society". Cardiaceps.org. Retrieved 2016-04-14. "About CardiacEPS - Cardiac ...
Some of these pathologies include cardiac arrhythmia (such as atrial fibrillation), cardiac hypertrophy, Duchenne muscular ... Honore, E., Patel, A. A., Kohl, P., Franz, M. R. & Sachs, F. in Cardiac Mechano-Electric Feedback and Arrhythmias: From Pipette ... Peyronnet R, Nerbonne JM, Kohl P (2016). "Cardiac mechano-gated ion channels and arrhythmias". Circ. Res. 118 (2): 311-29. doi: ... Cardiac arrhythmias Hypertension. Mechanosensation Large-conductance mechanosensitive channel Small-conductance ...
Oppenheimer, Stephen M.; Cechetto, DF; Hachinski, VC (1 May 1990). "Cerebrogenic Cardiac Arrhythmias". Archives of Neurology. ... cardiac enzymes, arrhythmias, and sudden death following acute stroke. This would eventually lead to the discovery that the ... Oppenheimer, SM; Hachinski, VC (February 1992). "The cardiac consequences of stroke". Neurologic Clinics. 10 (1): 167-76. doi: ... insula of the brain is the mediator of these various cardiac complications. Knowing this alters doctors to monitor the heart ...
Circ Arrhythmia Electrophysiol. 3 (1): 96-104. doi:10.1161/CIRCEP.109.877142. PMID 20160177. Hastings JL, Levine BD (March 2012 ... and close relatives are often at risk for similar cardiac problems. The sudden cardiac deaths of 12 young American athletes ( ... Sudden cardiac death occurs in approximately one per 200,000 young athletes per year, usually triggered during competition or ... Screening athletes for cardiac disease can be problematic because of low prevalence and inconclusive performance of various ...
... severe cardiac arrhythmias; congenital or acquired heart valve defects; increased risk of bleeding; a history of myocardial ... Furthermore, IP(-/-) mice on a high salt diet develop significantly higher levels of hypertension, cardiac fibrosis, and ... For example, the IP agonist iloprost is contraindicated in patients with unstable angina; decompensated cardiac failure (unless ... "A Comparison of Inhaled Nitric Oxide Versus Inhaled Epoprostenol for Acute Pulmonary Hypertension Following Cardiac Surgery". ...
unstable angina; within 6 months of myocardial infarction; decompensated cardiac failure (unless under close medical ... supervision); severe arrhythmias; congenital or acquired heart-valve defects; within 3 months of cerebrovascular events; ...
van Loon, G (April 2019). "Cardiac Arrhythmias in Horses". The Veterinary Clinics of North America. Equine Practice. 35 (1): 85 ... Cardiac arrhythmia, Wikipedia medicine articles ready to translate, Wikipedia emergency medicine articles ready to translate). ... American Heart Association Electrocardiography and Arrhythmias Committee and Exercise Cardiac Rehabilitation, and Secondary ... involved in the regulation of cardiac conduction, modulation of ion channels and in cardiac development. Have been also ...
While there are no definitive data showing that long-duration space flight is associated with cardiac arrhythmias, there are ... At least two potential risk factors for arrhythmias have been reported either during or immediately after space flight: cardiac ... The incidence and clinical significance of cardiac arrhythmias during long-term exposure to microgravity experienced on the ... It is unknown whether long-duration exposure to microgravity itself may precipitate cardiac arrhythmias. Based on observations ...
Management of Cardiac Arrhythmias. Contemporary cardiology. Vol. 34. Hanumana Press. pp. 123-140. doi:10.1007/978-1-60761-161-5 ... A cardiac electrophysiology study (EP test or EP study) is a minimally invasive procedure using catheters introduced through a ... Handbook of cardiac electrophysiology : a practical guide to invasive EP studies and catheter ablation. Murgatroyd, Francis D. ... Then the electrophysiologist tries to provoke arrhythmias and reproduce any conditions that have resulted in the patient's ...
inherited cardiac arrhythmias, which was published that November by EP Europace. Folbigg's legal team used the paper as ... inherited cardiac arrhythmias". EP Europace. 23 (3): 441-450. doi:10.1093/europace/euaa272. ISSN 1099-5129. PMC 7947592. PMID ... which other variants in the same family had previously been associated with fatal cardiac arrhythmias such as, long QT syndrome ... Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy Registry, which ...
Jaeger, Fredrick J. "Cardiac Arrhythmias". Cleveland Clinic. Retrieved 19 January 2010. Graham-Rowe, Duncan (November 26, 2008 ... In addition to the risks inherent in cardiac surgery, the leads have themselves proved to be a weakness in some ICD designs. ... When an ICD detects a serious arrhythmia, it issues an electrical impulse to the heart muscle, of a magnitude sufficient to ... These patients tended to have genetic or other conditions predisposing them to sudden cardiac death due to a failure of the ...
inherited cardiac arrhythmias". EP Europace. 23 (3): 441-450. doi:10.1093/europace/euaa272. hdl:11343/272103. ISSN 1099-5129. ... in November 2020 showed that at least two of the children had genetic mutations that predisposed them to sudden cardiac death. ...
The arrhythmias that those with CPVT experience are caused by abnormalities in the way that cardiac muscle cells control their ... In patients treated with beta blockers, life-threatening arrhythmias are more likely if a person had already survived a cardiac ... Landstrom AP, Dobrev D, Wehrens XH (June 2017). "Calcium Signaling and Cardiac Arrhythmias". Circulation Research. 120 (12): ... Good articles, Articles with short description, Short description is different from Wikidata, Cardiac arrhythmia, Medical ...
Lovenox (Enoxaparin), for thrombosis, (its biggest seller in 2008). Multaq (Dronedarone), for cardiac arrhythmias. Nitrolingual ... Cardiovascular Adenoscan (Adenosine), for arrhythmias, marketed by Astellas. Altace (Ramipril), for hypertension, marketed by ...
Behere SP, Weindling SN (2014). "Inherited arrhythmias: The cardiac channelopathies". Annals of Pediatric Cardiology. 8 (3): ...
Delmar M, Makita N (May 2012). "Cardiac connexins, mutations and arrhythmias". Current Opinion in Cardiology. 27 (3): 236-241. ... that patients with an array of somatic mutations in GJA1 most often do not present with cardiac arrhythmias, even though ... thereby promoting cardiac arrhythmia. Currently, only rotigaptide, an antiarrhythmic peptide-based drug, and its derivatives, ... which is linked to cardiac arrhythmia; Hallermann-Streiff syndrome; and heart malformations, such as viscero-atrial heterotaxia ...
... works as an anti-arrhythmic agent and is used to treat cardiac arrhythmia. It induces rapid block of the ... Procainamide (PCA) is a medication of the antiarrhythmic class used for the treatment of cardiac arrhythmias. It is classified ... 1983). Drug Treatment of Cardiac Arrhythmias. Mount Kisco: Futura Publishing Company. pp. 73-74. ISBN 0879931906. Stiell, Ian G ... Procainamide is used for treating ventricular arrhythmias: ventricular ectopy and tachycardia and supraventricular arrhythmias ...
Catheter ablation of cardiac arrhythmias. Huang, Shoei K.,, Miller, John M. (John Michael), 1954- (Third ed.). Philadelphia, PA ... Conti, Andrea A. (2011). "Calling the Heart by Name: Distinguished Eponyms in the History of Cardiac Anatomy" (PDF). The Heart ... Cardiac anatomy, Human anatomy, Anatomy named for one who described it). ...
... arrhythmias and acute coronary syndromes; sport cardiology, cardiac remodelling of elite athletes. Since 1994, he has been ... Certification and was the first Hungarian clinical cardiac electrophysiologist to earn the Cardiac Pacing and Implantable ... He became board certified in cardiology in 1998 and obtained his PhD in ventricular arrhythmias in 1999. He also holds a ... "Experimental and clinical investigations of ventricular arrhythmias." 2021 Lions Fair Play Award, for his decade-long ...
Cardiac arrhythmia is any abnormality in the electrical activity of the heart. Arrhythmias range from mild to severe, sometimes ... The causes of cardiac arrhythmias are numerous, from structural changes in the conduction system (the sinoatrial and ... Hoffman, BF (September 1966). "Physiological Basis of Cardiac Arrhythmias. II". Modern Concepts of Cardiovascular Disease. 35 ( ... KVLQT1 Mutations Cause Cardiac Arrhythmias". Nature Genetics. 12 (1): 17-23. doi:10.1038/ng0196-17. PMID 8528244. S2CID 2902785 ...
Supraventricular Arrhythmias". ECG Learning Center. University of Utah. (Cardiac arrhythmia). ... are premature cardiac electrical impulses originating from the atrioventricular node of the heart or "junction". This area is ... not the normal but only a secondary source of cardiac electrical impulse formation. These premature beats can be found ...
"Presidents". Venice Arrhythmias. Retrieved 2016-06-24. "Dr. Andrea Natale, MD - La Jolla - Cardiology, Clinical Cardiac ... Natale serves as the Executive Medical Director at Texas Cardiac Arrhythmia Institute at St. David's Medical Center in Austin, ... and he is currently the executive director at the Texas Cardiac Arrhythmia Institute. Natale received his medical degree from ... 2005 and 2006 Texas Cardiac Arrhythmia Institute: The Bury + Partners Innovation Award 2009. Austin, Texas. Search Results for ...
Additional small risk of cardiac arrhythmias. Estrogen deprivation therapy Maximum androgen blockade Perlmutter and Lepor (2007 ...
Cardiac Arrhythmia Suppression Trial (CAST) Electrocardiogram Antiarrhythmic agents (category) Proarrhythmic agent Rang, ... This will aid our understanding and clinical management of cardiac arrhythmias and facilitate future therapeutic developments. ... Vaughan Williams, EM (1970) "Classification of antiarrhythmic drugs". In Symposium on Cardiac Arrhythmias (Eds. Sandoe E; ... Class I agents are grouped by what effect they have on the Na+ channel, and what effect they have on cardiac action potentials ...
"CHAPTER 33 - Therapy for Cardiac Arrhythmias." 2007. Elsevier. Middleton's Allergy Principles & Practice, N. F. Adkinson, B. S ...
The cardiac conduction system (and AV node part of it) coordinates myocyte mechanical activity. A wave of excitation spreads ... This also protects the ventricles from excessively fast rate response to atrial arrhythmias (see below). AV conduction during ... The atrioventricular node delays impulses by approximately 0.09s. This delay in the cardiac pulse is extremely important: It ... Bone morphogenetic protein (BMP) cell signaling plays a key role in diverse aspects of cardiac differentiation and ...
He later worked on cardiovascular disease and cardiac arrhythmia, and phenethylamines as antidepressants. He retired in 2001. ...
The official cause of death was cardiac arrhythmia, although later toxicology reports strongly suggested that polypharmacy was ...
30 Forgot medication Arrhythmia/ Anaemia Ischemia/ Infarction/ Infection Lifestyle: taken too much salt Upregulation of CO: ... PAID: Pulmonic & Aortic Insufficiency=Diastolic.p. 32 CARDIAC RIND:p. 34 Collagen vascular disease Aortic aneurysm Radiation ... 34 Pulmonary embolus Acidosis Tension pneumothorax Cardiac tamponade Hypokalemia/ Hyperkalemia/ Hypoxia/ Hypothermia/ ... Drugs (such as hydralazine) Infections Acute renal failure Cardiac infarction Rheumatic fever Injury Neoplasms Dressler's ...
The report alleged that Yang's ECT therapy triggered cardiac arrhythmia in the escaped patient, questioning the safety of ...
... an EKG and cardiology examination by a cardiologist if a patient is found to be at increased risk for a cardiac arrhythmia or ...
Cardiac muscle lies between the epicardium and the endocardium in the heart. Cardiac muscle cells generally only contain one ... Arrhythmia (irregular heartbeat) Cardiomyopathy (disease of the heart muscle) Costamere Shadrin, I. Y.; Khodabukus, A.; Bursac ... Contractions in cardiac muscle tissue are due to a myogenic response of the heart's pacemaker cells. These cells respond to ... Unlike skeletal and cardiac muscle tissue, smooth muscle tissue is not striated since there are no sarcomeres present. Skeletal ...
heart: heart failure, cardiac arrhythmia. hormones: diabetes (see below) and hypogonadism (insufficiency of the sex hormone ...
According to the publisher, the book describes the current state of cardiac arrhythmia treatment, and attempts to identify ... Overall, he recommended the book, calling it "a worthwhile addition to the literature on cardiac arrhythmia and antiarrhythmic ... Its 21 chapters cover a variety of topics related to cardiac arrhythmia and electrophysiology, primarily reviewing known ... In a review for Circulation, Kowey called the book "an admirable attempt" to develop a more targeted approach to arrhythmia ...
Antiarrhythmic agents may be an appropriate measure to treat cardiac arrhythmias resulting from doxepin overdose. Slow ... More serious adverse effects include respiratory depression, hypotension, coma, convulsions, cardiac arrhythmia, and ... ECG monitoring is recommended for several days after doxepin overdose due to the potential for cardiac conduction abnormalities ...
Bundle branch block Cardiac dysrhythmia (Cardiac arrhythmia) Catecholaminergic polymorphic ventricular tachycardia Ectopic beat ... cardiac ectopy) Ectopic pacemaker (Ectopic focus) First-degree atrioventricular block (First-degree AV block, PR prolongation) ... Cardiac electrophysiology AV nodal reentrant tachycardia (Atrioventricular nodal reentrant tachycardia) Accelerated ... Acute coronary syndrome Anomic aphasia Aortic dissection Aortic regurgitation Aortic stenosis Apoplexy Apraxia Arrhythmias ...
The right ventricle and the anatomy of the outflow tract, including any anatomical variations, are also assessed with cardiac ... Active infection, central vein occlusion, coronary occlusion, and need for other surgeries such as for arrhythmia are ... Percutaneous aortic valve replacement Cardiac catheterization Wilson W, Osten M, Benson L, Horlick E (January 2014). "Evolving ... Articles with short description, Short description with empty Wikidata description, Use dmy dates from June 2011, Cardiac ...
... has been reported to bind to the C-terminal domain of murine cardiac voltage-gated sodium channels (SkM2) causing altering ion ... Circ Arrhythmia Electrophysiol. 1 (3): 193-201. doi:10.1161/CIRCEP.108.769224. PMC 2726717. PMID 19684871. Hedley PL, Jørgensen ...
... to be cardiac in origin New-onset unexplained heart failure Survival of sudden cardiac death or dangerous cardiac arrhythmias ... MedlinePlus Medical Encyclopedia: Cardiac catheterization eMedicine: Cardiac Catheterization (Left Heart) (Webarchive template ... and the cardiac index, a hemodynamic parameter that relates the cardiac output to a patient's body size. Determination of ... "Cardiac catheterization is associated with superior outcomes for survivors of out of hospital cardiac arrest: review and meta- ...
CardiacSense is a developer of a wearable technology for continuous cardiac arrhythmia detection and vital signs monitoring. ... In case of an Arrhythmia, such as Atrial Fibrillation, the watch alerts the user and send messages to the patient's physician. ... and cardiac arrest. The device comes in the form of a wristwatch. It monitors heart rate (HR), heart rate variabilities (HRV), ...
Ultrasound Pulse oximetry Chest X-ray Echocardiogram Electrocardiogram Cardiac catheterization Cardiac CT scan Genetic testing ... Failure to thrive Recurrent chest infections Endocarditis Epilepsy Stroke Arrhythmia Heart failure Premature death Children ... Her condition was discovered in childhood but she refused to get any surgery to treat it (including cardiac catheterization), ... Radiological studies showed a ventricular septal defect alongside cardiac and arterial anomalies (heart silhouette enlargement ...
... probably precipitated a cardiac arrhythmia, and the subject, incapacitated in the water, was unable to save himself." Al ...
CPR was developed and accepted as the standard of care for out-of-hospital cardiac arrest; defibrillation, based in part on an ... increased understanding of heart arrhythmias, was introduced, as were new pharmaceuticals to be used in cardiac arrest ...
Arrhythmias: Sinus tachycardia is the most common abnormal heart rhythm associated with a pheochromocytoma and is experienced ... Norepinephrine (a catecholamine) is hypothesized to result in damaged cardiac tissue by inhibiting coronary blood flow and ... thereby strengthening the argument for early and accurate diagnosis in order to allow for cardiac remodeling and prevent ...
Results of Demand Pacing in Cardiac Arrhythmias - Peter Allen M.D., Eve Rotem M.D. - Annals of Thoracic Surgery, 8:2, Page 146 ... A Cardiac Surgery Anthology by C. Walton Lillehei, Page 187 1957 to 1982 Open Cardiac Surgery in British Columbia" - In the ... In 1987 and 1989 Allen was the visiting cardiac surgeon at the Ibn-al;Bitar Hospital in Baghdad, Iraq. The hospital was built ... In mid 1957 Allen returned to Vancouver and formed a cardiac team with surgeon, Philip Ashmore, anaesthetist William Dodds and ...
It causes or aggravates pre-existing conditions such as neuronal injury, myocardial infarction, cardiac arrhythmias, ...
Cardiac arrhythmia, All stub articles, Circulatory disease stubs). ... 1999). "Cardiac conduction defects associate with mutations in SCN5A". Nat. Genet. 23 (1): 20-1. doi:10.1038/12618. PMID ...
... shocking his heart back into a normal rhythm after he had suffered a cardiac arrhythmia during a match, was posted to YouTube ...
... is an international non-profit organization that promotes education and advocacy for cardiac arrhythmia ... "Sudden Cardiac Arrest (SCA) Awareness , UpBeat". www.upbeat.org. Retrieved 2020-05-04. "Sudden Cardiac Arrest Awareness ... Sudden Cardiac Arrest Awareness Month represents an initiative by the Heart Rhythm Society to raise awareness and help the ... The campaign targets heart attack survivors, who are at the highest risk for sudden cardiac arrest, and stresses the importance ...
Kadar E, Rush J, Wetmore L, Chan D (2004). "Electrolyte disturbances and cardiac arrhythmias in a dog following pamidronate, ...
On 8 July 2017, Nouri collapsed during a friendly match against Werder Bremen, due to cardiac arrhythmia. He was taken to the ... In July 2017, at age 20, during a pre-season friendly match, Nouri collapsed and suffered a cardiac arrhythmia attack, which ...
They observed that, while caesium-137 exposure did not cause any damage to heart cells or arrhythmias, results indicated that ... 2008) investigated the possible cardiac effects of 500 Bqkg−1 caesium-137 exposure in rats over 3 months. ... Busby says he bases his cardiac claims on the work of husband-and-wife team Yury Bandazhevsky and Galina Bandazhevskaya; known ... quite subtle cardiac impairment might worsen in some sensitive individuals over time. Also, Le Gal et al. (2006) found that the ...
... cardiac arrhythmias, various degrees of heart block and cardiac arrest. It may also result in spasm of accommodation, aching ...
... various cardiac arrhythmias, and hypotension The WHO states praziquantel is safe during pregnancy. Animal studies have failed ...
... or cardiac arrhythmias Nuchal rigidity Subhyaloid retinal hemorrhages Altered level of consciousness Anisocoria, nystagmus ...
Medical Center is the first hospital in the Midwest to offer a new advanced robotic technology for the treatment of cardiac... ... Left untreated, certain arrhythmias can significantly increase the risk of stroke, heart failure and sudden cardiac arrest. ... New Technology for Treating Cardiac Arrhythmias. Missouri Baptist Medical Center is the first hospital in the Midwest to offer ... Robotic cardiac ablation is well-documented as a beneficial alternative to manual cardiac ablation. Publications have noted ...
Heal Your Gut and Heart Rate Mantra for Cardiac Arrhythmia treatments. ... Cardiac arrhythmia. I started with the Hydrogen Peroxide theraphy for another problem (Chrons disease), also I was ... I thought it was the best to use magnesium taurate to cure cardiac arrhythmia? Can anyone verify the best magnesium to take for ... Hereditary Arrhythmia Posted by Jessica (Nyc) on 08/23/2013. Great site, thank you all for sharing this information, your ...
HRS 2020 Science: A Global Perspective on COVID-19, Cardiac Arrhythmia Characteristics & Management Strategies ... In this HRS 2020 Science Release Two session, authors of a global survey of 1,100+ arrhythmia professionals, focusing on the ... Explore the survey results in more depth by reading the full article published in the Journal of Interventional Cardiac ... Founded in 1979, HRS is a leading resource on cardiac pacing and electrophysiology. Our specialty organization represents ...
Other categories referring to Model of arrhythmias in a cardiac cells network (Casaleggio et al. 2014). ... Model of arrhythmias in a cardiac cells network (Casaleggio et al. 2014) ... non-fatal arrhythmias widely observed in the heart. Using a computational model of a two-dimensional network of cardiac cells, ... arrhythmias can develop from post-ischemic alteration of the electrical connectivity in a relatively small area of the cardiac ...
In the case of an abnormal heart rhythm, called an arrhythmia, it cannot pump as well.. Atrial fibrillation (AF) is the most ... GI and cardiac functions. Deb has previously held several key leadership positions at companies including Johnson & Johnson and ...
Cardiac arrhythmias. / Gottlieb, Sheldon; Marine, Joseph; Calkins, Hugh. Principles of Ambulatory Medicine: Seventh Edition. ... Gottlieb, S., Marine, J., & Calkins, H. (2012). Cardiac arrhythmias. In Principles of Ambulatory Medicine: Seventh Edition (pp ... Gottlieb, S, Marine, J & Calkins, H 2012, Cardiac arrhythmias. in Principles of Ambulatory Medicine: Seventh Edition. Wolters ... Cardiac arrhythmias. In Principles of Ambulatory Medicine: Seventh Edition. Wolters Kluwer Health. 2012. p. 992-1028 ...
JCS/JHRS 2021 Guideline Focused Update on Non-Pharmacotherapy of Cardiac Arrhythmias DOI Web Site PubMed 176 References ...
... and R-on-T complexes in patients with primary arrhythmias or arrhythmias secondary to various cardiac disorders (e.g., CAD, ... Cardiac Arrhythmias. Treatment of frequent ventricular premature complexes (VPCs), including uniform and multiform VPCs and/or ... Decreases exercise-induced heart rate, inhibits reflex orthostatic tachycardia, and may decrease or leave unchanged cardiac ... Ventricular Arrhythmias. Oral. Initially, 200 mg twice daily. Increase gradually until optimum effect is achieved. Usual ...
Arrhythmia symptoms are very diverse. This is due to the fact that the center of cardiac arrhythmia can be found both within ... In Germany arrhythmias (heart rate disorders) are the domain of highly specialized cardiologists-arrhythmologists. Medigerman ... After establishing the type of arrhythmia, the treatment process comes into play as a two-tier strategy. Such strategy is aimed ...
Cardiac arrhythmias and cancer. by admin · Published 1 June 2022. · Updated 7 December 2022. ... The true incidence of arrhythmias and sudden death is quite difficult to evaluate due to the peculiar condition of oncologic ... Anyway, any kind of arrhythmia may be shown in cancer patients, both spontaneously or due to many provocative conditions, and ... Dislipidemie Cardiovascular disease Donna Outpatient cardiology Sudden cardiac death Comorbidities Women Pericarditis Statine ...
People from around the world come to Texas Cardiac Arrhythmia for treatment of the most challenging atrial and ventricular ... This document explains Texas Cardiac Arrhythmias financial policy.. Confidential Health History English , Spanish. The ... 2021 Texas Cardiac Arrhythmia Web Design by Code Team Blue ... Heart Arrhythmias and Disorders. *Substance Causing Arrhythmias ...
CinE caRdiac magneTic resonAnce to predIct veNTricular arrhYthmia) with deep learning for VA risk prediction from cine cardiac ... CinE caRdiac magneTic resonAnce to predIct veNTricular arrhYthmia) with deep learning for VA risk prediction from cine cardiac ... CinE caRdiac magneTic resonAnce to predIct veNTricular arrhYthmia) with deep learning for VA risk prediction from cine cardiac ... CinE caRdiac magneTic resonAnce to predIct veNTricular arrhYthmia) with deep learning for VA risk prediction from cine cardiac ...
Cardiac arrhythmia. Hyperkalemia can lead to electrocardiographic changes and life-threatening cardiac arrhythmia, including ... Severe electrolyte disturbances, such as hyperkalemia and hypocalcemia, predispose patients to cardiac arrhythmia and seizures. ... Hypocalcemia can lead to QT interval lengthening, which predisposes patients to ventricular arrhythmia. ...
Learn about leading treatments for arrhythmia like leadless pacemakers and epicardial ablation offered at OHSUs Knight ... Cardiac ablation We thread catheters (small, soft tubes) through blood vessels to the heart. Electrodes on the catheters find ... Arrhythmias and Heart Rhythm * Understanding Arrhythmias and Heart Rhythm Disorders * Arrhythmia and Heart Rhythm Diagnosis and ... Diagnosing arrhythmia. Physical exam: We will ask you about your medical history and symptoms, and listen to the speed and ...
Verapamil in cardiac arrhythmia. The Indian Journal of Chest Diseases & Allied Sciences. 1979 Jan; 21(1): 1-9. ...
... daily coffee consumption does not trigger incident heart arrhythmias, according to an analysis of prospectively collected data ... Specifically about cardiac arrhythmias, the review said "while caffeine is commonly considered a trigger for arrhythmias by ... "There has been a lot of public interest about a possible association of caffeine and arrhythmias," but an adverse effect from ... The analysis excluded people with prevalent arrhythmia at baseline, so the study couldnt address the impact of coffee ...
Blaufuss Multimedia Heart Sounds and Cardiac Arrhythmias Tutorial This website allows visitors to see and hear extensive ... Blaufuss Multimedia Heart Sounds and... Blaufuss Multimedia Heart Sounds and Cardiac Arrhythmias Tutorial ...
Read this chapter of Cardiac Arrhythmias: Interpretation, Diagnosis, and Treatment, 2e online now, exclusively on ... There has been a sea change in the last 25 years to our therapy of cardiac arrhythmias. Surgery to cure arrhythmias is nearly ... "Preface." Cardiac Arrhythmias: Interpretation, Diagnosis, and Treatment, 2e Prystowsky EN, Klein GJ, Daubert JP. Prystowsky E.N ... Eric N. Prystowsky, et al.eds. Cardiac Arrhythmias: Interpretation, Diagnosis, and Treatment, 2e. McGraw Hill; 2020. Accessed ...
Drug treatment of cardiac arrhythmias / edited by Lawrence A. Gould. Contributor(s): Gould, Lawrence AMaterial type: Text ... Publication details: Mount Kisco, N.Y. : Futura, 1983. Description: 436 pISBN: 0879931906Subject(s): Arrhythmia -- drug therapy ... Anti-arrhythmia agentsNLM classification: QV 150 Tags from this library: No tags from this library for this title. Log in to ...
... is suffering from pneumonia and cardiac arrhythmia.. This was revealed in a letter to the Economic and Financial Crimes ... our client is undergoing treatment for pneumonia and cardiac arrhythmia, and, has recently been advised to seek further ... noting that he is suffering from pneumonia and cardiac arrhythmia. ...
... or other chlorofluorocarbons in confined spaces may cause death by cardiac arrhythmia or asphyxiation. ... two deaths from cardiac arrhythmia). May and Blotzer [1984] reported two separate incidents of deaths resulting from cardiac ... He was overcome and later died from cardiac arrhythmia. Two other workers were also overcome while trying to rescue him; both ... Of the eight deaths, seven were due to asphyxiation and one to cardiac arrhythmia. One additional death was reported from an ...
A Review on Role of Yoga in the Management of Patients with Cardiac Arrhythmias.. Sharma, Gautam; Mooventhan, A; Naik, ... However, this is the first-ever systematic review performed to report the role of yoga in arrhythmia. We have performed a ... Results showed that yoga could be considered an efficient adjuvant in reducing arrhythmia (paroxysmal atrial fibrillation, ... and in improving health-related QoL of arrhythmia patients. However, there is a lack of randomized controlled trials and a ...
... the cardiac sodium channel linked to different inherited cardiac arrhythmias (ICA) phenotypes or/and syndromes. The genetic ... The cardiac sodium channel its mutations and their spectrum arrhythmia phenotypes. J Hum Growth Dev. 2016; 26(3): 281-96. DOI: ... A mutation in the β3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype. Circ Cardiovasc Genet. 2009;2 ... Our group and others found new mutations in the β3 subunits associated with Brugada syndrome and cardiac conduction disease ...
Cardiac Arrhythmias If you have a cardiac (heart) arrhythmia, you have an abnormal heart rhythm-which can mean your heart beats ... Some types of arrhythmias may not cause any symptoms at all, while others can be a medical emergency. ... These heart-related health conditions include coronary artery disease (CAD), arrhythmias, heart attack, and heart failure, ...
CARDIAC ARRHYTHMIAS. A wide range of benign and malignant arrhythmias has been reported with cocaine use. The arrhythmias are ... 24 Other cardiac problems include myocarditis, cardiomyopathy, and arrhythmias. ... Isner JM, Estes NA, Thompson PD, et al. Acute cardiac events temporally related to cocaine abuse. N Engl J Med1986;315:1438-43. ... In contrast, cardiac troponins are more sensitive and specific for myocardial injury and should be used for the diagnosis of MI ...
JOURNAL OF CARDIAC ARRHYTHMIAS, 24(4), 396-398. Retrieved from https://jca.org.br/jca/article/view/2573 ...
... inherited cardiac arrhythmia disorders, R176Q, Research, RyR2, sudden cardiac death ... Preventing sudden cardiac death with genome editing October 30, 2018. October 30, 2018. cardiomyocytes, catecholaminergic ... Each year, at least 3 million people worldwide die of sudden cardiac death. In the U.S., this number reaches up to 450,000 ...
... that pesticides can disrupt the heart rhythm have prompted a closer study into the link between pesticides and cardiac ... arrhythmia, Trouw reports. We are on the trail of that link, research leader Bianca Brundel, professor of psychology and a ... New study into link between pesticides and cardiac arrhythmia Clear indications that pesticides can disrupt the heart rhythm ... She is a specialist in cardiac arrhythmias at the Amsterdam University Medical Center. ...
This study aims to learn what signs distinguish patients who have a higher risk of an arrhythmia that leads to sudden cardiac ... Participants will also wear a heart rhythm monitor to help researchers learn whether sleep apnea is linked to arrhythmia. The ... Insertable Cardiac Monitor-Guided Early Intervention to Reduce Atrial Fibrillation Burden Following Catheter Ablation ( ... These problems include fetal arrhythmia and conduction disorders such as Brugada syndrome. To participate in this study, you ...
If untreated, disturbances in normal cardiac rhythm result in impaired cardiac pumping ability, and certain arrhythmias are ... "Treatment of Cardiac Arrhythmias." Pharmacology in Rehabilitation, 5e Ciccone CD. Ciccone C.D.(Ed.),Ed. Charles D. Ciccone. ... Treatment of Cardiac Arrhythmias. In: Ciccone CD. Ciccone C.D.(Ed.),Ed. Charles D. Ciccone.eds. Pharmacology in Rehabilitation ... Treatment of cardiac arrhythmias. Ciccone CD. Ciccone C.D.(Ed.),Ed. Charles D. Ciccone. (2016). Pharmacology in Rehabilitation ...
  • After establishing the type of arrhythmia, the treatment process comes into play as a two-tier strategy. (medigerman.com)
  • These will depend on your medical history and type of arrhythmia. (ohsu.edu)
  • The most common type of arrhythmia is atrial fibrillation , which causes an irregular and fast heart beat. (medlineplus.gov)
  • Explore the survey results in more depth by reading the full article published in the Journal of Interventional Cardiac Electrophysiology . (hrsonline.org)
  • Founded in 1979, HRS is a leading resource on cardiac pacing and electrophysiology. (hrsonline.org)
  • The functional genomics in vitro studies are part of the new process to be translated into potential treatments to restore the dysfunction cardiac electrophysiology linked within mutations in the SCN5A gene 2 . (bvsalud.org)
  • Our purpose was to "write a comprehensive textbook on an integrated approach to cardiac arrhythmias for individuals without a background in clinical electrophysiology. (mhmedical.com)
  • To understand how antiarrhythmic drugs exert their effects, the chapter begins with a review on the origin and spread of electrical activity throughout the heart (cardiac electrophysiology). (mhmedical.com)
  • Further, we have added new chapters on atrial fibrillation, catheter ablation of supraventricular tachycardia, catheter ablation of ventricular tachycardia, and provide a major update in the chapters on sudden cardiac death and device therapy. (mhmedical.com)
  • During an average 5.25 years of follow-up, these people had more than 13,000 incident arrhythmic events, including 4,748 episodes of atrial fibrillation or flutter and 798 supraventricular tachycardia events, as well as fewer numbers of ventricular arrhythmias and many episodes of less clinically relevant events like skipped beats. (medscape.com)
  • The adjusted analysis showed an average, statistically significant 3% incremental drop in both all incident arrhythmias and in incident atrial fibrillation episodes for each additional cup of coffee drunk a day, for up to 6 daily cups. (medscape.com)
  • Atrial fibrillation, caused by irregular contraction of the atria, is the most common cardiac arrhythmia. (zetolemos.com)
  • Today, French, European and American recommendations mainly place ablation with radiofrequency or cryotherapy as the first-line treatment, since it alone guarantees the definitive treatment of cardiac arrhythmia and especially atrial fibrillation. (zetolemos.com)
  • Some types of arrhythmias may not cause any symptoms at all, while others can be a medical emergency. (health.com)
  • 1 Various problems in the origination and conduction of electrical activity in the heart can lead to distinct types of arrhythmias. (mhmedical.com)
  • This is followed by a presentation of the basic mechanisms responsible for producing disturbances in cardiac rhythm and the common types of arrhythmias seen clinically. (mhmedical.com)
  • The new technology at MoBap - robotic magnetic navigation (RMN) - introduces the benefits of robotic precision and safety to cardiac ablation, a common, minimally invasive procedure used to treat arrhythmias. (missouribaptist.org)
  • Robotic cardiac ablation is well-documented as a beneficial alternative to manual cardiac ablation. (missouribaptist.org)
  • Publications have noted that the robotic procedure, on average, results in fewer adverse events and better procedure success for patients when compared with manual cardiac ablation. (missouribaptist.org)
  • At the same time, there have been remarkable advances in catheter ablation technology and its application to treat a wide variety of cardiac arrhythmias, as well as development of newer implantable cardiac electrical devices and indications for their use. (mhmedical.com)
  • This means that this ablation is the only way to definitively and completely cure cardiac arrhythmia. (zetolemos.com)
  • Left untreated, certain arrhythmias can significantly increase the risk of stroke, heart failure and sudden cardiac arrest. (missouribaptist.org)
  • If untreated, disturbances in normal cardiac rhythm result in impaired cardiac pumping ability, and certain arrhythmias are associated with cerebrovascular accidents, cardiac failure, and other sequelae that can be fatal. (mhmedical.com)
  • Better models to identify individuals at low risk of ventricular arrhythmia (VA) are needed for implantable cardioverter-defibrillator (ICD) candidates to mitigate the risk of ICD-related complications. (elsevier.com)
  • We designed the CERTAINTY study (CinE caRdiac magneTic resonAnce to predIct veNTricular arrhYthmia) with deep learning for VA risk prediction from cine cardiac magnetic resonance (CMR). (elsevier.com)
  • Chemically induced cardiac (ventricular) arrhythmia, fibrillation, and death have been confirmed in experimental monkeys, dogs, and mice exposed by inhalation to CFC-113 and a number of other CFCs. (cdc.gov)
  • ST-segment depression was significantly related to ventricular arrhythmia. (who.int)
  • Millions of individuals worldwide suffer from arrhythmias - abnormal heart rhythms including the heart beating too quickly, too slowly or with an irregular pattern. (missouribaptist.org)
  • In the case of an abnormal heart rhythm, called an arrhythmia, it cannot pump as well. (galvanizetx.com)
  • If you have a cardiac (heart) arrhythmia, you have an abnormal heart rhythm-which can mean your heart beats too fast, too slow, or just irregularly. (health.com)
  • As mentioned in our last letter to you dated February 10, 2023, our client is undergoing treatment for pneumonia and cardiac arrhythmia, and, has recently been advised to seek further attention abroad. (amazonaws.com)
  • Our specialty organization represents medical, allied health, and science professionals from more than 90 countries who specialize in cardiac rhythm disorders. (hrsonline.org)
  • This is due to the fact that the center of cardiac arrhythmia can be found both within the sinus node (sinus rhythm maintenance disorders) and outside of it. (medigerman.com)
  • In this large, population-based, prospective study, moderate habitual coffee drinking was associated with a lower risk of arrhythmia," EunJeong Kim, MD , said at the annual scientific sessions of the Heart Rhythm Society, held online because of COVID-19. (medscape.com)
  • An arrhythmia can be broadly defined as any significant deviation from normal cardiac rhythm. (mhmedical.com)
  • 2 , 3 Fortunately, a variety of drugs are available to help establish and maintain normal cardiac rhythm. (mhmedical.com)
  • 4 Nonetheless, antiarrhythmic drugs remain a primary option for many patients with arrhythmias or as an adjunct to maintain normal rhythm after cardiac surgery. (mhmedical.com)
  • It's actually a heart arrhythmia a rhythm disorder that affects the atria, ventricles, and all organs of the heart . (zetolemos.com)
  • An arrhythmia is a problem with the rate or rhythm of your heartbeat. (medlineplus.gov)
  • Our group and others found new mutations in the β 3 subunits associated with Brugada syndrome and cardiac conduction disease with a significant reduction in the peak sodium current by the co-interaction with the mutant β subunits and SCN5A channels 3 . (bvsalud.org)
  • Inhalation of printer-emitted particles impairs cardiac conduction, hemodynamics, and autonomic regulation and induces arrhythmia and electrical remodeling in rats. (cdc.gov)
  • In Germany arrhythmias (heart rate disorders) are the domain of highly specialized cardiologists-arrhythmologists . (medigerman.com)
  • The cardiac patients taking antiarrhythmic drugs also may be in rehabilitation for any number of other neuromuscular or musculoskeletal disorders. (mhmedical.com)
  • Arrhythmia symptoms are very diverse. (medigerman.com)
  • The true incidence of arrhythmias and sudden death is quite difficult to evaluate due to the peculiar condition of oncologic patients, because of their complex and confusing symptoms and signs. (cardiologiaambulatoriale.eu)
  • Each year, at least 3 million people worldwide die of sudden cardiac death. (bcm.edu)
  • In June 2007, NIOSH issued an Alert on the most common cause of fire fighter fatalities-sudden cardiac death. (cdc.gov)
  • The Alert, Preventing Fire Fighter Fatalities Due to Heart Attacks and Other Sudden Cardiovascular Events , incorporates findings from 131 NIOSH investigations, examines the circumstances of these cardiac events, reviews the current fire service standards, provides case reports, and makes recommendations for preventing injury and death to fire fighters from preventable cardiovascular conditions. (cdc.gov)
  • As illustrated in the Alert, a firefighter's compromised physical fitness combined with work-related exposures and physical demands known to trigger sudden cardiac events can have deadly outcomes. (cdc.gov)
  • RS explains the Gastric Cardiac effect of stomach gas, acid reflux, and dysbiosis in irritating the Vagus nerve and how that triggers our irregular heart beats among causing other life bothersome side effects, like chest pain, dizziness and vertigo. (earthclinic.com)
  • This cardiac arrhythmia is usually caused by cardiovascular diseases such as high blood pressure, valvulopathy, heart failure, myocardial infarction. (zetolemos.com)
  • RMN allows physicians to safely and effectively treat patients with complex arrhythmias, reaching areas of the heart that cannot be treated using traditional, manual techniques. (missouribaptist.org)
  • In this HRS 2020 Science Release Two session, authors of a global survey of 1,100+ arrhythmia professionals, focusing on the arrhythmic manifestations as well as treatment strategies in hospitalized COVID-19 patients, reveal and discuss the results. (hrsonline.org)
  • Anyway, any kind of arrhythmia may be shown in cancer patients, both spontaneously or due to many provocative conditions, and because of direct toxic effects of cancer treatments. (cardiologiaambulatoriale.eu)
  • Patients with VA (n = 96) had a significantly higher cine risk score than those without VA. Multivariate analysis showed that the cine risk score was significantly associated with VA after adjusting for clinical characteristics, cardiac structure and function including CMR-derived scar extent. (elsevier.com)
  • A Review on Role of Yoga in the Management of Patients with Cardiac Arrhythmias. (bvsalud.org)
  • and in improving health -related QoL of arrhythmia patients . (bvsalud.org)
  • While we hoped clinical electrophysiologists would find our book useful, our intent was to educate the broader field of clinicians, for example, medical students, house staff, primary care physicians, cardiologists, and nurses, on the diagnosis and treatment of patients with cardiac arrhythmias. (mhmedical.com)
  • While other textbooks on cardiac arrhythmias are available, we felt there remained a void in providing our practical application of electrophysiological principles and electrocardiographic correlations to the broader community involved in caring for patients as well as the clinical electrophysiologist. (mhmedical.com)
  • Like the first edition, this book represents our personal approach to patients with cardiac arrhythmias. (mhmedical.com)
  • Specifically about cardiac arrhythmias, the review said "while caffeine is commonly considered a trigger for arrhythmias by physicians and patients alike there is minimal evidence to support this misconception. (medscape.com)
  • You will often work directly with cardiac patients in cardiac rehabilitation and fitness programs. (mhmedical.com)
  • Many of these patients may be taking antiarrhythmics to help control and prevent the onset of arrhythmias. (mhmedical.com)
  • Patients who experienced arrhythmia during HD had higher left ventricular mass and left ventricular mass index, lower post-dialysis K+ level, higher QTc and QTdc both before and after HD. (who.int)
  • A biventricular pacemaker placement (cardiac resynchronization therapy) is used to treat heart failure if the heart's two lower chambers aren't pumping together. (ohsu.edu)
  • Cocaine misuse has a major effect in young adult drug users with resulting loss of productivity and undue morbidity with cocaine related cardiac and cerebrovascular effects. (bmj.com)
  • Cocaine misuse and its related morbidity are important and have to be considered on the differential diagnosis of cardiovascular events in young adults because of its major effect and the resulting loss of productivity and undue morbidity with its related cardiac and cerebrovascular events. (bmj.com)
  • In conclusion, our model strongly supports the hypothesis that non-fatal arrhythmias can develop from post-ischemic alteration of the electrical connectivity in a relatively small area of the cardiac cell network, and suggests experimentally testable predictions on their possible treatments. (yale.edu)
  • At OHSU, we offer the widest array of arrhythmia treatments and services in Oregon. (ohsu.edu)
  • Surgery to cure arrhythmias is nearly extinct, and new antiarrhythmic drug development has been stagnant. (mhmedical.com)
  • Access to OHSU experts in sleep apnea, genetics, heart failure and cardiac surgery. (ohsu.edu)
  • The content of our second edition reflects these changes in our field, and we have deleted specific chapters on arrhythmias in acute myocardial infarction, pharmacologic therapy, operative therapy of arrhythmias, and noninvasive methods. (mhmedical.com)
  • Two dogs developed severe arrhythmias, and the third experienced fibrillation and cardiac arrest. (cdc.gov)
  • At this point cardiac arrest is inevitable and even death of the subject. (zetolemos.com)
  • What Is Cardiac Arrest? (medlineplus.gov)
  • These heart-related health conditions include coronary artery disease (CAD), arrhythmias, heart attack , and heart failure, among others. (health.com)
  • Missouri Baptist Medical Center is the first hospital in the Midwest to offer a new advanced robotic technology for the treatment of cardiac arrhythmias. (missouribaptist.org)
  • Drug treatment of cardiac arrhythmias / edited by Lawrence A. Gould. (who.int)
  • Arrhythmias are complex and you need a treatment tailored to your condition. (ohsu.edu)
  • As indicated throughout this chapter, antiarrhythmic drugs are associated with many side effects, including an increased chance of arrhythmias (pro-arrhythmic effect). (mhmedical.com)
  • Here we explore the possible processes leading to the occasional onset and termination of the (usually) non-fatal arrhythmias widely observed in the heart. (yale.edu)
  • Lidocaine-induced Brugada syndrome phenotype linked to a novel double mutation in the cardiac sodium channel. (bvsalud.org)
  • A mutation in the β 3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype. (bvsalud.org)
  • Compound heterozygous mutations P336L and I1660V in the human cardiac sodium channel associated with the Brugada syndrome. (bvsalud.org)
  • This catheter will then be advanced into the cardiac atria, specifically the pulmonary artery inlet. (zetolemos.com)
  • All of the deaths resulted from exposures to CFC-113 and subsequent cardiac arrhythmia or asphyxiation. (cdc.gov)
  • There has been a lot of public interest about a possible association of caffeine and arrhythmias," but an adverse effect from daily consumption of a moderate amount of coffee "is more legend and anecdote than fact based," commented Andrew D. Krahn, MD , an electrophysiologist, professor of medicine, and head of cardiology at the University of British Columbia and St. Paul's Hospital in Vancouver. (medscape.com)
  • This document explains Texas Cardiac Arrhythmia's financial policy. (tcaheart.com)
  • The former extracts cardiac structure and function features from cine CMR in a form of cine fingerprint in a fully unsupervised fashion, and the latter takes in the cine fingerprint and outputs disease outcomes as a cine risk score. (elsevier.com)
  • The National Institute for Occupational Safety and Health (NIOSH) requests assistance in reducing the risk of death from cardiac arrhythmia and asphyxiation in workers exposed to 1,1,2-trichloro-1,2,2-trifluoroethane (more commonly known as CFC-113 or by a trade name such as Freon 113 ® , Genetron 113 ® , Halocarbon 113 ® , or Refrigerant 113 ® ) or to other chlorofluorocarbons (CFCs). (cdc.gov)
  • Evidence suggests that yoga is safe and effective in improving various risk factors , quality of life (QoL), and psychological burden that is related to arrhythmia . (bvsalud.org)
  • The main message of our study is that it does not appear to be deleterious to continue with moderate amounts of habitual coffee intake regarding a risk of overall arrhythmia," said Dr. Kim, a cardiac electrophysiologist at the University of California, San Francisco. (medscape.com)
  • according to Paris American Hospital it is now possible to recover from cardiac arrhythmia thanks to a technological device that can eliminate the short circuits responsible for cardiac arrhythmias. (zetolemos.com)
  • Moderate, daily coffee consumption had no apparent adverse effect for triggering incident heart arrhythmias, and even linked with a small but statistically significant drop in arrhythmias in an analysis of prospectively collected data from nearly 300,000 U.K. residents. (medscape.com)
  • And when it changes for no apparent reason above, we are talking about cardiac arrhythmia. (zetolemos.com)
  • This was revealed in a letter to the Economic and Financial Crimes Commission, through his lawyer, Umeh Kalu, who declared that the Senator would not be available due to ill health as he had already arranged medical appointments overseas, noting that he is suffering from pneumonia and cardiac arrhythmia. (amazonaws.com)
  • She is a specialist in cardiac arrhythmias at the Amsterdam University Medical Center. (nltimes.nl)
  • Arrhythmia - I used to have lower heart rate but I found natural remedies from the guava leaves which this plants grows abundantly in our place. (earthclinic.com)